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ABSTRACT
CRYSTALLOGRAPHIC STUDIES OF TERPENE SYNTHASES: IMPORTANT ENZYMES THAT
SYNTHESIZE ANTIBIOTIC AND BIOFUEL PRECURSORS, AROMATIC ESSENTIAL OIL
COMPOUNDS AND ANTI-CANCER DERIVATIVES
Patrick Neil Blank
David W. Christianson

Terpene synthases synthesize highly complex natural products from linear
isoprenoid starting molecules. These products often have a wide variety of applications
spanning multiple industries. In order to unravel the production pathway of these
important compounds, macromolecular crystallography via structural biology
techniques can yield enzyme crystal structures. These crystal structures provide
snapshots of biocatalysis, often providing clues to support a proposed chemical
mechanism when combined with computational modeling. Through studying crystal
structures of geranylgeranylglyceryl phosphate synthase, epi-Isozizaene synthase,
sesquisabinene synthase, and cucumene synthase, this work aims to further the
mechanistic understanding of the respective natural products that have usefulness in
the medical, fuel, and flavor industries.
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Preface
The observable Universe is described by modern cosmological theory as a
portion of the greater Multiverse comprising a multidimensional spacetime fabric which
has been and continues to be fashioned, woven and perturbed by energy. All forms of
energy, including matter and radiation, emanated from an infinitely dense gravitational
singularity over 13 billion years ago. The early moments of inflation from the singularity
exhibited violently high temperatures, so high that quarks and electrons were the only
subatomic particles in existence. The Universe did begin to cool, however, allowing
quarks time enough to interact and form larger subatomic particles, namely protons and
neutrons. Eventually, through further cooling, protons, neutrons and electrons came
together to form the first atoms held together by the nuclear force and the
electromagnetic force. Primordial gas was comprised mostly of hydrogen, the simplest
element. This gas coalesced through gravitational fields to form stellar nebulas, yielding
stars and groups of stars called galaxies. The dense star cores fused hydrogen nuclei into
helium, emitting many sorts of radiation in the process. As larger stars formed with
more dense cores, more of the heavier elements populating the periodic table were
formed via extreme helium nucleogenesis reactions. Atoms began to associate and bond
to one another forming crystals and molecules respectively, in manners homogenously
and heterogeneously. Primordial materials, stemming from organized chemical
substances of varying complexity, began gravitational orbit around stars, colliding and
separating in cosmic dance. Planets formed, and particular combinations of distance
xv

from the pertinent star with protective atmospheres that deflect or absorb harmful
radiation produced conditions suitable for stable liquid phases to exist. On Earth, this
meant liquid water, which was and still is critical to support life, which is hypothesized
to have first began near hydrothermal vents at the bottom of the oceans. Single cellular
life and simple molecular organization eventually gave way to multicellular life with
complex molecular organization. Ever convoluted chemical reaction schemes yielded
greater and greater complexity, giving rise to life as we know it today. Some of Nature’s
most exquisitely complex reactions are catalyzed by enzymes called terpene synthases.
Crystallographic study of these enzymes allows a brief glimpse into the formation of
complicated organic natural products. Thus, each crystal structure obtained nudges
forward the greater frontier of human understanding of the Universe.

xvi

Chapter 1: Structural Biology of Template-Directed Catalysis by
Terpene Synthases
Adapted with permission from Christianson, D.W., Blank, P.N. (2019) Structural
Biology of Template-Directed Catalysis by Terpene Synthases. Comprehensive
Natural Products. Accepted. 2019 Copyright Elsevier.

1.0 Abstract
More than 80,000 terpenes have been identified to date, making this the largest
known family of natural products. The molecular basis of chemodiversity is rooted in
terpene synthases. This enzyme family consists of prenyltransferases that link linear
isoprenoids to isoprenoid or nonisoprenoid co-substrates, and terpene cyclases that
utilize linear isoprenoids as substrates for complex multi-step cyclization reactions. The
era of terpene synthase structural biology began with the first X-ray crystal structure
determinations of terpene synthases more than 20 years ago – a class I
prenyltransferase, two class I terpene cyclases, and one class II terpene cyclase. Since
then, myriad structural, enzymological, and protein engineering studies have shown
how these enzymes catalyze the most complex carbon-carbon bond-forming reactions
in nature. This Review focuses specifically on the past, present and future of class I
terpene synthases.

1

1.1 Introduction
Terpene synthases (also known as terpenoid synthases or isoprenoid synthases)
catalyze the most complex carbon-carbon bond-forming reactions in nature, in that
more than half of the substrate carbon atoms usually undergo changes in bonding
and/or hybridization during the course of a single enzyme-catalyzed reaction.1-7 This
mechanistic complexity underlies the vast chemodiversity of the terpenome,8-12 which
currently encompasses more than 80,000 different natural products as classified in the
Dictionary of Natural Products (http://dnp.chemnetbase.com).13,14 Remarkably, the
biosynthetic roots of chemodiversity reside in the simple 5-carbon precursors,
dimethylallyl diphosphate and isopentenyl diphosphate, which can undergo head-to-tail
coupling reactions catalyzed by prenyltransferases to form longer isoprenoid
diphosphates such as C10 geranyl diphosphate, C15 farnesyl diphosphate, and C20
geranylgeranyl diphosphate.15,16 The exponential amplification of chemodiversity arises
from reactions subsequently catalyzed by terpene cyclases, which utilize isoprenoid
diphosphates as substrates to generate a great variety of hydrocarbon skeletons
typically containing multiple fused rings and stereocenters (Figure 1.1).17,18 Together,
prenyltransferases and terpene cyclases comprise the greater family of terpene
synthases. The biosynthetic chemodiversity emanating from these enzymes arises from
their catalytic function as templates for isoprenoid coupling or cyclization reactions.
In this Review, we focus on the structural biology of metal ion-dependent class I
terpene synthases, with an emphasis on their function as templates for catalysis. First,
2

we review the structural biology of the archetypical prenyltransferase, farnesyl
diphosphate synthase, which catalyzes the coupling of dimethylallyl diphosphate with
two molecules of isopentenyl diphosphate to form a linear C15 product. Structural and
mechanistic studies of farnesyl diphosphate synthase then provide a foundation for
understanding structure-function relationships in UbiA, a membrane-embedded
prenyltransferase involved in ubiquinone A biosynthesis. Finally, structural and
enzymological studies of these prenyltransferases inform the study of terpene cyclases,
the principal generators of chemodiversity. Notably, class I prenyltransferases and
cyclases share a common evolutionary origin based on conservation of an identical
protein fold, regardless of whether these enzymes function in the cytosol, the
membrane, or other cellular compartments. Accordingly, their catalytic mechanisms
share many common features, including chemical strategies for managing and
manipulating highly reactive carbocation intermediates in the aqueous milieu of the cell.
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Figure 1.1: DMAPP and IPP Coupling Cyclization Cascade. Dimethylallyl diphosphate
(DMAPP) and isopentenyl diphosphate (IPP) are coupled in head-to-tail fashion by
prenyltransferases to yield linear isoprenoid diphosphates, which in turn are substrates
for terpene cyclases. The 5-carbon isoprenoid groups are color-coded to follow their
biosynthetic progress. Irregular (non-head-to-tail) coupling reactions are also possible.
Enzyme abbreviations: BPPase, bornyl diphosphate synthase; CPPase, chrysanthemyl
diphosphate synthase; FPPase, farnesyl diphosphate synthase; GGPPase, geranylgeranyl
diphosphate synthase; LSase, limonene synthase; SQSase, squalene synthase; TSase,
trichodiene synthase; TxSase, taxadiene synthase. From ref. 18, as inspired by
Sacchettini and Poulter in ref. 17. Reprinted with permission from AAAS.
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1.2 Prenyltransferases
The era of terpene synthase structural biology began 25 years ago with the crystal
structure determination of the avian prenyltransferase, farnesyl diphosphate synthase,
by Sacchettini and Poulter.19 This structure revealed a unique fold consisting of an αhelical bundle that, following its unexpected identification in bacterial and plant terpene
cyclase structures,20,21 was designated the “class I terpene synthase fold” (Figure 1.2).22
Two aspartate-rich motifs, DDXXD, were located at the mouth of the active site on
helices D and H (boldface indicates residues implicated in metal ion coordination). These
aspartate-rich motifs had been predicted to bind catalytic Mg2+ ions based on studies of
related prenyltranferases,23,24 and their metal binding function in farnesyl diphosphate
synthase was confirmed based on the binding of Sm3+ ions.19
The crystal structure of farnesyl diphosphate synthase from Escherichia coli reveals
that the two aspartate-rich motifs coordinate to 3 Mg2+ ions, which are also coordinated
by the thiolodiphosphate group of the unreactive substrate analogue dimethylallyl-Sthiolodiphosphate.25 In general, structural studies of farnesyl diphosphate synthase and
related prenyltransferases reveal that the substrate diphosphate group requires
coordination to 3 Mg2+ ions and hydrogen bonds with 3 basic residues (arginines and/or
lysines) to trigger diphosphate departure and formation of the allylic cation that initiates
the reaction sequence (Figure 1.3).26
Intriguingly, recent structural analysis suggests that the class I terpene synthase
fold evolved through gene duplication and fusion of an ancestral 4-helix bundle
5

protein.27 Omitting helices A and B as originally designated by Sacchettini and Poulter in
avian farnesyl diphosphate synthase (Figure 1.2),19 helices C, D, E, and F (designated 1,
2, 3, and 4, respectively, by Huang and colleagues27) comprise one 4-helix bundle that is
topologically equivalent to the second 4-helix bundle formed by helices G, H, I, and K
(designated 5, 6, 7, and 8, respectively, by Huang and colleagues27). The resulting
pseudo 2-fold symmetry axis is clearly evident in the structure of E. coli farnesyl
diphosphate synthase (Figure 1.4).25,27 Accordingly, the aspartate-rich motifs on helices
D (helix 2) and H (helix 6) are topologically equivalent and persisted through the
evolutionary divergence of the amino acid sequence following gene duplication and
fusion.

6

Figure 1.2: The crystal structure of avian farnesyl diphosphate synthase was the first to
reveal the α-fold of a class I terpene synthase. Aspartate-rich segments DDXXD (red) are
located at the mouth of the active site on helices D and H and coordinate to catalytic
metal ions. Positions of active site residues conserved in other terpene synthases are
greenish blue; positions of conserved basic residues are dark blue. Reproduced from ref.
19. Copyright 1994 American Chemical Society.
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Figure 1.3: Farnesyl diphosphate synthase reaction sequence. Farnesyl diphosphate
synthase is a processive enzyme that catalyzes the successive addition of isopentenyl
diphosphate (IPP) to a growing isoprenoid chain, starting with dimethylallyl diphosphate
(DMAPP). Once formed, geranyl diphosphate (GPP) shifts into the former DMAPP
binding site, thereby allowing a second molecule of IPP to enter the active site for
another round of catalysis to generate the C15 product farnesyl diphosphate (not
shown). The length of the final product is determined by the depth of the pocket that
fits the growing isoprenoid moiety. Accordingly, the active site pocket serves as a onedimensional template for catalysis.
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Figure 1.4: E. coli farnesyl diphosphate synthase folds and motifs. (A, B) The structure
of E. coli farnesyl diphosphate synthase exhibits pseudo two-fold symmetry through the
association of two 4-helix bundles. Helices 1–4 in the first bundle correspond to helices
5–8 in the second bundle (corresponding helices have identical colors). This symmetry
suggests that gene duplication and fusion of a primordial 4-helix bundle protein gave
rise to the class I terpene synthase fold. (C) Aspartate-rich metal-binding motifs are
conserved on topologically equivalent helices 2 and 6. The view shows the complex with
dimethylallyl-S-thiolodiphosphate, isopentenyl diphosphate, and 3 Mg2+ ions. The red
asterisk in the left panel indicates the bond corresponding to the scissile C-O bond of
dimethylallyl diphosphate. The red arrow indicates the new carbon-carbon bond to be
formed in the condensation reaction. Reprinted from ref. 27. Creative Commons
Attribution
4.0
International
Public
License,
http://creativecommons.org/licenses/by/4.0/legalcode.
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This structural relationship is further evident in the superposition of the 4-helix
bundles in the related prenyltransferase UbiA from Archaeoglobus fulgidus (Figure
1.5).27 Thus, the evolutionary origins of the class I terpene synthase fold are
unmistakably rooted in the fundamental structural motif of an ancient 4-helix bundle
protein. Notably, farnesyl diphosphate synthase is designated as a key ancestral protein
domain in the Last Universal Common Ancestor that preceded the divergence of the
kingdoms of life,28 and 4-helix bundle proteins are thought to represent one of the most
ancient protein architectures based on phylogenomic-proteomic analysis of protein
domain

structures

in

the

CATH

Protein

Structure

Classification

Database

(http://cathdb.info).29 Thus, the evolution of the class I terpene synthase fold is rooted
in the earliest events of the evolution of living systems.
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Figure 1.5: The structure of UbiA from A. fulgidus. AfUbiA exhibits the class I terpene
synthase fold and exhibits pseudo two-fold symmetry between 4-helix bundles defined
by transmembrane helices TM1–4 and TM5–8. Superposition of these 4-helix bundles
illustrates their structural homology (corresponding helices have identical colors,
consistent with the color scheme of farnesyl diphosphate synthase in Figure 1.4).
Reprinted from ref. 27. Creative Commons Attribution 4.0 International Public License,
http://creativecommons.org/licenses/by/4.0/legalcode.
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The conservation of fold and metal ion-binding sites in class I terpene synthases
leads to conservation of function with regard to the catalytic strategy for substrate
activation. The mechanism of farnesyl diphosphate synthase proceeds through an
ionization-condensation-elimination sequence (Figure 1.3),15,16 and high resolution
crystal structures illuminate structural features of catalysis.19,25 Upon the binding of
isopentenyl diphosphate and dimethylallyl diphosphate, the diphosphate group of
dimethylallyl diphosphate coordinates to 3 Mg2+ ions and forms hydrogen bonds with 3
basic residues.26 These interactions trigger protein conformational changes that
encapsulate the active site, protecting the substrates from bulk solvent. These
interactions also trigger the ionization of dimethylallyl diphosphate to form an allylic
carbocation, stabilized in part by charge-pairing with the inorganic pyrophosphate
anion.30-32 Carbon-carbon bond formation is achieved through alkylation of the C3-C4
double bond of isopentenyl diphosphate by the C1 atom of dimethylallyl diphosphate
(structural evidence25 for this step is shown in Figure 1.4C). A tertiary carbocation
intermediate results; stereospecific elimination of the pro-R proton at C2 yields geranyl
diphosphate.33,34
The co-product of the chain elongation reaction, inorganic pyrophosphate, likely
serves as the general base that mediates deprotonation of the final carbocation
intermediate,35-38 consistent with the binding orientations of the unreactive substrate
analogue dimethylallyl-S-thiolodiphosphate and isopentenyl diphosphate in complex
with E. coli farnesyl diphosphate synthase.25 The chain elongation product geranyl
12

diphosphate then shifts position to allow a second molecule of isopentenyl diphosphate
to bind. A second ionization-condensation-elimination sequence ultimately results in the
generation of farnesyl diphosphate.
Prenyltransferases such as farnesyl diphosphate synthase are processive
enzymes, in that they repeat the same mechanistic sequence using molecular building
blocks as guided by a template. In chain elongation enzymes, the template is defined
simply by the depth of the active site pocket that accommodates the growing isoprenoid
chain, as evident in crystal structures of coupling enzymes that generate short-,
medium-, and long-chain isoprenoid diphosphate products.39-45 Furthermore, the depth
of the pocket can be engineered through site-directed mutagenesis to generate
alternative products. For example, the active site pocket of avian farnesyl diphosphate
synthase can be converted into a “bottomless pit”, resulting in the production of C20-C70
chain elongation products.46 The longest such isoprenoid generated by an engineered
prenyltransferase is the C95 chain elongation product generated by an engineered
variant of octaprenyl diphosphate synthase (Figure 1.6).40
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Figure 1.6: Engineered Chain Elongation Product. Bulky amino acid side chains define
the base of the active site pocket that serves as the template directing product chain
lengths in the greater family of prenyltransferases. The base of the pocket can be
adjusted by mutagenesis to make increasingly longer isoprenoid products. Reprinted
with permission from ref. 40. Copyright 2004 American Chemical Society.
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1.3 Aromatic Prenyltransferases
The greater family of prenyltransferases includes enzymes that utilize isoprenoid
and aromatic co-substrates, such as enzymes that function in the biosynthesis of
ubiquinone (coenzyme Q) and menaquinone (vitamin K).47 Recent crystal structure
determinations of the prenyltransferase UbiA from two different species, Aeropyrum
pernix and Achaeoglobus fulgidus, reveal that these enzymes, too, adopt the class I
terpene synthase fold (Figure 1.7).27,48 Strikingly, however, UbiA is an integral
membrane protein. It is remarkable that the class I terpene synthase fold is readily
adaptable for function as a membrane-embedded protein as well as a soluble cytosolic
protein.
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Figure 1.7: UbiA fold and function. UbiA adopts the α-helical fold of a class I terpene
synthase, but it functions as a polytopic transmembrane protein. The active site cavity is
formed by the α-helical bundle (blue) and is capped by loops and shorter α-helices
(pink). Metal ion-binding aspartate-rich motifs are located at the mouth of the active
site on helices 2 and 6. The small aromatic substrate enters the active site from the
cytoplasm, and the long isoprenoid substrate enters the active site through a lateral
portal. From ref. 48. Reprinted with permission from AAAS.
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UbiA catalyzes an electrophilic aromatic substitution reaction as it couples a
polyprenyl diphosphate to the ortho position of para-hydroxybenzoic acid.49,50 The
activation chemistry for the prenyl diphosphate substrate is identical to that previously
described for farnesyl diphosphate synthase (Figure 1.3), in that metal coordination and
hydrogen bond interactions trigger substrate ionization to yield a reactive allylic
carbocation. Like farnesyl diphosphate synthase, UbiA contains two aspartate-rich metal
ion-binding motifs at the opening of the active site, NDXXDXXXD and DXXXD (boldface
indicates residues implicated in metal ion coordination; note that the amino acid
sequences of these motifs have diverged from the characteristic DDXXD sequence found
in avian farnesyl diphosphate synthase).24,51 Metal-binding motifs are located in short
helices contained in loop segments connecting helices TM2 and TM3 (designated HL23),
and TM6 and TM7 (designated HL67), respectively, and comprise the cap domain that
encapsulates the active site prior to catalysis (Figure 1.7).
The 2.4 Å-resolution crystal structure of UbiA from Archaeoglobus fulgidus
complexed with geranyl diphosphate and two Mg2+ ions serves as a foundation for the
proposed reaction mechanism (Figure 1.8).27 Briefly, the substrate diphosphate group
likely forms 6-membered ring chelates with each Mg2+ ion; these metal ion coordination
interactions, plus hydrogen bond interactions with R22 and K146, provide the
electrophilic impetus to trigger substrate ionization and formation of the allylic
carbocation intermediate, which may be stabilized through cation-π interactions with
Y139 and charge-charge interactions with the inorganic pyrophosphate co-product.
17

Alkylation of the aromatic ring yields an arenium ion intermediate, which then
undergoes inorganic pyrophosphate-mediated proton elimination. The polyprenylquinol
product is then released back into the membrane. For vitamin K biosynthesis, oxidation
of the quinol moiety yields methaquinone; for coenzyme Q biosynthesis, subsequent
hydroxylation, O-methylation, and oxidation of the quinol moiety yields ubiquinone.
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Figure 1.8: Proposed mechanism of UbiA based on structural studies of the enzyme
from Archaeoglobus fulgidus. Since this enzyme functions in menaquinone biosynthesis,
the aromatic co-substrate is 2-methyl-1,4-dihydroxynaphthoquinol. Residue numbers in
parentheses correspond to the human ortholog UBIAD1. Reprinted from ref. 27.
Creative
Commons
Attribution
4.0
International
Public
License,
http://creativecommons.org/licenses/by/4.0/legalcode.
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1.4 Terpene Cyclases
Terpene synthases catalyze intermolecular condensation reactions, as
exemplified by farnesyl diphosphate synthase and UbiA, but they also catalyze
intramolecular condensation reactions, i.e., cyclization reactions. The first crystal
structures of class I terpene cyclases were those of pentalenene synthase from
Streptomyces exfoliatus and 5-epi-aristolochene synthase from Nicotiana tabacum
(Figure 1.9).20,21 Surprisingly, these bacterial and plant sesquiterpene cyclases revealed
conservation of the class I terpene synthase fold despite insignificant amino acid
sequence identity with avian farnesyl diphosphate synthase, indicating divergent
evolution from a common ancestor early in the evolution of terpene biosynthesis.
Metal ion-binding function is sustained in pentalenene synthase and 5-epiaristolochene synthase, as indicated by conservation of the characteristic aspartate-rich
segment DDXXD on helix D. However, the second aspartate-rich segment found on helix
H

in

prenyltransferases

has

diverged

(N,D)D(L,I,V)X(S,T)XXXE (boldface indicates

almost
residues

universally
implicated

in
in

cyclases

to

metal

ion

coordination).52,53 This sequence is referred to as the “NSE/DTE motif”, or simply the
“NSE motif”, and its chemical function is the chelation of the Mg2+B ion in the trinuclear
metal cluster required for catalysis.53 The topological equivalence of these motifs on
helices D and H, respectively, suggests that the NSE motif diverged from the aspartaterich motif after gene duplication and fusion of the 4-helix bundle ancestor of the class I
20

terpene synthase fold. A terpene cyclase almost always contains one aspartate-rich
motif and one NSE motif, but there is an exception to this general rule: the plant
sesquiterpene cyclase δ-cadinene synthase contains two aspartate-rich motifs and no
NSE motif, yet it is clearly a terpene cyclase – not a prenyltransferase – that functions in
gossypol biosynthesis.54

21

Figure 1.9: Class I Cyclase Architecture. Class I terpene cyclases are found with α, αβ, or
αβγ domain architecture (α, β, and γ domains are blue, green, and yellow, respectively;
the N-terminal helix of the β domain is magenta). The α domain represents the class I
terpene synthase fold; aspartate-rich and NSE metal-binding motifs are indicated (red
and orange, respectively). The βγ domain assembly observed for squalene-hopene
cyclase represents the class II terpene synthase fold, in which an alternative mechanism
is used for substrate activation involving general acid catalysis with an aspartic acid
motif (brown). Reprinted with permission from ref. 62. Copyright 2011 Nature
Publishing Group.
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As evident in Figure 1.9, class I terpene cyclases adopt varied domain
architectures, but the domain common to all contains the active site and comprises the
fundamental class I terpene synthase fold. Based on bioinformatics analysis and
structural classification, this domain is designated the “α” domain.55,56 Individual α
domain cyclases are most often found in bacterial and fungal terpene cyclases, such as
the sesquiterpene cyclases pentalenene synthase (Figure 1.9)20 and trichodiene
synthase,53 or the diterpene cyclase CotB2.57 In contrast, plant cyclases such as the
sesquiterpene cyclase 5-epi-aristolochene synthase (Figure 1.9)21 and the monoterpene
cyclases bornyl diphosphate synthase58 and limonene synthase59-61 contain a smaller Nterminal domain, designated the “β” domain,55,56 preceding the catalytic α domain (note
that the Greek letters do not refer to secondary structure). Although the β domain in αβ
cyclases does not directly participate in the chemical steps of catalysis, the N-terminal
polypeptide segment of the β domain provides a secondary “cap” for the active site and
stabilizes the closed active site conformation. Some plant cyclases, such as the
diterpene cyclases taxadiene synthase (Figure 1.9)62 and abietadiene synthase,63 as well
as the sesquiterpene cyclase bisabolene synthase,64 contain a third domain, designated
the “γ” domain,55,56 inserted between the first and second helices of the β domain to
yield αβγ domain architecture. Thus, class I terpene cyclases adopt α, αβ, or αβγ domain
architecture. Parenthetically, class II terpene cyclases operate through an alternative
catalytic mechanism and adopt βγ domain architecture, such as the triterpene cyclase
squalene-hopene cyclase (Figure 1.9),65 or αβγ domain architecture, as observed in the
23

diterpene cyclase ent-copalyl diphosphate synthase.66,67 Aspects of the evolution of
terpene cyclase domain architecture and function have been recently reviewed.56,68
The crystal structures of the α-domain cyclase pentalenene synthase and the αβdomain cyclase 5-epi-aristolochene synthase provided the first opportunities for
understanding structure-mechanism relationships in terpene cyclase active sites.20,21
Prior studies of terpene cyclization cascades pointed to a critical role for the enzyme
catalyst as a template to hold the flexible polyisoprenoid substrate in the proper
conformation for cyclization chemistry.1-3 With regard to substrate flexibility, consider
that there are three free C–C bond rotations per 5-carbon isoprenoid group in a
polyisoprenoid chain. In comparison, there are two free bond rotations per amino acid
in a polypeptide chain (Cα–N and Cα–C). In essence, a polyisoprenoid chain is
approximately 50% more flexible than a polypeptide chain of comparable size.
Consequently, there will be a substantial entropic cost to hold a polyisoprenoid chain in
a specific conformation for catalysis. The active site contour of a terpene cyclase, i.e.,
the template for catalysis, thus serves as an entropy sink to facilitate the chemistry of
catalysis.
For example, consider that hundreds of different hydrocarbon skeletons derive
from farnesyl diphosphate, the universal sesquiterpene precursor. Even so, initial
cyclization of farnesyl diphosphate through C1-C11 or C1-C10 bond formation is
generally achieved from only four cyclization-competent conformations or their
enantiomorphs (Figure 1.10) (alternative cyclization pathways can occur through C1-C6
24

or C1-C7 bond formation; C1-C6 bond formation is discussed in section 1.4.3).1 Thus, the
three-dimensional contour of the terpene cyclase active site – the template for catalysis
– selects the single substrate conformation required for a productive cyclization reaction
and largely prevents alternative substrate conformations that would lead to off-pathway
reactions.
In the remainder of this Review, we describe examples of C1-C11, C1-C10, C1-C6,
and tandem C1-C14/C10-C15 cyclization reactions in which structural biology
approaches, mainly X-ray crystallography but also including small-angle X-ray scattering
(SAXS), have illuminated molecular details of catalysis, especially with regard to the
critical function of the terpene cyclase active site as a template for catalysis.

1.4.1 C1-C11 Cyclization Reactions
1.4.1.1 Pentalenene Synthase
The C1-C11 bond forming reaction is anti-Markovnikov, in that it results in the
formation of a secondary carbocation that is not as stable as the tertiary carbocation
that would result from C1-C10 bond formation. Such a reaction is catalyzed by the
sesquiterpene cyclase pentalenene synthase to generate the angular triquinane
hydrocarbon precursor of the antibiotic pentalenolactone.69,70 Enzymological studies
using isotopically labeled substrates allowed Cane and colleagues to propose a detailed
mechanism for the cyclization cascade.71-75 Subsequent quantum chemical calculations
by Gutta and Tantillo suggested an alternative pathway for pentalenene formation, as
25

summarized in Figure 1.11.76 Support for this alternative pathway was acquired from
kinetic isotope effect studies using an isotopically labeled substrate.77 This result
represented a landmark in the use of computational chemistry approaches to delineate
complex enzyme mechanisms.
Pentalenene synthase was the first bacterial terpene cyclase to yield a high
resolution crystal structure,20 and this structure provided the first view of the threedimensional contour that serves as a template for the cyclization cascade. The active
site was found to be predominantly hydrophobic in nature, composed of aliphatic and
aromatic residues, and thus complementary to the chemical nature of the lipophilic
substrate. It was proposed that aromatic residues could stabilize high energy
carbocation intermediates through cation-π interactions, such that the partial negative
charge of ring π electrons would provide electrostatic stabilization of positively charged
carbocations and their flanking transition states in the cyclization cascade.20 Both
aromatic and aliphatic residues contributed to the three-dimensional contour of the
active site.
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Figure 1.10: Conformations of farnesyl diphosphate that enable C1-C11 or C1-C10 bond
formation upon ionization of the diphosphate group (OPP).1 Mirror-image
conformations are also possible. As a template for catalysis, the active site contour of a
sesquiterpene cyclase generally excludes all but one of these conformations upon
substrate binding.
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Figure 1.11: Catalytic mechanism of pentalenene synthase consistent with
enzymological studies and quantum chemical calculations.76,77 Abbreviations: OPP =
diphosphate; PPO–, PPOH = inorganic pyrophosphate. 1,2-hydride or -alkyl migrations
are indicated by magenta arrows.
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Molecular modeling studies with the pentalenene synthase active site show that
the active site contour is complementary in shape to the specific conformation of
farnesyl diphosphate required for initial C1-C11 cyclization (Figure 1.12A).20
Interestingly, the side chain of F77 provides a steric protuberance that confers a degree
of curvature to the active site contour that is complementary to the three-dimensional
contour of pentalenene itself (Figure 1.12B). Thus, the crystal structure of pentalenene
synthase provided the first indication that the active site contour of a terpene cyclase is
very product-like in shape; the template not only selects the proper starting
conformation of the flexible substrate, but the template also chaperones the
conformations of carbocation intermediates in the reaction pathway toward a single
cyclization product. Some terpene synthases catalyze cyclization reactions with high
fidelity, i.e., only a single cyclization product is generated as directed by a strict
template; other cyclases are more promiscuous and generate multiple products,
indicating a more permissive template. In this regard, γ-humulene synthase stands out
as an extreme example, as it generates an array of 52 sesquiterpene olefins.78
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Figure 1.12: Pentalenene synthase modeling. (A) Model of substrate farnesyl
diphosphate (C = green, diphosphate = red) bound in the active site of pentalenene
synthase, showing the conformation required for the trajectory of C1-C11 bond
formation (white dashed line) in the first step of catalysis. (B) Model of pentalenene
(green) bound in the active site of pentalenene synthase, showing that the threedimensional contour of the active site cavity is complementary in shape to the product.
This structural complementarity highlights the role of the active site contour as a
template for catalysis. Reprinted with permission from Ref. 20. Copyright 1997
American Association for the Advancement of Science.
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1.4.1.2 Cucumene Synthase
Cucumene synthase is another sesquiterpene cyclase that catalyzes an antiMarkovnikov C1-C11 cyclization reaction,79 and the recent crystal structure
determination of this enzyme allows for inspection of its three-dimensional active site
contour.80 Notably, the linear triquinane product of this enzyme was predicted using a
computational approach that incorporated primary structure analysis and the
construction of a homology model to evaluate the active site template.79 This represents
the first successful step toward predicting the multi-ring product of a terpene cyclase
based solely on analysis of the amino acid sequence and predicted enzyme structure.
The catalytic mechanism of cucumene synthase has been recently summarized
(Figure 1.13).80 As with the mechanism of pentalenene synthase, coordination of the
substrate diphosphate group to the trinuclear metal cluster triggers ionization and C1C11 cyclization to yield the humulyl cation, which after a 1,2-hydride transfer leads to
formation of the protoilludyl cation. The cyclization pathway of cucumene synthase
then diverges from that of pentalenene synthase. Tandem 1,2-alkyl migrations lead to
formation of the linear triquinane skeleton of the cucumyl cation; subsequent 1,3hydride transfer and proton elimination, possibly occurring in concert, yields cucumene.
The active site contour of cucumene synthase is complementary in shape to the
linear triquinane product (Figure 1.14), consistent with the function of a cyclization
template. Interestingly, there is a curvature to the active site contour that matches the
curvature of the specific product stereoisomer generated by cucumene synthase,
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(5S,7S,10R,11S)-cucumene. The active site template enforces the proper conformation
of substrate farnesyl diphosphate – the same conformation as enforced in the active site
of pentalenene synthase, conformation A as shown in Figure 1.10 – and chaperones the
reaction sequence through the same protoilludyl carbocation encountered in the
pentalenene synthase reaction, but diverging thereafter toward cucumene formation.
As with pentalenene synthase, the active site template of cucumene synthase is of
paramount importance as it directs the initial anti-Markovnikov C1-C11 cyclization
reaction. Also important in directing this chemistry are active site aromatic residues,
which simultaneously serve as part of the template and also stabilize carbocation
intermediates through cation-π interactions.
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Figure 1.13: Cucumene synthase mechanism. 1,2- or 1,3-hydride transfers are
represented by red arrows, 1,2-alkyl migrations are represented by green arrows.
Abbreviations: PPO = diphosphate; –OPP, PPOH = inorganic pyrophosphate. Reprinted
from ref. 80.
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Figure 1.14: Cucumene Modeling. Two approximately orthogonal stereoviews showing
a model of cucumene (C = salmon, H = white) bound in the active site of T181N
cucumene synthase. Reprinted from ref. 80. [See Chapter 6].

33

1.4.1.3 Fusicoccadiene Synthase
The universal substrate of diterpene cyclases, C20 geranylgeranyl diphosphate
(Figure 1.1), can also undergo an anti-Markovnikov C1-C11 cyclization reaction. Just as
with a sesquiterpene cyclase, a diterpene cyclase must serve as a template to hold the
flexible substrate in the proper conformation for carbon-carbon bond formation once
the cyclization cascade commences. Due to the additional 5-carbon isoprenoid unit of
geranylgeranyl diphosphate in comparison with farnesyl diphosphate, the active site of
a diterpene cyclase must be larger to accommodate the larger substrate. The bigger the
isoprenoid substrate, the greater the entropic cost to hold it fixed for catalysis – thus,
the template function of a diterpene cyclase is especially critical for catalysis.
The diterpene cyclase fusicoccadiene synthase catalyzes the first committed
step in the biosynthesis of the toxin fusicoccin A by the fungus Phomopsis amygdali.81-84
Fusicoccadiene synthase is a bifunctional enzyme with αα domain architecture, in which
the C-terminal α domain is the prenyltransferase that generates geranylgeranyl
diphosphate, and the N-terminal α-domain is the diterpene cyclase that utilizes
geranylgeranyl diphosphate to form fusicoccadiene (Figure 1.15).84 The amino acid
sequence identity between the N-terminal and C-terminal domains is 19%. Analytical
ultracentrifugation studies indicate that fusicoccadiene synthase is a hexamer, so the
overall domain and oligomeric structure is described as (αα)6.85 Based on substrate
competition experiments, most of the geranylgeranyl diphosphate generated by the Cterminal prenyltransferase domain remains on the enzyme for cyclization in the N34

terminal cyclase domain, suggesting the possibility of proximity channeling or cluster
channeling within the hexameric assembly.86
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Figure 1.15: Fusicoccin A Production. The prenyltransferase domain of fusicoccadiene
synthase couples dimethylallyl diphosphate (DMAPP) with three successive molecules of
isopentenyl diphosphate (IPP) (blue box). Geranylgeranyl diphosphate (GGPP) is then
utilized for fusicoccadiene formation in the cyclase domain (red box). Additional
biosynthetic decoration (green) leads to fusicoccin A. Reprinted with permission from
ref. 85. Copyright 2016 American Chemical Society.
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X-ray crystal structures of the individual prenyltransferase domain (Figure 1.16A)
and cyclase domain (Figure 1.16B) of fusicoccadiene synthase reveal the characteristic
fold of a class I terpene synthase.85 The structure of each was determined in complex
with three metal ions and a bisphosphonate inhibitor that partially mimics the substrate
diphosphate group. Metal coordination and hydrogen bond interactions of the
bisphosphonate moieties crosslink and cap the mouth of each active site. Notably, the
prenyltransferase domain exhibits hexameric quaternary structure, as first observed for
human geranylgeranyl diphosphate synthase.44 This presumably reflects the hexameric
quaternary structure observed for full-length fusicoccadiene synthase.85
The three-dimensional active site contour of the cyclase domain is
complementary in shape to fusicoccadiene, which shows that the template for catalysis
is quite product-like (Figure 1.16C). Even so, fusicoccadiene is somewhat promiscuous as
a cyclase since it also generates (+)-δ-araneosene as well as an uncharacterized
diterpene as minor products (Figure 1.17). An unusual transannular proton transfer
figures prominently in the cyclization mechanism as outlined by Toyomasu and
colleagues,87 which proceeds through tandem C1-C11 and C10-C14 carbon-carbon bond
forming reactions.
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Figure 1.16: Fusicoccadiene synthase. (A) Prenyltransferase domain in the closed active
site conformation. Aspartate-rich motifs on helices D and H (red) coordinate to 3 Co2+
ions (magenta spheres) along with a bisphosphonate inhibitor (stick figure). (B) Cyclase
domain in the closed active site conformation. Aspartate-rich and NSE motifs (red and
orange, respectively) coordinate to 3 Mg2+ ions (magenta spheres) along with a
bisphosphonate inhibitor (stick figure). (C) Product fusicoccadiene (blue stick figure)
docked into the active site contour of the cyclase domain (gray meshwork). The active
site contour is very product-like in shape, thereby reflecting its role as a template for
catalysis. Reprinted with permission from ref. 85. Copyright 2016 American Chemical
Society.
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Figure 1.17: Catalytic mechanism of fusicoccadiene synthase, which yields
fusicoccadiene as a major product and (+)-δ-araneosene as a minor product. A third
uncharacterized diterpene is also generated (not shown). Reprinted with permission
from ref. 85. Copyright 2016 American Chemical Society.
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Although full-length fusicoccadiene synthase is not amenable to crystallization,
the low resolution three-dimensional structure of the full-length enzyme has been
studied used small-angle X-ray scattering (SAXS).85 The crystal structure of the
hexameric prenyltransferase domain of fusicoccadiene synthase fit into the ab initio
molecular envelope calculated from SAXS data required only minor adjustments, which
then allowed for the placement of the three crystallographic dimers of the cyclization
domain. With this domain placement, the C-terminus of the N-terminal cyclization
domain and the N-terminus of the C-terminal prenyltransferase domain are separated
by ~25 Å, a span that could be easily linked by the 60-residue interdomain segment
(Figure 1.18). This model of the full-length enzyme provides a plausible starting point for
studying substrate channeling within the bifunctional assembly.86
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Figure 1.18: Fusicoccadiene synthase hexameric structure and envelope. (a)
Fusicoccadiene synthase hexamer modeled into the low-resolution ab initio molecular
envelope calculated from small-angle X-ray scattering data. Prenyltransferase domains
are green and cyclase domains are blue. (b) Experimental data fit with the theoretical
scattering profile calculated from the hexamer model (teal solid line) indicates an
excellent fit of the model in the molecular envelope. Reprinted with permission from
ref. 85. Copyright 2016 American Chemical Society.
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1.4.2 C1-C10 Cyclization Reactions
The C1-C10 bond forming reaction occurs in Markovnikov fashion, in that the
more stable intermediate, a tertiary carbocation, is formed. Such a reaction is catalyzed
by 5-epi-aristolochene synthase from N. tabacum in the biosynthesis of capsidiol, a
phytoalexin generated in response to fungal or viral infection,88-90 and aristolochene
synthases from Penicillium roqueforti and Aspergillus terreus in the biosynthesis of
fungal toxins such as gigantenone and bipolaroxin.91,92 These enzymes catalyze the
cyclization of farnesyl diphosphate to form alternative diastereomers of a bicyclic
sesquiterpene, so their active site templates have evolved to direct this cyclization
chemistry with stereochemical precision.
1.4.2.1 5-epi-Aristolochene Synthase
5-epi-Aristolochene synthase was the first plant terpene cyclase to yield a high
resolution crystal structure (Figure 1.9), thereby providing an unprecedented view of a
catalytic template with αβ domain architecture for C1-C10 cyclization reactions in
biology.21 The active site contour is mainly hydrophobic in nature, composed of aliphatic
and aromatic residues. Here, too, aromatic residues likely stabilize high energy
carbocation intermediates through cation-π interactions. Crystal structures of
complexes with farnesyl diphosphate and analogues show how the enzyme functions as
a template to hold the flexible isoprenoid substrate in a single, productive conformation
for catalysis.21,93
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Numerous enzymological studies94-97 interpreted in view of the enzyme structure
indicate that substrate ionization, C1-C10 cyclization, and proton elimination yields
intermediate germacrene A, which then undergoes transannular carbon-carbon bond
formation to yield the eudesmane carbocation. Subsequent 1,2-hydride transfer, 1,2methyl migration, and proton elimination yield the bicyclic product, 5-epi-aristolochene
(Figure 1.19).
Importantly, 5-epi-aristolochene synthase served as a paradigm for engineering
terpene cyclization templates even before its crystal structure was determined. Domain
swapping experiments with premnaspirodiene synthase (also known as vetispiradiene
synthase), which also catalyzes a reaction proceeding through a eudesmane carbocation
intermediate, indicate that the active site template chaperones the conformation of this
intermediate along one cyclization pathway or the other.98,99 Crystal structures of
chimeric enzymes yield important structure-function relationships that clarify our
understanding of the reaction mechanisms of both cyclases.93
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Figure 1.19: Reaction manifold for farnesyl diphosphate cyclization by 5-epiaristolochene synthase, accounting for the generation of major and minor products by
wild-type and variant cyclases. As classified by Noel and colleagues,93 class A products
(gray) result from proton elimination from early carbocation intermediates, class B
products (yellow) directly derive from the eudesmane carbocation, class C products (C1,
blue; C2, red; C3, green) derive from the eudesmane carbocation through three
different alkyl migrations, and class D products (purple) derive from the (cis,trans)farnesyl carbocation. Reprinted with permission from ref. 93. Copyright 2016 Japan
Antibiotics Research Association.
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As a template for catalysis, wild-type 5-epi-aristolochene synthase is moderately
promiscuous, since it generates only 78.9% 5-epi-aristolochene; 24 minor products are
also generated.100 This catalytic versatility can be amplified through mutagenesis: in an
exhaustive study of 418 different site-specific variants, Noel and colleagues
demonstrate that amino acid substitutions in the active site contour influence
cyclization fidelity and promiscuity in a quantifiable and predictable manner.101
1.4.2.2 Aristolochene Synthase
In comparison with the plant-derived 5-epi-aristolochene synthase with αβ
domain architecture, fungal aristolochene synthases from P. roqueforti and A. terreus
adopt single α domain architectures.102,103 Structures of the latter enzyme complexed
with a variety of substrate analogues and carbocation intermediate analogues have also
been determined.103-105 Accordingly, A. terreus aristolochene synthase provides an
excellent framework for understanding how C1-C10 isoprenoid cyclization reactions are
catalyzed.
Numerous enzymological studies completed prior to the crystal structure
determinations suggest the catalytic mechanism outlined in Figure 1.20.91,106-110 Briefly,
initial C1-C10 bond formation yields (S)-(–)-germacrene A, which then undergoes
transannular carbon-carbon bond formation to yield the (+)-eudesmane carbocation. A
1,2-hydride transfer followed by (or in concert with) a 1,2 methyl migration yields a
tertiary carbocation intermediate at C7; stereospecific deprotonation at C8 yields (+)aristolochene.
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Figure 1.20: Mechanism of FPP cyclization by aristolochene synthase (PPO =
diphosphate; PPO–, PPOH = inorganic pyrophosphate) (Proposed). Also shown are
substrate analogue farnesyl-S-thiolodiphosphate (FSPP) and aza analogues of
carbocation intermediates 1–5. Crystal structures of aristolochene synthase complexed
with these analogues allow for a detailed analysis of the template function of the active
site contour. Reprinted with permission from ref. 105. Copyright 2013 American
Chemical Society.

High-resolution crystal structures of unliganded aristolochene synthase and its
complexes reveal significant changes between open and closed active site
conformations (Figure 1.21). These structural changes involve segmental shifts of helices
as well as ordering of loops surrounding the active site. Active site closure fully
encapsulates the template for catalysis, thereby providing an environment in which
highly reactive carbocations are shielded from bulk solvent. The closed active site
conformation is stabilized by 3 metal ions and the substrate diphosphate group, which
crosslink and cap the mouth of the active site.
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Figure 1.21: Aristolochene synthase open to closed conformation. Conformational
transition of aristolochene synthase from the open, unliganded conformation to the
closed, liganded conformation. Aspartate-rich and NSE metal ion-binding motifs are red
and orange, respectively. This conformational change is triggered by the binding of 3
Mg2+ ions and the diphosphate group of the unreactive substrate analogue farnesyl-Sthiolodiphosphate (FSPP) as well as other analogues of the substrate and carbocation
intermediates.103-105
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The crystal structure of aristolochene synthase complexed with 3 Mg2+ ions and
inorganic pyrophosphate reveals an empty active site with a product-like contour into
which a molecule of aristolochene can be modeled (Figure 1.22).103 In this model, the C6
and C8 atoms are positioned to interact with inorganic pyrophosphate, the co-product
of the cyclization reaction. Accordingly, inorganic pyrophosphate is the presumed
general acid-general base that mediates the stereospecific proton transfers indicated in
Figure 1.20.103
Aromatic residues in the aristolochene synthase active site are well-positioned to
stabilize carbocation intermediates and their flanking transition states through cation-π
interactions, and these interactions stabilize the binding of aza analogues of carbocation
intermediates (Figure 1.20).105 Although some aza analogues bind with orientations that
are considered non-productive with regard to conformations required during catalysis,
the most product-like of all the analogues, inhibitor 4 (Figure 1.20), binds with an
orientation similar to that expected for the corresponding carbocation intermediate
(Figure 1.23). This binding conformation corresponds to that previously modeled for
product binding to the aristolochene synthase–Mg2+3–inorganic pyrophosphate complex
(Figure 1.22), thereby confirming that the active site template is product-like in shape.
It is notable that a trapped water molecule comprises part of the active site
template in aristolochene synthase (Figure 1.23). At first glance, this seems at odds with
the notion that highly reactive carbocation intermediates must be protected from
premature quenching by solvent through full active site closure. However, the water
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molecule trapped in the active site of aristolochene synthase is tethered by hydrogen
bonds with three protein residues, and it is positioned in such a way that it cannot react
with the empty 2p orbitals of carbocation intermediates.105,111 Thus, as long as a water
molecule trapped in the active site of a terpene cyclase is rendered functionally inert,
fixed in a location where it cannot react with a carbocation, such a water molecule can
serve as an integral component of the cyclization template.
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Figure 1.22: Sesquiterpene cyclization template and modeling: the active site contour
of aristolochene synthase in the open (top) and closed (bottom) conformations (blue
meshwork; for clarity, no enzyme atoms are shown). The conformational transition to
the closed conformation is triggered by the binding of 3 Mg2+ ions and co-product
inorganic pyrophosphate. The active site contour is product-like in shape, into which
product aristolochene is modeled (purple stick figure). In this binding orientation, the C6
and C8 atoms of aristolochene are close to the O3 atom of inorganic pyrophosphate,
suggesting that inorganic pyrophosphate serves as the general base-general acid
catalyst as outlined in Figure 1.20. Reprinted with permission from ref. 103. Copyright
2007 American Chemical Society.
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Figure 1.23: Aristolochene Synthase Active Site. Stereoview showing a simulated
annealing omit map of compound 4 (Figure 1.20) bound in the active site of
aristolochene synthase. Metal coordination and hydrogen bond interactions are shown
as red and black dashed lines, respectively. The orientation of this product-like
carbocation analogue corresponds to that modeled for the product in Figure 1.22 (the
view here is rotated approximately 180˚ relative to that in Figure 1.22). Water molecule
"w" (small red sphere) comprises part of the cyclization template and remains trapped
in all enzyme-carbocation analogue complexes. Reprinted with permission from ref.
105. Copyright 2013 American Chemical Society.

51

1.4.3 C1-C6 Cyclization Reactions
1.4.3.1 epi-Isozizaene Synthase
As exemplified by the epi-isozizaene synthase mechanism, initial C1-C6
cyclization of farnesyl diphosphate requires an ionization-recombination-reionization
sequence to achieve trans-cis isomerization of the C2-C3 double bond, which enables
formation of the 6-membered ring bisabolyl carbocation intermediate (Figure
1.24).112,113 A 1,2-hydride shift then yields the homobisabolyl cation, which undergoes
further cyclization to yield epi-isozizaene. This reaction is the first committed step in the
biosynthesis of the antibiotic albaflavenone by Streptomyces coelicolor A3(2).114,115
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Figure 1.24: FPP Cyclization by EIZS. Mechanism of farnesyl diphosphate (FPP, 2)
cyclization catalyzed by epi-isozizaene synthase, proceeding through bisabolyl
carbocation intermediate 5 enroute to the formation of epi-isozizaene 3. Mechanistic
details were determined using isotopically labeled substrates as indicated. Reprinted
with permission from ref. 113. Copyright 2009 American Chemical Society.
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The crystal structure of epi-isozizaene synthase reveals the single α domain
enzyme structure characteristic of a bacterial cyclase (Figure 1.25A). Structural
comparison of the unliganded enzyme with that of its complex with 3 Mg2+ ions,
inorganic pyrophosphate, and the benzyltriethylammonium cation reveals structural
changes that accompany the conformational transition from the open to the closed
active site conformations.116 In the closed conformation, inorganic pyrophosphate
coordinates to 3 Mg2+ ions and accepts hydrogen bonds from R194, K247, R338, and
Y339 (Figure 1.25B). These interactions would also serve to activate the substrate
diphosphate group to generate the initial farnesyl cation-inorganic pyrophosphate ion
pair. Notably, the benzyltriethylammonium cation is fully encapsulated in the active site,
making cation-π interactions with the aromatic side chains of F95, F96, and F198 (Figure
1.25C). Such interactions could also stabilize actual carbocation intermediates and their
flanking transition states in catalysis.
The active site contour of epi-isozizaene synthase is a product-like template that
directs the farnesyl diphosphate cyclization cascade, but it is somewhat promiscuous in
this function since the wild-type enzyme generates 79% epi-isozizaene when studied at
the standard assay temperature of 30˚ C; a mixture of alternative sesquiterpenes
comprises the remaining 21% of products generated.116 Analysis of the active site
contour reveals a three-dimensional shape that is not unambiguously fit with product
epi-isozizaene (Figure 1.26). Interestingly, however, cyclization fidelity improves with
decreasing temperature: epi-isozizaene synthase is a much higher fidelity cyclase at 20˚
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C, generating 93% epi-isozizaene; at 4˚ C, it is nearly perfect as a high-fidelity cyclase and
generates 99% epi-isozizaene.117 The activation barriers leading to alternative cyclization
products are sufficiently high that off-pathway reactions are minimal at lower
temperatures.
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Figure 1.25: Stereoviews of epi-isozizaene synthase. (A) Superposition of unliganded
(magenta) and liganded (green; ligands omitted for clarity) epi-isozizaene synthase.
Structural changes in helix H and the H-α-1 and J-K loops lead to active site closure. (B)
Metal coordination and hydrogen bond interactions (black and red dashed lines,
respectively) in the complex with 3 Mg2+ ions and inorganic pyrophosphate. (C)
Simulated annealing omit maps show the binding of Mg2+ ions A, B, and C (magenta
spheres), inorganic pyrophosphate (stick figure: P = orange, O = red), and the
benzyltriethylammonium cation (stick figure: C = yellow, N = blue). The quaternary
ammonium cation is stabilized by cation-π interactions with F95, F96, and F198 (red
dashed lines). Reprinted with permission from ref. 116. Copyright 2010 American
Chemical Society.
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Figure 1.26. Modeling EIZ into EIZS Active Site Cavity. The binding of 3 Mg2+ ions
(magenta spheres) and inorganic pyrophosphate (blue stick figure) to epi-isozizaene
synthase triggers active site closure (left), encapsulating the cyclization template within
a three-dimensional contour (magenta meshwork) into which epi-isozizaene can be fit
(right). Here, the fit is not as unambiguous as it is for aristolochene synthase in Figure
1.22, perhaps reflecting the fact that epi-isozizaene synthase is a more promiscuous
cyclase. Reprinted with permission from ref. 116. Copyright 2010 American Chemical
Society.
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The preparation of a library of 40 single-point variants designed to remold the
active site contour of epi-isozizaene synthase quintuples the overall number of major
and minor products generated, including the conversion of the enzyme into nine
different sesquiterpene synthases generating alternative major products (olefins and
alcohols): the F96A variant generates predominantly (E)-β-farnesene, the F96N variant
generates predominantly farnesol, the F96H variant generates predominantly nerolidol,
the W203F variant

generates predominantly (Z)-γ-bisabolene, the F95H variant

generates predominantly β-curcumene, the F96S, F96M, and F96Q variants generate
predominantly sesquisabinene, the F95M variant generates predominantly βacoradiene, the F198L variant generates predominantly β-cedrene, and the F96W
variant generates predominantly zizaene.117,118 The complete reaction manifold is
illustrated in Figure 1.27. It is remarkable that even single-point amino acid substitutions
can mask the reaction pathway leading to epi-isozizaene formation and unmask new
reaction pathways leading to previously unidentified products.

58

Figure 1.27: Biosynthetic manifold of epi-isozizaene synthase and its site-specific
variants. The predominant cyclization product, epi-isozizaene, is highlighted in a cyan
box, and predominant cyclization products of site-specific variants are highlighted in
blue boxes. Minor side products generated by wild-type and variant cyclases are
highlighted in yellow boxes. Reprinted with permission from ref. 118. Copyright 2017
American Chemical Society.
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1.4.3.2 (+)-Bornyl Diphosphate Synthase
The C1-C6 cyclization reaction is the hallmark of a monoterpene cyclase, since
this is the only cyclization pathway accessible to the C10 substrate geranyl diphosphate.
Thus, a monoterpene cyclase similarly requires an ionization-recombination-reionization
sequence to achieve trans-cis isomerization of the C2-C3 double bond of geranyl
diphosphate, which enables formation of the 6-membered ring α-terpinyl carbocation
intermediate. Myriad cyclic monoterpene skeletons derive from this intermediate, as
illustrated in Figure 1.28.119
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Figure 1.28: Cyclic monoterpenes derive from the terpinyl carbocation intermediate.
Reprinted with kind permission of Springer Science and Business Media from ref. 119.
Copyright 2000 Springer-Verlag.
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The first monoterpene cyclase to yield a crystal structure was (+)-bornyl
diphosphate synthase, a homodimer of subunits with αβ domain architecture (Figure
1.29).58 The cyclization cascade catalyzed by this cyclase is unusual in that inorganic
pyrophosphate is not a co-product, but instead recombines with the final carbocation
intermediate to form the product.120 The mechanism of catalysis has been thoroughly
delineated in detailed enzymological studies (Figure 1.30).121-126 Briefly, metal iontriggered ionization of geranyl diphosphate yields the geranyl cation, to which inorganic
pyrophosphate recombines at C3 to form linalyl diphosphate. Following rotation of the
C2-C3 single bond from a transoid to a cisoid conformation, metal ion-triggered
reionization yields the cis-linalyl carbocation, which allows C1-C6 ring closure to yield
the α-terpinyl carbocation intermediate. Transannular carbon-carbon bond formation
then leads to the 2-bornyl carbocation intermediate, with which inorganic
pyrophosphate ultimately recombines to form (+)-bornyl diphosphate. Interestingly,
theoretical and computational studies suggest that the 2-bornyl cation represents a
transition state structure on the potential energy surface of the cyclization cascade.127130

X-ray crystal structures of (+)-bornyl diphosphate synthase complexed with aza
analogues of carbocation intermediates in the cyclization cascade (Figure 1.30) and
inorganic pyrophosphate reveal structural insights on the catalytic mechanism.58 As is
common for all class I terpene cyclases, molecular recognition of inorganic
pyrophosphate, as well as the diphosphate group of substrate and product, is achieved
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by 3 Mg2+ ions and 3 basic residues (Figure 1.31), and this molecular recognition feature
triggers active site closure (Figure 1.32). The active site is fully encapsulated, thereby
ensuring that highly reactive carbocation intermediates are not susceptible to
premature quenching by bulk solvent. Interestingly, however, a water molecule is
trapped in the enclosed active site along with bound substrate analogues, and this
water molecule is observed even in the enzyme-product complex.58 Located near the
gem-dimethyl group of (+)-bornyl diphosphate in the crystal structure of the enzymeproduct complex (Figure 1.33), this water molecule is held in place by hydrogen bonds
with active site residues as well as the product diphosphate group. Thus, this water
molecule is rendered chemically inert and cannot react with carbocation intermediates.
As also observed with aristolochene synthase,105,111 a trapped water molecule in the
active site can serve as a vital part of the active site contour, i.e., the cyclization
template, thereby contributing to the conformational control of isoprenoid substrate
binding.
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Figure 1.29: Dimer of (+)-bornyl diphosphate synthase. Each monomer adopts αβ
domain architecture (α domain = blue, β domain = green) and dimer assembly is
mediated by the α domain. Metal ion binding motifs in each domain are red (aspartaterich motif) and orange (NSE/DTE motif). Reprinted with permission from ref. 58.
Copyright 2002 National Academy of Sciences, U.S.A.
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Figure 1.30: Catalytic mechanism of (+)-bornyl diphosphate synthase. The isoprenyl
diphosphate ester oxygen atom of the substrate (red) reconnects to the product based
on the results of positional isotope exchange experiments.125,126 Crystal structures of
enzyme complexes with aza analogues of carbocation intermediates (boxes) provide
structural inferences on the catalytic mechanism. Reprinted with permission from ref.
58. Copyright 2002 National Academy of Sciences, U.S.A.
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Figure 1.31: Bornyl Diphosphate Synthase Stereoview showing the molecular
recognition of diphosphate/inorganic pyrophosphate in the active site. Structures are
color-coded as follows: Mg2+3-inorganic pyrophosphate complex (yellow), Mg2+3inorganic pyrophosphate and 2-azabornane complex (magenta), and Mg2+3-(+)-bornyl
diphosphate complex (blue). Reprinted with permission from ref. 58. Copyright 2002,
National Academy of Sciences, U.S.A.
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Figure 1.32: Bornyl diphosphate synthase open / closed conformations. Stereoviews of
the unliganded open active site conformation (A) and the close active site conformation
(B) of (+)-bornyl diphosphate synthase. The viewer is looking into the active site in the α
domain (blue); the β domain is green. Aspartate-rich and DTE metal-binding motifs are
red and orange, respectively. Dotted lines indicate disordered polypeptide segments.
The N-terminal segment becomes ordered upon the binding of ligands and helps cap the
active site in the closed conformation. Reprinted with permission from ref. 58. Copyright
2002, National Academy of Sciences, U.S.A.
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Figure 1.33: The enclosed active site contour in (+)-bornyl diphosphate synthase is
complementary in shape to the aza analogue of the 2-bornyl cation (A) and product (+)bornyl diphosphate (B). A buried water molecule (#110) is trapped in the active site and
comprises an integral part of the active site contour.58
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A left-handed helical conformation is required for substrate geranyl diphosphate
in the initial C1-C6 cyclization reaction in the mechanism of (+)-bornyl diphosphate
synthase (Figure 1.30). The active site contour thus plays a critical role as a template to
ensure that the (4R)-α-terpinyl carbocation is generated enroute to (+)-bornyl
diphosphate. The three-dimensional contour of the enzyme active site is shown in
Figure 1.33. Here, too, the template is product-like in its overall shape, and thus
chaperones reactive conformations toward the generation of one predominant product.
Given that (+)-bornyl diphosphate synthase is a moderately promiscuous cyclase, also
generating minor cyclization products pinene, camphene, and limonene,120 the productlike template is somewhat permissive. Aromatic residues F578 and W323 form part of
the active site contour and make cation-π interactions with the positively charged
ammonium groups of aza analogues. Similarly, F578 and W323 may stabilize
carbocation intermediates and their flanking transition states in catalysis.
While crystal structures of all three aza analogues of carbocation intermediates
shown in Figure 1.30 have been determined in complex with (+)-bornyl diphosphate
synthase, only 2-azabornane – which mimics the 2-bornyl carbocation intermediate –
binds in a productive manner, i.e., mimicking the orientation of the actual carbocation
intermediate.58 Other cationic aza analogues appear to bind so as to optimize their
electrostatic charge-charge interactions with the inorganic pyrophosphate anion, thus
optimizing the thermodynamics of enzyme-inhibitor association. This phenomenon has
also been observed for the binding of aza analogues to other terpene cyclases, such as
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the sesquiterpene cyclases aristolochene synthase105 and trichodiene synthase.131,132
The structure of an enzyme-analogue complex determined at thermodynamic
equilibrium may not necessarily correspond to the structure of a true catalytic
intermediate encountered during catalysis, i.e., achieved through the lowest accessible
transition state. That binding interactions along the reaction coordinate of catalysis are
under kinetic control rather than thermodynamic control may explain why
nonproductive binding modes are occasionally observed for certain analogues,
especially those for which strong interactions, e.g., charge-charge interactions with
inorganic pyrophosphate, might dominate the binding thermodynamics. In other words,
productive conformations along a reaction pathway during catalysis are under kinetic
control and not thermodynamic control.
That being said, it is important to note that product-like aza analogues tend to
bind productively, i.e., in a product-like fashion. The binding orientation of 2azabornane in the (+)-bornyl diphosphate synthase-Mg2+3-2-azabornane complex aligns
with that of (+)-bornyl diphosphate in the structure of the enzyme-product complex,
and each structure fits the active site contour perfectly (Figure 1.33).58 This is also the
case for aza analogues of carbocation intermediates in the aristolochene synthase
reaction (Figure 1.20). Thus, the structures of enzyme-analogue complexes must be
interpreted with all reasonable care and chemical insight.
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1.4.3.3 (+)- and (–)-Limonene Synthases
Intriguing examples of C1-C6 cyclization reactions proceeding through the αterpinyl carbocation intermediate are those catalyzed by (–)- and (+)-limonene
synthases, which catalyze a simple proton elimination from the carbocation
intermediate to yield one limonene enantiomer or the other; (–)-limonene is illustrated
in Figure 1.28. However, this mechanistic simplicity belies the critical role of the active
site template that governs product stereochemistry. How different must the threedimensional active site contours be to direct the formation of alternative limonene
stereoisomers?
The active site contour of (–)-limonene synthase from Mentha spicata133-137
directs the binding of substrate geranyl diphosphate with a right-handed helical
conformation (Figure 1.34). After the ionization-recombination-reionization sequence
required for C1-C6 bond formation, the 4S-α-terpinyl is formed, which after proton
elimination yields (–)-4S-limonene. (–)-Limonene synthase is a high-fidelity enzyme and
generates 94% (–)-limonene; minor side products pinene and myrcene are also
observed.138
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Figure 1.34: Cyclization of GPP catalyzed by (–)-(4S)-limonene synthase. Reprinted with
permission from ref. 59. Copyright 2007, National Academy of Sciences, U.S.A.
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In the reaction catalyzed by (+)-limonene synthase, the substrate geranyl
diphosphate must adopt a left-handed helical conformation prior to the ionizationrecombination-reionization sequence. After C1-C6 bond formation, this leads to the 4Rα-terpinyl cation, which yields (+)-limonene after proton elimination.
Significantly, (+)-limonene synthase and (–)-limonene synthase represent the
first terpene cyclases generating mirror-image products for which crystal structures
have been determined. The structure of (–)-limonene synthase from M. spicata reveals
a dimer of subunits with αβ domain architecture similar to that observed for (+)-bornyl
diphosphate synthase (Figure 1.29).59 The structures of unliganded and liganded (+)limonene synthase from Citrus sinensis reveal similar tertiary and quaternary
structure.60,61 Even though the active site templates of each enzyme direct
enantiomorphic substrate binding conformations, the amino acid side chains defining
the active site contour of each enzyme are highly conserved (the overall amino acid
sequence identity is 45%) (Figure 1.35). Thus, subtle differences in these active site
contours provide sufficient chemical information to govern the binding of substrate
geranyl diphosphate in one conformation or the other so as to generate a specific
limonene enantiomer.
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Figure 1.35: Limonene Synthase Superposition and Analysis (A) Superposition of the
active sites of (+)-limonene synthase (blue) and (–)-limonene synthase (green); most
active site residues are conserved. (B) Analysis of the complex between (+)-limonene
synthase and 2-fluorogeranyl diphosphate (FGPP) (green), and the complex between (–
)-limonene synthase and 2-fluorolinalyl diphosphate (FLPP) (salmon), reveals that two
residues defining the active site contour, M458 and N345 of (–)-limonene synthase and
corresponding residues I450 and I336 of (+)-limonene synthase, govern enantiomorphic
substrate binding conformations. Reprinted with permission from ref. 60 and ref. 61.
Copyright 2017, American Chemical Society.
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Based on the results of elegant X-ray crystallographic studies and structural
analyses, Oprian and colleagues discovered that a pair of amino acid side chains defining
the three-dimensional contour of each enzyme active site, M458 and N345 of (–)limonene synthase and corresponding residues I450 and I336 of (+)-limonene synthase,
direct the binding conformation of geranyl diphosphate as right-handed or left-handed,
respectively.61 The side chain of M458 would clash with the substrate if it adopted an
incorrect left-handed conformation in the active site of (–)-limonene synthase, and the
side chain of I336 would clash with the substrate if it adopted an incorrect right-handed
conformation in the active site of (+)-limonene synthase (Figure 1.35). Once the
precatalytic substrate binding conformation is thus fixed, the stereochemical outcome
of the cyclization cascade is established. This example shows how even subtle features
in the cyclization template encode and direct structure and stereochemistry in a terpene
cyclase reaction.

1.4.4 C1-C14 Cyclization Reaction: Taxadiene Synthase
The diterpene cyclase taxadiene synthase from Taxus brevifolia (Pacific yew)
catalyzes the first committed step in the biosynthesis of Taxol (paclitaxel),139 a
blockbuster drug used in cancer chemotherapy.140-144 Recombinant expression and
purification of a pseudomature form of the enzyme lacking the plastidial targeting
sequence facilitated detailed studies of the catalytic mechanism (Figure 1.36).145,146
Briefly, substrate ionization facilitates C1-C14 bond formation, likely in concert with
C10-C15 bond formation, to yield the verticillen-12-yl carbocation intermediate.146-148
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Following an unusual intramolecular proton transfer147,149,150 from C11 to the re face of
C7 to yield the verticillen-8-yl carbocation, transannular ring closure yields the taxen-4yl carbocation, which undergoes proton elimination to yield taxa-4,11-diene.
The X-ray crystal structure of taxadiene synthase was the first of a diterpene
cyclase and was also the first to reveal αβγ domain architecture in a terpene synthase
(Figure 1.9).62 The binding of 3 Mg2+ ions and substrate analogue 2-fluorogeranylgeranyl
diphosphate confirmed the functionality of the class I active site in the α domain (Figure
1.37). The β and γ domains of taxadiene synthase have no known function in catalysis,
although the N-terminal polypeptide segment may help to cap the active site upon
substrate binding. Given the disorder observed for the J–K loop, the active site is
thought to adopt a partially closed conformation, which is consistent with the binding of
the substrate analogue in a nonproductive conformation. A plausible model of the fully
closed active site conformation has been generated using computational approaches.151

Figure 1.36: Catalytic mechanism of taxadiene synthase. Taxadiene undergoes
subsequent biosynthetic modifications to yield the cancer chemotherapeutic drug Taxol.
Reprinted with permission from ref. 62. Copyright 2011 Nature Publishing Group.
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Figure 1.37: FGP Bound in Taxadiene Synthase. Stereoview of a simulated annealing
omit map showing the binding of 3 Mg2+ ions and 2-fluorogeranylgeranyl diphosphate
(FGP) in the active site of taxadiene synthase. Reprinted with permission from ref. 62.
Copyright 2011 Nature Publishing Group.
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Even though the taxadiene synthase active site is not fully closed in the crystal
structure of the complex with 2-fluorogeranylgeranyl diphosphate and 3 Mg2+ ions, the
active site is almost completely encapsulated, capped by the metal ions and
diphosphate group of the substrate analogue.62 Analysis of the active site contour and
evaluation of its function as a template for catalysis yields two plausible orientations for
product binding (Figure 1.38). Given that the measured volume of the taxadiene
synthase active site is much larger than that of the substrate, and given that there is
typically a close correlation between volumes of fully closed terpene cyclase active sites
and the molecular volumes of their substrates (Figure 1.39), it is likely that the active
site contour of taxadiene synthase would become even more product-like in shape upon
full active site closure, which in turn ought to yield a less ambiguous fit for the binding
of taxadiene.

78

Figure 1.38: Taxadiene Synthase Active Site Contours. Stereoviews of the encapsulated
three-dimensional contour of the taxadiene synthase active site (protein atoms omitted
for clarity). For reference, 3 Mg2+ ions (magenta spheres) and 2-fluorogeranylgeranyl
diphosphate (stick figure, C = grey, P = orange, O = red) are shown. (A) Product
taxadiene (blue stick figure) is modeled in the enclosed active site contour. This
orientation is consistent with the proposed role of inorganic pyrophosphate as the
stereospecific general base that terminates the cyclization cascade (see Figure 1.36). (B)
An alternative orientation of taxadiene fits in the active site contour, allowing for the
possibility that Y688 could serve as the stereospecific general base; the green dashed
line indicates the possible trajectory of proton transfer. Reprinted with permission from
ref. 62. Copyright 2011 Nature Publishing Group.
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Figure 1.39: Active site volumes measured in the crystal structures of terpene cyclases
are generally slightly larger than the corresponding substrate and product volumes.
Some active site volumes, such as those measured for 5-epi-aristolochene synthase
(EAS) and taxadiene synthase (TXS), are much larger, consistent with incomplete active
site closure. Squalene-hopene cyclase (SHC) and oxidosqualene cyclase (OSC) are class II
terpene cyclases. Other abbreviations are as follows: isoprene synthase (ISPS), (–)limonene synthase (LMNS), (+)-bornyl diphosphate synthase (BPPS), epi-isozizaene
synthase (EIZS), aristolochene synthase (ARS), trichodiene synthase (TDS). Reprinted
with permission from ref. 62. Copyright 2011 Nature Publishing Group.
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1.5 Concluding Remarks
With farnesyl diphosphate synthase represented in the Last Universal Common
Ancestor that preceded the divergence of the kingdoms of life,28 the evolutionary roots
of the class I terpene synthase fold seem to approach the origin of life. Class I terpene
synthases catalyze the most complex carbon-carbon bond-forming reactions in all forms
of life, so it is reasonable to speculate that these enzymes were critical players early in
the history of living systems as carbon management strategies evolved. The evolution of
the class I terpene synthase fold from gene duplication and fusion of a primordial 4-helix
bundle protein27 shifts the evolutionary history to an even earlier timeline, since 4-helix
bundle proteins comprise one of the most ancient of protein architectures.29
Class I terpene synthases evolved as templates for catalysis of terpene coupling
and cyclization reactions; the hallmark of this chemistry is the generation and
manipulation of highly reactive carbocation intermediates. These reactions can be
intermolecular or intramolecular, involving pairs of isoprenoid substrates as in the
farnesyl diphosphate synthase reaction, pairs of isoprenoid and non-isoprenoid
substrates as in the aromatic prenyltransferase reaction, or a single substrate as in
terpene cyclase reactions. In each case, the active site template of the terpene synthase
chaperones the binding conformation of the flexible isoprenoid substrate through a
well-orchestrated sequence of carbocation intermediates leading to one exclusive or
predominant product.
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Farnesyl diphosphate synthase and related prenyltransferases comprise onedimensional templates for catalysis, in that the depth of the active site pocket governs
the length of the chain elongation product. Terpene cyclases comprise threedimensional templates for catalysis, in that the active site contour governs the threedimensional structure and stereochemistry of the cyclic terpene product. Both onedimensional and three-dimensional active site templates are product-like in shape, so all
the information necessary to predict the product of a terpene synthase reaction is
encoded in the protein structure. With regard to terpene cyclases, active site templates
can be strikingly different as they select for substrates of different lengths, e.g., C10
geranyl diphosphate, C15 farnesyl diphosphate, or C20 geranylgeranyl diphosphate.
Active site templates can also be strikingly different as they accommodate a single such
substrate and chaperone its cyclization to form dramatically different hydrocarbon
skeletons. Alternatively, active site templates need exhibit only subtle differences to
direct the formation of alternative stereoisomers of the same product.
Given that the product outcome of a terpene synthase is encoded in the threedimensional contour of the active site, it should be possible to decode this information
in a predictive fashion. Impressive success in this regard has been reported with the
identification of cucumene synthase and the successful de novo prediction of its linear
triquinane product based on computational analysis.79 Interestingly, computational
analysis of monoterpene carbocation structures indicates that known cyclic
monoterpenes represent just a small subset of the theoretically maximum number of
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possible carbon skeletons that can be formed from geranyl diphosphate.152 Thus, new
terpene cyclases remain to be discovered in nature or developed through protein
engineering. Structural biology approaches will continue to guide these discoveries as
terpene natural products become increasingly more prominent in medicine and
biotechnology in the years to come.
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Chapter 2: Structural studies of geranylgeranylglyceryl
phosphate synthase, a prenyltransferase found in thermophilic
Euryarchaeota
Adapted with permission from Blank, P.N., Barnett, A.A., Alderfer, K.E., Gillott,
B.N., Christianson, D.W., Himmelberger, J.A. (2019) Structural studies of
geranylgeranylgluyceryl phosphate synthase, a prenyltransferase found in
thermophilic Euryarchaeota. Acta Crystallographica Section D. Submitted.
Copyright 2019 IUCr.

2.0 Abstract:
Archaea are uniquely adapted to thrive in harsh environments; one of these
adaptations is the archaeal membrane lipids that are characterized by their isoprenoid
alkyl chains connected via ether linkages to glycerol-1-phosphate. The membrane lipids
of the thermophilic and acidophilic euryarchaeota Thermoplasma volcanium are
exclusively glycerol dibiphytanyl glycerol tetraethers. The first committed step in the
biosynthetic pathway of these archaeal lipids is the formation of the ether linkage
between glycerol-1-phosphate and geranylgeranyl diphosphate, and is catalyzed by the
enzyme geranylgeranylglyceryl phosphate synthase (GGGPS). The 1.72 Å crystal
structure of GGGPS from T. volcanium (TvGGGPS) in complex with glycerol and sulfate is
reported herein. The crystal structure reveals that TvGGGPS is a dimer, which is
consistent with the absence of an aromatic anchor residue in helix α5’ that is required
for hexamerization in other GGGPS homologs, and thought to provide thermostability. A
phylogenetic analysis of the Euryarchaeota and parallel ancestral state reconstruction
investigated the relationship between optimal growth temperature and the ancestral
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sequences. The presence of an aromatic anchor residue is not explained by temperature
as an ecological parameter. Molecular modeling indicated that the active site of the
TvGGGPS dimer may be able to accommodate longer isoprenoid substrates, supporting
an alternative pathway of isoprenoid membrane lipid synthesis.
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2.1 Introduction
The terpenome encompasses a diverse and expansive collection of more than
86,000 natural products as currently catalogued in the Dictionary of Natural Products
(http://dnp.chemnetbase.com). Terpenoids are key constituents of primary and
secondary metabolism and are engaged in all aspects of cellular processes throughout
the three domains of life (Gershenzon & Dudareva, 2007; Christianson, 2017).
Terpenoids involved in primary metabolism include the quinones (ubiquinone),
photosynthetic pigments (chlorophyll and carotenoids), sterols, and membrane lipids;
terpenoids involved in secondary metabolism include specialized molecules involved in
communication, defense, signal transduction, thermotolerance, and reproduction (Cane
& Ikeda, 2012; Tetali, 2019).
Ether-linked isoprene-based membrane lipids are an intriguing category of
terpenoids that are unique to archaea (Jain, 2014). Maintaining membrane integrity is
critical to the survival of an organism. At low temperatures, membranes can become
static, forming a rigid gel that does not permit the necessary functions of flexibility and
transport; at high temperatures, increased thermal energy can result in a disordered
membrane that is too fluid to maintain its barrier properties. In order to maintain
optimal liquid crystalline membrane properties, organisms have evolved mechanisms of
‘homeoviscous adaptation’ that sustain membrane integrity at the optimal growth
temperature of the organism (Siliakus et al., 2017). These mechanisms include both the
evolution of native phenotypes (genome evolution) as well as short term stress
adaptations. Although not entirely unique to archaea, ether-linked isoprene-based
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membrane lipids are the basis of the ‘lipid divide’ between bacteria/eukarya and
archaea (Matsumi et al., 2011; Yokobori et al, 2016), and are thought to facilitate the
survival of extremophiles in harsh aqueous environments, since ether linkages are more
resistant to hydrolysis at higher temperatures than the ester linkages typically contained
in membrane phospholipids from mesophiles (Jain et al., 2014). An additional feature of
many archaeal membranes is the presence of glycerol dialkyl glycerol tetraethers
(GDGT), which form a monolayer membrane that provides additional thermal stability.
However, the complete biosynthetic pathway for GDGTs has yet to be fully uncovered
(Jain et al., 2014; Villanueva et al., 2014).
Many of the enzymes involved in archaeal lipid synthesis have been identified,
starting with the enzymes that catalyze the biosynthesis of the simple 5-carbon
precursor, isopentenyl diphosphate (IPP) and/or its isomer dimethylallyldiphosphate
(DMAPP), from which all terpenoids derive. The classical mevalonic acid (MVA) pathway
for the biosynthesis of IPP in eukaryotes, as well as some species of archaea and
bacteria, has been known since the 1950’s (Beytia & Porter, 1976). In contrast, most
bacteria generate IPP using a distinct non-MVA pathway named for the first committed
metabolite, 2-C-methyl-D-erythritol 4-phosphate (MEP) (Rohmer, 1999).
Recently, two modified MVA pathways have been identified in archaea. In most
archaea, mevalonate 5-phosphate is converted into isopentenyl phosphate (IP) by the
dual functional enzyme mevalonate 5-phosphate decarboxylase (4.1.1.33) which
catalyzes both the phosphorylation of the 3-OH of mevalonate using ATP, followed by
decarboxylation. Next, IP is phosphorylated by isopentenyl phosphate kinase (2.7.4.46)
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to form IPP (Vannice et al., 2013; Dellas et al., 2013). A second modified MVA pathway
was identified in Thermoplasma acidopilium (Vinokur et al., 2016, 2014; Azami et al.,
2014) and is thought to exist in a select group of extreme acidophiles belonging to the
order Thermoplasmatales, which also includes Thermoplasma volcanium. In this
pathway, mevalonate is phosphorylated by mevalonate 3-kinase (2.7.1.185) to form
mevalonate 3-phosphate, and then two separate enzymes catalyze the phosphorylation
of the 5-OH by ATP (mevalonate 3-phosphate 5-kinase, 2.7.1.186), and the
decarboxylation (mevalonate 3,5-bisphosphate decarboxylase, 4.1.1.110) to form IP
(Fig. 2.1A). Mevalonate 5-phosphate decarboxylase from Roseiflexus castenholzii does
not exhibit kinase activity at low pH, which suggests that two separate enzymes have
evolved to catalyze the phosphorylation and decarboxylation reactions in the low pH
extreme environment in which Thermoplasmates exist (Vinokur et al., 2016). These
alternative MVA pathways found in archaea share the first three or four steps of the
classical eukaryotic MVA pathway and result in the generation of IPP and DMAPP, which
are then linked together by the archaeal prenyltransferase geranylgeranyl diphosphate
synthase to form geranylgeranyl diphosphate (GGPP). GGPP is a linear achiral diterpene
which serves as the precursor of archaeal membrane lipids.
The first committed step in the biosynthesis of archaeal diether and bipolar
tetraether membrane lipids is catalyzed by geranylgeranylglyceryl phosphate synthase
(GGGPS), a long-chain prenyltransferase that catalyzes the coupling reaction of GGPP
with glycerol-1-phosphate (G1P) (Fig. 2.1B) (Jain et al., 2014). There is an important
stereochemical distinction in the three-carbon substrate required by the GGGPS
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enzyme: archaea exclusively integrate G1P into their membrane lipids, whereas the
enantiomer glycerol-3-phosphate (G3P), found in bacteria and eukarya, is not utilized.
Although there are rare examples of G1P incorporation into membrane lipids in both
Gram-positive and Gram-negative bacteria, including Bacillus subtilis, the function of
these lipids is unknown (Guldan et al., 2011).
Phylogenetic analysis and biochemical characterization of several GGGPS
enzymes results in the identification of two groups, I and II, which can be further
classified as archaeal (group Ia or IIa) or bacterial (group Ib or IIb). To date, crystal
structures of GGGPS enzymes from Flavobacterium johnsoniae (FjGGGPS, group IIb)
(Peterhoff et al., 2014), Methanothermobacter thermautotrophicus (MtGGGPS, group
IIa) (Peterhoff et al., 2014), and Archaeoglobus fulgidus (AfGGGPS, group Ia) (Payandeh
et al., 2006) have been reported; additionally, the crystal structure of the enzyme from
Thermoplasma acidophilum (TaGGGPS, group IIa) has been deposited in the Protein
Data Bank (PDB 5B69). Furthermore, the crystal structures of PcrB, a group Ib
prenyltransferase homolog of GGGPS, from Geobacillus kastophilus, Bacillus subtilis, and
Staphylococcus aureus have been determined (Peterhoff et al., 2014; Ren et al., 2013).
PcrB is a heptaprenylglycerol phosphate synthase, which acts upon longer isoprenoid
substrates than GGGPS, whereas the bacterial group II homolog from F. johnsoniae
exhibits GGGPS activity (Peterhoff et al., 2014). Each GGGPS (and PcrB) exhibits the
characteristic (αβ)8 fold of a TIM-barrel, with the modification of helix α3 being replaced
by an extended polypeptide chain. Homologs of GGGPS adopt different oligomerization
states – FjGGGPS and AfGGGPS are dimers, and MtGGGPS is a hexamer. The
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hexamerization state of mtGGGPS is thought to provide thermostability in
hyperthermophilic organisms (Linde et al., 2018).
To broaden our understanding of this enzyme family, we now report the
expression, purification, crystallization, and structure determination of the group IIa
enzyme GGGPS from the thermophilic archaea Thermoplasma volcanium (TvGGGPS). In
addition, we present the first ancestral sequence reconstruction (ASR) of GGGPS
sequences. Previously, questions pertaining to the potential functions of GGGPS and
other proteins in archaeans have utilized amino acid similarity analyses (e.g., (Peterhoff
et al., 2014)). However, these analyses are problematic, as they do not take into account
the ecological or evolutionary mechanisms leading to the extant amino acid sequences
being compared, but rather the degree of sequence “similarity”. Similarity between
proteins can indeed be a product of shared ancestry; however, homoplasy, or shared
similarity due to convergent evolution, can obfuscate the origin of protein sequences
and structures. Evolutionary phenomena that are informative in assessing protein
functions, such as homoplasy, cannot be rigorously assessed by similarity analyses (see
Yang & Rannala, 2012). Furthermore, the effect of ecological parameters on protein
evolution, such as growth temperature optima, are absent in these analyses. Ecological
parameters affect protein function, and thus also affect the evolution of the amino acid
sequences. Therefore, the use of phylogenetic analyses in assessing protein function
potentiates the broader understanding of protein function (e.g., Liu et al., 2018).
Ancestral state reconstruction (ASR) is a method by which ancestral character
states can be extrapolated from those in living taxa ( Cunningham et al., 1998; Peterhoff
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et al. 2014). ASR methodology has been applied to questions exploring the evolution of
discrete and continuous character states (e.g., Reyes et al., 2018) as well as the
evolution of amino acid sequences (Liu et al., 2018; Cai et al., 2004). Furthermore, ASR
strategies have also targeted the ancestral reconstruction of niche habitability, using
temperature as an ecological character (e.g., Vieites et al., 2009). The ability to live in
environments under extreme temperatures necessitated the evolution of proteins
capable of performing their enzymatic reactions within these extreme conditions
(Boussau et al. 2008; David & Alm, 2011). To understand how GGGPS proteins evolved
in response to differing environmental temperatures in the lineage leading to T.
volcanium, we performed parallel ASRs of habitat temperatures and GGGPS amino acid
sequences of members belonging to Euryarchaeota, which includes T. volcanium. Using
these analyses, we find that the residues that facilitate hexamerization of GGGPS
enzymes are a result of convergent evolution and that temperature is not the primary
factor influencing the evolution of the hexamerization residues.
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2.2 Methods
2.2.1 Cloning, Expression, and Purification. The gene encoding GGGPS
was amplified from genomic DNA and cloned into the p7XNH3 plasmid, which provided
an N-terminal His10 tag, using the FX cloning method (Geertsma & Dutzler, 2011) with
forward primer 5’-atatatGCTCTTCtAGTactatactgaagcagatgatgagaaag and reverse
primer 5’-tatataGCTCTTCaTGCaaccgaattttttatttcaatgctttt.
The construct was verified by sequencing. Heterologous expression of GGGPS
was carried out in Escherichia coli BL21(DE3) cells. Overnight cultures of E. coli carrying
the p7XNH3-GGGPS plasmid were grown in Lysogeny Broth (LB) media containing 50
μg/mL kanamycin. The overnight culture was used to inoculate 1 L of this media, and
the E. coli was grown at 37°C for 5 hours until the OD600 reached 0.5. Transcription of
the GGGPS gene was initiated by supplementing the media with 1 mM IPTG. After 5
hours the cells were harvested by centrifugation, resuspended in 50 mL of buffer A [20
mM sodium phosphate (pH 7.4), 500 mM sodium chloride, 5 mM imidazole], and cell
membranes were disrupted by ultrasonication for six minutes. Cell lysate was clarified
by centrifugation at 16,000 RPM (30600 g) for 1 hour. For purification, the clarified
lysate was loaded on a 1-mL HisTrap FF column (GE Life Sciences) pre-washed with
buffer A at room temperature. A peristaltic pump maintained column flow, and GGGPS
was eluted with buffer B [20 mM sodium phosphate (pH 7.4), 500 mM sodium chloride,
500 mM imidazole]. Protein fractions were analyzed using SDS-PAGE, and purified
fractions were combined. The total amount of protein was determined by Bradford
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Assay. The final buffer was exchanged to buffer A by repeated dilution and
concentration using a 10,000 MWCO Protein Concentrator (Thermo Scientific Pierce).

2.2.2 Crystallization and Structure Determination. GGGPS was
crystallized by the hanging drop vapor diffusion method. Typically, a 3 !L drop of
protein solution [4 mg/mL GGGPS, 20 mM sodium phosphate (pH 7.4), 500 mM NaCl, 5
mM imidazole, 100 mM benzyltriethylammonium chloride (BTAC) and 10 mM MgCl2]
was added to 3 !L of precipitant solution [1.8–2.2 M ammonium sulfate, 100 mM Tris
(pH 7-8)] and equilibrated against 1 mL of precipitant solution in the well reservoir.
Crystals shaped somewhat like “almond slivers” appeared within several days. These
crystals were harvested and transferred to a cryoprotective buffer [2.0 M ammonium
sulfate, 100 mM Tris (pH 7.5), 25% glycerol], then flash-cooled in liquid nitrogen.
X-ray diffraction data were collected from GGGPS crystals at the Stanford
Synchrotron Radiation Lightsource (SSRL), beamline 12-2. Crystals diffracted to 1.72 Å
resolution and belonged to tetragonal space group P41212 with unit cell parameters a =
b = 73.76 Å, c = 122.60 Å. Diffraction data were indexed, integrated, and scaled using
iMOSFLM (Battye et al., 2011). Data statistics were evaluated using XTRIAGE to rule out
pseudotranslation and other crystallographic imperfections. The initial electron density
map was phased by molecular replacement with PHASER using a modified version of the
crystal structure of the prenyltransferase from Flavobacterium johnsoniae (fjGGGPS,
PDB 4JEJ) (Peterhoff et al., 2014) without ligands as a search model (McCoy et al., 2007).
Manual model building and refinement were performed using COOT and PHENIX,
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respectively (Adams et al., 2010; Emsley et al., 2010). Sulfate, glycerol, imidazole, and
water molecules were added in later stages of refinement. Structure validation was
performed with MOLPROBITY (Chen et al., 2010). Molecular superpositions were
calculated using the SSM superpose algorithm in COOT and/or the alignment action in
PyMOL (Krissinel & Henrick 2004; PyMOL). Figures were prepared using PyMOL. Data
collection and refinement statistics are recorded in Table 2.1.
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Table 2.1: Data collection and refinement statistics for TvGGGPS
GGGPS-SO42--GOL
complex
SSRL
12-2
Pilatus6
12657.999
0.979
P 41212
73.76, 73.76,
122.60
90, 90, 90
73.76-1.72 (1.751.72)
356557/36732
(18956/1916)
0.071 (1.336)
0.023 (0.443)
0.998 (0.791)
15.2 (1.4)
9.7 (9.9)
100.0 (100.0)
0.198 (0.341)
0.206 (0.386)

Enzyme
Synchrotron
Beamline
Detector
Energy (eV)
Wavelength (Å)
Space group
a, b, c (Å)
α, β, γ (°)
Resolution (Å)
Total/unique no. of
reflections
Rmerge
Rp.i.m.
CC1/2
I/σ(I)
Redundancy
Completeness (%)
Rwork
Rfree
No. of non-hydrogen
atoms:
protein
ligand
solvent

1913
27
223

Average B-factors (Å2)
macromolecules
ligand
solvent
Root-mean-square
deviation from ideal
geometry
bonds (Å)
angles (°)
Ramachandran plot (%)
favored

37
46
48

0.004
0.6
97.98
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allowed
outlier
Rotamer outliers (%)
Clashscore

2.02
0.00
0.48
4.82

PDB accession code

6NKE
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2.2.3 Substrate docking in TvGGGPS
To simulate binding of geranylgeranylpyrophosphate (GGPP) into TvGGGPS,
molecular modeling of GGPP into the active site cavity of 3W00 was conducted in a
similar manner to previous studies on other terpene synthases (Blank et al., 2019a;
Blank et al., 2019b). The bound FSPP molecule in Chain B of the 3W00 dimer was
removed using the delete function in COOT (Emsley et al., 2010). GGPP was drawn in a
structure editor and transformed into a SMILES string, which was then converted into a
readable pdb format by the SMILES Translator and Structure File Generator (National
Cancer Institute, https://cactus.nci.nih.gov/translate/). Geometric optimization of the
resultant small molecule pdb coordinates was performed in Phenix (Adams et al., 2010),
before uploading to PyMOL. The DoGSiteScorer (http://dogsite.zbh.unihamburg.de) was
used to generate an active site mesh that served as a guide for active site pocket
selection. GetCleft and FlexAID Pymol plugins, part of the NRGsuite software, were then
used to obtain active site clefts into which the small molecule GGPP was docked
(Gaudreault et al. 2015).

2.2.4 Phylogenetics and Ancestral State Reconstructions. GGGPS
amino acid sequences for 131 species of cultured archaeans belonging to the
Euryarchaeota, as well as GGGPS sequences of two bacteria (Caldisphaera lagunensis
and Caldithrix abyssi), were downloaded from InterPro (Mitchell et al., 2018). Only
sequences for cultured species were selected in order to use their optimal growth
temperatures for a subsequent ancestral state reconstruction of this character. These
selected sequences were then aligned using MUSCLE with eight iterations (Edgar, 2004).
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The resulting alignment was used to construct a maximum-likelihood tree using PhyML
(Guindon et al., 2010) and the Smart Model Selection (SMS) tool (Lefort et al., 2017).
Branch support was tested using approximate Bayes (Anisimova et al., 2011). This
resulted in a phylogenetic reconstruction with a log-likelihood of -27694.89397 using
the LG matrix with the best “decoration” of G+I (BIC= 57188.90368) (Fig. 2.2A).
In order to infer the sequence evolution of GGGPS proteins in the Euryarchaeota,
the original MUSCLE alignment and the resulting maximum-likelihood tree were used as
the basis for an ancestral reconstruction of GGGPS protein sequences using FastML
(Ashkenazy et al., 2012) under the LG substitution model and the gamma distribution.
This reconstructed the optimal amino acid sequences of 134 ancestral nodes using
marginal reconstruction.
To better understand the temperature niches in which ancestral GGGPS proteins
were evolving in, we sought to perform a parallel ASR using optimal growth
temperatures as a character. To this end, we used the Phytools R package (Revell, 2012).
Initially, we scaled the tree to time using the package Chronos. We then used the
fastAnc to estimate the maximum likelihood ancestral temperatures for each ancestral
node. Where optimal temperature ranges were given, we used the average of this
range.
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2.3 Results and Discussion
2.3.1 Three-dimensional structure of TvGGGPS complexed with glycerol
and sulfate
The 1.72 Å-resolution crystal structure of the TvGGGPS-glycerol-SO42- complex
reveals the TIM-barrel fold first identified in the group I archaeal prenyltransferase
AfGGGPS (PDB 2F6X) (Payandeh et al., 2006) and subsequently the group II archaeal
prenyltransferase MtGGGPS (PDB 4MM1) (Peterhoff et al., 2014). As observed in these
enzymes, helix α3 of TvGGGPS is similarly replaced by an extended polypeptide chain.
As suggested in the structure determination of AfGGGPS, this structural feature is
believed to aid in the formation of a cavity housing GGPP, a long, hydrophobic
substrate. An additional deviation from classical TIM-barrel architecture includes an
additional 12-residue helix (α0) found at the N-terminus that forms a plug at the bottom
of the TIM-barrel. The polypeptide chain is highly ordered, with only 3 residues
disordered at the C-terminus (N250–V252). The rms deviation between TvGGGPS and
the group IIa enzyme mtGGGPS is 0.63 Å for 197 Cα atoms (44% amino acid sequence
identity), and the rms deviation between TvGGGPS and the group IIb bacterial
homologue FjGGGPS is 0.822 Å for 189 Cα atoms (30% amino acid sequence identity).
The active site of GGGPS must be able to accommodate the binding of two
distinct phosphate containing substrates; G1P and GGPP. The electron density map of
TvGGGPS reveals the binding of glycerol, sulfate, and several ordered water molecules
in the active site (Fig. 2.3). Given that the concentrations of sodium phosphate and
ammonium sulfate in the crystallization drop were approximately 10 mM and 2 M,
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respectively, we interpreted the electron-dense peak adjacent to glycerol as a sulfate
ion rather than a phosphate ion. The binding of the diphosphate moiety of GGPP is
thought to require the presence of a magnesium ion which would facilitate the binding
of the negatively charged phosphate to the highly conserved asparatate-22 of loop βα1
and serine-51 of loop βα2 (Peterhoff et al., 2014). Despite the presence of 10 mM
magnesium in the crystallization conditions, there was no electron density attributable
to magnesium anywhere in the active site.
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Figure 2.1: GGGPS reaction scheme. A. Modified mevalonate pathway for the synthesis
of IPP in extreme acidophiles of the order thermoplasmatales, which includes T.
volcanium. B. GGPPS catalyzes the condensation of DMAPP with three units of IPP to
form geranylgeranyl pyrophosphate. The first committed step in the biosynthesis of
archaeal membrane lipids is the formation of the ether linkage between GGPP and
glycerol-1-phosphate. C. The proposed mechanism for the ether bond formation
involves ionization of GGPP to form the allylic carbocation, followed by nucleophilic
attack of the C-3 OH of glycerol at C1 of the geranylgeranyl carbocation. E172 of GGGPS
acts as a base to activate glycerol for nucleophilic attack.
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Figure 2.2: Phylogenetic reconstruction. The phylogenetic reconstruction used to
estimate ancestral GGGPS sequences and ancestral growth temperature optima. (A)
Phylogram showing the maximum-likelihood reconstruction of the relationships
between the GGGPS amino acid sequences from selected members of Euryarchaeota.
See the methods section for the phylogenetic reconstruction details. The colored nodes
represent aBayes support values (see scale). The nodes used for the alignment in Fig. 2.6
are labeled. (B) A ladderized version of the same tree in A showing optimal growth
temperature changes throughout GGGPS evolution. The parallel bars at the base of the
tree represent branches that were condensed to easily visualize the tree. Species names
are highlighted based on the amino acid inhabiting the “anchor” position in the GGGPS
protein. W = tryptophan; Y = tyrosine; F = phenylalanine. See legend for further details.
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Figure 2.3: Stereoviews of the TvGGGPS Active Site. A mixture of cartoon style ribbon
plot and sidechain stick style depict the active site with C atoms (cyan), S atom (yellow),
N atoms (blue), O atoms (red), H2O (red spheres), and glycerol C atoms (purple). (Top
Pane) Polder maps (green) contoured to 6σ and 9σ show well-ordered placement of
SO42- and glycerol ligands respectively. (Bottom Pane) Hydrogen bonding interactions
(blue dashed lines) reveal ligand binding interactions and H2O network (red, translucent
spheres).
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Together the binding of the sulfate ion and glycerol molecule roughly mimic the
binding of G1P, through the (βα)8-barrel standard phosphate binding motif, in which
side-chain and backbone amino groups from three loops of the barrel (loops βα6, βα7,
βα8) hydrogen bond directly with the phosphate group (Peterhoff et al., 2014). In the
TvGGGPS structure reported here, the sulfate ion accepts hydrogen bonds from S175
and G176 of loop βα6, and G202 and R204 of loop βα7. In the TvGGGPS structure, loop
βα8 does not interact with the sulfate ion. Glycerol is bound in the active site just below
the sulfate; one of the primary hydroxyl groups of glycerol donates a hydrogen bond to
the sulfate, with a hydrogen bonding distance of 2.7 Å. Numerous water molecules are
observed bound in the active site, and some of these water molecules appear to be
disordered between two mutually exclusive sites (water molecules 136 and 201). The
glycerol molecule is held in the active site by several conserved hydrogen bonds. The
secondary hydroxyl group of glycerol donates a hydrogen bond to E172 and accepts a
hydrogen bond from Y170, and the primary hydroxyl group that doesn’t interact with
the sulfate donates a hydrogen bond to E172 in a manner similar to that observed for
G1P bound in the active site of AfGGGPS (Payandeh et al., 2006). Y170 and E172 are
conserved residues that together with a conserved leucine on sheet β1 (L20 in
TvGGGPS) are thought to confer stereoselectivity for G1P binding in group II enzymes.
Since the glycerol and sulfate are separated by 2.7 Å compared to G1P, the glycerol and
sulfate together do not exactly mimic the binding of G1P. Interestingly, if the sulfate
group were a phosphate group that was covalently bound to the closest glycerol
hydroxyl group it would correspond to G3P, not G1P. This suggests that the TvGGGPS
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active site reported here is likely slightly open (since loop βα8 does not interact with the
sulfate), which would allow for either G1P or G3P to bind in the active site. Although
archaea exclusively incorporate G1P instead of G3P into their membrane lipids, a
biochemical analysis of purified GGGPS from Methanococcus maripaludis revealed an
eightfold preference for G1P over G3P, suggesting that GGGPS is promiscuous with
respect to the stereochemistry of the glycerol phosphate substrate (Caforio et al., 2018).
In the study, high levels (20-30%) of archaeal ether lipids were incorporated in the
membranes of E. coli through heterologous expression of archaeal ether lipid
biosynthesis genes including GGGPS.
Magnesium ions are required for GGGPS catalytic activity, specifically for
coordination by the diphosphate moiety of the isoprenoid substrate, which facilitates
ionization of the diphosphate group to form the allylic cation (Fig. 2.1C); however,
magnesium is not required for G1P binding. In the structure of GGGPS from the
bacterium F. johnsoniae (PDB ID 4JEJ, Peterhoff et al., 2014), two Mg2+ ions appear in
almost the exact position as two water molecules in TvGGGPS (water molecules 1 and
20). We suggest that the FjGGGPS magnesium ions (Mg 304 and Mg 305) are water
molecules that were erroneously interpreted, particularly because they do not have
proper metal coordination geometries. Mg 304 makes 4 interactions in the FjGGGPS
structure: a 2.8 Å interaction with the backbone carbonyl O of V229, a 2.9 Å interaction
with the backbone NH of G209, a 2.6 Å interaction with O3 of G1P, and a 2.4 Å
interaction with the backbone NH of I211. Additionally, Mg 305 makes 4 interactions in
the fjGGGPS structure: a 2.8 Å interaction with the backbone NH of A233, a 2.6 Å
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interaction with the backbone carbonyl O of I211, a 2.7 Å interaction with O3 of G1P,
and a 3.0 Å interaction with water 530. These interactions are much longer than the
generally accepted range for magnesium ion coordination interactions (2.0–2.2 Å)
(Zheng et al., 2015) and are more consistent with hydrogen bond interactions. Indeed,
that these interactions include backbone NH groups indicates hydrogen bonds rather
than metal coordination, since amide NH groups are unlikely to ionize to enable metal
ion coordination. Further, the geometry of interactions is tetrahedral, consistent with
saturated hydrogen bonding around a water molecule, rather than octahedral, which is
typically observed for hexacoordinate magnesium ions. Thus, Mg 304 and Mg 305 in
FjGGGPS are instead most likely to be well-ordered water molecules, each surrounded
by a tetrahedral array of hydrogen bond interactions. This conclusion is consistent with
evaluation through the server checkmymetal (Zheng et al., 2017).

2.3.2 Quaternary structure of GGGPS and Ancestral State Reconstructions
While TvGGGPS crystallizes with one monomer in the asymmetric unit, a
crystallographic symmetry operation yields dimeric quaternary structure as confirmed
by PISA (Krissinel & Henrick, 2007). Dimeric quaternary structure is also observed for
AfGGGPS and the bacterial homologues FjGGGPS and PcrB. Interestingly, the crystal
structure of MtGGGPS revealed a hexamer that can be described as a trimer of dimers.
Several other group II archaeal GGGPS enzymes have been identified as forming
hexamers via static light scattering experiments (Peterhoff et al., 2014; Linde et al.,
2018). The quaternary structure of the MtGGGPS dimer is identical to that of the
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TvGGGPS dimer. The MtGGGPS hexamer is held together by a key ‘aromatic anchor’,
W141 on helix α5’, that fits into a cavity formed by the loop region of α5’α5 of an
adjacent subunit. In TvGGGPS the ‘aromatic anchor’ residue has been replaced with an
arginine (R139) and the oligomerization state is a dimer. Mutagenesis experiments
revealed that replacing W141 in mtGGGPS with an alanine residue results in disruption
of the hexamerization interface, favoring the formation of the dimer. Furthermore,
differential scanning calorimetry and fluorimetry experiments indicate that the
MtGGGPS hexamer has significantly higher thermostability relative to the dimer and
monomer (Linde et al., 2018). Oligomerization is a common adaptation of thermophilic
proteins, along with increased number of disulfide bonds, increased salt-bridging and
increased surface charges (Reed et al., 2013). Indeed, an in vitro mutagenic analysis by
Linde et al. (2018) led to the conclusion that the hexamerization of the
Methanothermobacter thermautotrophicus GGGPS homologs ensures their structural
and functional stability at its high growth temperature optimum (65-70° C) (Linde et al.,
2018). Additionally, using protein sequence similarity analyses, Peterhoff et al. (2014)
suggested that an aromatic amino acid anchor (tryptophan, tyrosine or phenylalanine) is
necessary for the hexamerization of GGGPS proteins. Our phylogenetic analyses
produced a tree of Euryarchaeota GGGPS sequences with high statistical support, dating
back to an estimated 4 billion years ago (Battistuzzi & Hedges 2009) (Fig. 2.2A). We then
used this phylogenetic reconstruction to assess the evolution of GGGPS protein
sequences and their association to growth temperature optima using Phytools and
FastML (Fig. 2.2B).
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Of one interesting note, the position of the bacteria C. abyssi was nested within
Euryarchaeota (Fig. 2.2, Node 21). This is likely due to an artifact of phylogenetic
reconstruction, such as long branch attraction (reviewed in Bergsten, 2005) inherent in
dealing with quickly evolving, or challenging taxa. Indeed, the position of C. abyssi
within prokaryotes is still uncertain, with it being classified as a member of
Sphingobacteria (Munoz et al., 2011) or Deferribacterales (Rosenberg et al., 2014). The
placement of this taxon within the Euryarchaeota represents intriguing evidence of
convergence of the GGGPS protein, as it shares a growth temperature optima with
many of the allied taxa within our tree.
The ASR analyses for growth temperature optima were consistent with data of
this type, with large variances in deeper, more ancestral nodes, and with smaller
variances in relatively recent ancestral nodes (Cunningham et al., 1998). Most notably,
this analysis suggests that the temperature optima for this clade has changed
dramatically over the course of archaean evolution. For example, the last common
ancestor of the group had a relatively high growth temperature optimum. This optimum
subsequently lowered as these clades radiated, and a few clades convergently reverted
back to growing at high temperatures (e.g., the clade encompassing Thermococcus sp.
and Pyrococcus sp., and the clade comprising Thermofilum sp. and Pyrobaculum sp.)
(Fig. 2.2B). These results suggest that temperature optima are not a stable ecological
parameter within Euryarchaeota as the group radiated to differing ecological niches.
We asked whether there was an association between growth temperature
optima and the presence of these amino acid anchors in GGGPS homologs. Surprisingly,
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we found that those GGGPS proteins with a tryptophan at this position had a statistically
lower growth temperature optimum than those with a tyrosine or phenylalanine at this
position (Fig. 2.4). Furthermore, the growth temperature optima for the tryptophan
group was lower than those with any other amino acid other than a tyrosine or
phenylalanine at this position. Also, the growth temperature optima for those with a
tyrosine or phenylalanine at this position were not significantly different from one
another, nor when compared to the temperature optima for those with any other
amino acid at this position (Fig. 2.4). These results suggest that, in contrast to previously
suggested roles for these amino acid “anchors,” (Peterhoff et al., 2014), the presence of
these amino acids is not explained by temperature as an ecological parameter.
Interestingly, the presence of these anchors, when mapped onto our phylogeny (Fig.
2.2), appear to be the result of convergent evolution, or homoplasy, as these have
arisen in a number of clades independently (Fig. 2.2). As these clades have both
relatively “high” and “low” temperature optima, we must further conclude that
temperature is likely not a factor driving the evolution of these “anchor” amino acids.
These analyses are the first, to our knowledge, that incorporate evolutionary and
ecological data. Using “similarity” as a criterion for assessing protein function can be
useful. However, similarity analyses fail to capture the biological processes shaping
protein evolution. Thus, ASR and phylogenetic analyses are needed in order to fully
capture protein function in its biological and historical context.
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Figure 2.4: A boxplot showing the relationship between growth temperature optima
and the amino acid occupying the “anchor” position for oligomerization. W =
tryptophan; Y = tyrosine; F = phenylalanine; Other = any other amino acid. The GGGPS
homologs with a tryptophan at the anchor position had a significantly lower growth
temperature optimum than those with an Y, F, or “Other” at this position (p=0.04195,
p= 0.00898 and p= 0.00101, respectively). Comparisons of the growth temperature
optima for those with an Y, F or “Other” at this position were not significant. Statistical
analyses were performed by using an ANOVA with a post hoc Tukey HSD. * p<0.05;
**p<0.01. Center lines show the medians; box limits indicate the 25th and 75th
percentiles as determined by R software; whiskers extend 1.5 times the interquartile
range from the 25th and 75th percentiles, outliers are represented by dots.
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2.3.3 GGPP Binding site and proposed biosynthetic pathway
The long, flexible isoprenoid substrate of GGGPS requires a large hydrophobic
binding groove. The hydrophobic cavity in TvGGGPS is on the C-terminal face of the βbarrel and is capped by helix α5a formed by residues G134-G141. The cavity is lined by
hydrophobic residues including L20, F77, F93, M94, F104, A112, L116, V130, V137 and
M140. These residues, amongst others, likely play a role in directing the lipophilic
portion of the GGPP substrate to the proper position before initiation of the transferase
reaction. The binding groove in TvGGGPS is interrupted by the β3α3 loop at the Nterminal side of ‘helix’ a3 of the TIM barrel. The TIM barrel motif in GGGPS has ‘helix’ a3
either partially or fully replaced with a coil. In the case of TvGGGPS, the a3 ‘helix’ adopts
random coil structure. The flexible coil allows residues G79-S81 to protrude into the
GGPP binding pocket into a position that would obstruct GGPP binding. The residual
electron density in the binding groove suggests that there are several water molecules
that bind in the active site in the TvGGGPS crystal structure with partial occupancy.
However, one ordered glycerol is observed in the base of the pocket below loop, and
hydrogen bonds to H108.
It is not surprising that, when an isoprenoid substrate is not bound in the active
site, the pocket somewhat collapses on itself, illustrating the flexibility of the enzyme.
Previous work has investigated the role of ‘limiter’ residues found in the base of the
isoprenoid binding cavity that are thought to influence the length of the isoprenoid
substrate that can bind; for example, W99 in AfGGGPS limits the length of the binding
pocket (Guldan et al., 2011). In the TvGGGPS structure, the isoprenoid cavity appears to
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be somewhat collapsed, so no limiter residues can be confidently identified in the
absence of a bound substrate. Interestingly, however, there is an opening at the base of
the cavity that could allow a longer isoprenoid substrate to extend out of the binding
pocket (Fig. 2.5).
The possibility of whether a GGGPS enzyme could accommodate a longer
substrate is especially intriguing in light of a recent alternative archaeal membrane lipid
biosynthetic pathway presented by Villanueva and colleagues (Villanueva et al., 2014).
These authors present evidence that the current archaeal lipid synthesis pathway
requires an unlikely head-to-head condensation reaction between two archaeol
molecules to form the dibiphytanyl glycerol tetraether (GDGT-0), catalyzed by a yet-tobe identified enzyme. Furthermore, GDGT-0 is proposed to undergo unlikely internal
cyclization reactions involving non-activated methyl groups that form 1-8 cyclopentane
moieties, also catalyzed by an unidentified enzyme. Villanueva and colleagues present
an alternative synthesis scheme which effectively switches the order of head-to-head
coupling of the C-20 isoprenoids and the linking to glycerol and head groups.
Accordingly, these authors suggest renaming the GGGPS enzyme isoprenylglyceryl
phosphate (IPGP) in light of its substrates G1P and a biphytanyl moiety (head-to-head
condensed C-40 isoprenoid) that may have undergone internal cyclization reactions.
This alternative scheme would require the GGGPS enzyme to accommodate a variety of
substrates with varying numbers of cyclopentane rings, since a variety of tetraether
lipids are found in the Thermoplasmates including GDGT-0 and GDGT-1-8. To investigate
whether the TvGGGPS crystal structure is consistent with the proposed alternative
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pathway, we aligned the structures of tvGGGPS and the PcrB homolog from Bacillus
subtilis (PDB ID 3W00) which contained a bound C-15 isoprenoid farnesyl
thiodiphosphate (FSPP) (Ren et al., 2013). Using the position of FSPP as a guide, we
modeled GGPP in the binding site of TvGGGPS and determined that the base of the
binding cavity for the isoprenoid substrate is exposed to solvent (Fig. 2.5). This suggests
that it is possible for a longer isoprenoid substrate to bind in the active site of the
enzyme, and for the diphosphate moiety on the biphytanyl to extend out from the
bottom of the active site where it would be surrounded by solvent. The hydrophobic
cavity could be accessed by small movements of helix 5α’ and loops β2α2 and β3α3.
However, when we aligned the hexameric MtGGGPS structure, it appeared that the
opening at the base of the active site is partially blocked in the hexamer, which may
impede binding of a longer substrate (Fig. 2.5). Since many of the group II archaeal
GGGPS enzymes are predicted to form hexameric structures, additional modeling and
structural analysis is needed to determine whether hexameric quaternary structure can
accommodate a biphytanyl substrate.
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Figure 2.5: GGGPS MOLECULAR SURFACES (Top) Stereoview of 3W00 A and B dimer
transparent molecular surface diagram portrayed in gray. A GGPP (gray C atoms) small
molecule is docked in the red molecular contour of the 3W00 active site cavity. G1P
remains untouched from 3W00 coordinates (black C atoms). Sulfate and glycerol
molecules are overlaid from TvGGGPS superposition (lime C atoms and yellow S atom).
A second glycerol from TvGGGPS lies near the bottom of the active site cavity. All P
atoms are colored orange and all O atoms are colored red. (Bottom) Stereo Cartoon
depiction of 3W00 shown in dark blue ribbon plot superimposed with TvGGGPS in cyan
ribbon plot. Molecular contour of the 3W00 active site is shown again, but this time by
purple meshwork. All other colors remain the same, except C atoms of GGPP are
colored black for contrast. Note the protrusion of cyan loop into the active site cavity
from TvGGGPS.
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2.3.4 Ancestral Reconstruction of divergence of MtGGGPS from TvGGGPS
M. thermautotrophicus and T. volcanium are both thermophilic Euryarchaeota
that shared a common ancestor approximately 3.5 billion years ago according to
www.timetree.org (Kumar, 2017). These two species of thermophilic archaea have
similar optimal growth temperatures of 65-70 oC (T. thermoautotrophicus) and 60 oC (T.
volcanium). However, other aspects of their environment are quite different: M.
thermoautotrophicus belongs to the class Methanobacteria and thrives in environments
with a pH near 7, whereas T. volcanium belongs to the class Thermoplasmata and is
acidophilic (optimal pH 2.0). The membrane lipid composition of the two species are
distinct as well; cell membranes in M. thermoautotrophicus include both diethers
(archaeol) and tetraethers without cyclopentane rings (Yoshinaga et al., 2015), whereas
the membranes of T. volcanium contain exclusively tetraethers, and a significant
proportion of those tetraethers contain cyclopentane rings (Schouten et al., 2013). The
membrane of T. volcanium is ideally suited to its acidic environment – a monolayer
membrane is nearly impermeable to protons and the presence of pentacycles improve
lipid packing and enhance the rigidity and stability of the membrane (Siliakus, 2017).
According to the alternative biosynthetic pathway presented by Villanueva et al. (2014),
the GGGPS (or IPGP) enzyme would have functional plasticity to accommodate a range
of substrates; therefore, the GGGPS enzyme would have evolved to optimally catalyze
the reactions required to produce the membrane lipids unique to each organism.
To illustrate the utility of an ancestral reconstruction, we explored the ancestral
relationships between the sequences of MtGGGPS and TvGGGPS beginning with the
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predicted sequence of GGGPS from the last common ancestor of MtGGGPS and
TvGGGPS (sequence N79 in Fig. 2.2 and Fig. 2.6). The N-terminal region of the ancestral
sequences was not reconstructed in any of the ancestral sequences even though all
extant sequences have an N-terminal α-helix (α0). Due to the high degree of diversity in
their amino acid sequence, the highly conservative maximum-likelihood algorithms
likely discarded these from ancestral sequences due to this disparity. Similarly, the Cterminal region (helix α8) of the ancestral sequences as well as the central portion of
helix α1 also was not reconstructed, except for three highly conserved residues at the
end of helix α8. Helices α0, α1 and α8 are located on the opposite face of the enzyme
relative to the active site and are not involved in binding the substrate or catalysis;
therefore, greater variability in sequence is expected. The extant sequences of
MtGGGPS and TvGGGPS share 44% sequence identity. Several regions of the ancestral
alignment show strict conservation throughout evolution, specifically sheets β1, β2, β3,
β4, β5 and β7, whereas greater variability in sequence is found in the helices. The
residues involved in binding to the phosphate and glycerol portions of the G1P substrate
are strictly conserved, as are the residues that coordinate to Mg2+ (Fig. 2.7). The
aromatic anchor residue in the ancestral sequences from N79 to the hexameric
MtGGGPS (N80, N81, N82, N84, N94, and N95) is predicted to be a tryptophan, despite
the predicted lowering of the optimal growth temperature from 58 oC for N79 to 44 oC
for N94. The aromatic anchor residue was replaced with a positively charged arginine
residue in ancestral sequence N103, and it persisted in ancestral sequences N105, N111,
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and the dimeric TvGGGPS. The ASR suggests that a multitude of amino acid residue
alterations occurred as the methanogens diverged from the thermoplasmatales.
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Figure 2.6: Molecular Surfaces of Dimer AC and Monomer E (Top) 3W00 dimer is now
shown by an opaque gray surface in stereo, and aforementioned red surface and purple
meshwork defining the active site are superimposed. Monomer E of the 4MM1 hexamer
is shown by pink ribbon plot and surface to block the potential exit opening at the
bottom of the 3W00 active site. (Bottom) Rotated diagonally downward to highlight
how monomer E completely blocks the other potential active site exit.
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Figure 2.7. Alignment of Ancestral State Reconstruction of GGGPS amino acid
sequences of ancestral nodes leading to the extant TvGGGPS and MtGGGPS sequences.
See Fig. 2.2 for node positions. Residues likely to coordinate to magnesium ions are
indicated with *. Residues likely to hydrogen bond directly to the phosphate moiety of
G1P are indicated with †. Residues likely to hydrogen bond directly to the glyceryl
hydroxyls of G1P are indicated with ‡. The aromatic anchor residue position is indicated
with •.
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2.4 Conclusions
Archaea have evolved to synthesize unique membrane lipids which consist of
isoprene-based alkyl chains linked to G1P via ether linkages. Furthermore, the
membranes of many archaea including the order Thermoplasmates of the
Euryarchaeota consist of a monolayer formed by GDGTs. The monolayer formed by
these lipids is densely packed and impermeable to protons, which facilitates the growth
of thermophilic and acidophilic archaea, including T. volcanium. One enzyme critical for
the biosynthesis of archaeal membrane lipids is GGGPS. The structure of dimeric
TvGGGPS suggests that the end of the active site cavity may be open, which would
enable it to accept an isoprenoid substrate that is longer than 20 carbons. This
structural feature could support the alternative archaeal membrane lipid biosynthetic
pathway proposed by Villanueva et al. (2014). Even so, hexamerization of GGGPS, as
observed in MtGGGPS, would likely impede binding of longer substrates in the GGGPS
active site. Although the majority of GGGPS homologs possess an aromatic anchor
residue, the presence of an aromatic anchor does not coincide with a higher optimal
growth temperature, and the oligomerization state of the majority of these homologs is
not known. Future enzymatic studies are needed to determine the substrates that are
accepted by GGGPS in order to further elucidate the entire archaeal membrane
biosynthetic pathway.
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Chapter 3: Substitution of Aromatic Residues with Polar
Residues in the Active Site Pocket of epi-Isozizaene Synthase
Leads to the Generation of New Cyclic Sesquiterpenes
Adapted with permission from Blank, P.N., Barrow, G.H., Chou, W.K.W., Duan, L.,
Cane, D.E., Christianson, D.W. (2017) Substitution of Aromatic Residues with
Polar Residues in the Active Site Pocket of epi-Isozizaene Synthase Leads to the
Generation of New Cyclic Sesquiterpenes. Biochemistry 56(43), 5798-5811.
Copyright 2017 American Chemical Society.

3.0 Abstract
The sesquiterpene cyclase epi-isozizaene synthase (EIZS) catalyzes the cyclization
of farnesyl diphosphate to form the tricyclic hydrocarbon precursor of the antibiotic
albaflavenone. The hydrophobic active site pocket of EIZS serves as a template as it
binds and chaperones the flexible substrate and carbocation intermediates through the
conformations required for a multi-step reaction sequence. We previously
demonstrated that the substitution of hydrophobic residues with other hydrophobic
residues remolds the template and expands product chemodiversity [Li, R., Chou, W. K.
W., Himmelberger, J. A., Litwin, K. M., Harris, G. G., Cane, D. E., and Christianson, D. W.
(2014) Biochemistry 53, 1155-1168]. Here, we show that the substitution of hydrophobic
residues – specifically, Y69, F95, F96, and W203 – with polar side chains also yields
functional enzyme catalysts that expand product chemodiversity. Fourteen new EIZS
mutants are reported that generate product arrays in which 8 new sesquiterpene
products have been identified. Of note, some mutants generate acyclic and cyclic
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hydroxylated products, suggesting that the introduction of polarity in the hydrophobic
pocket facilitates the binding of water capable of quenching carbocation intermediates.
Furthermore, the substitution of polar residues for F96 yields high-fidelity
sesquisabinene synthases. Crystal structures of selected mutants reveal that residues
defining the three-dimensional contour of the hydrophobic pocket can be substituted
without triggering significant structural changes elsewhere in the active site. Thus, more
radical nonpolar-polar amino acid substitutions should be considered when terpenoid
cyclase active sites are remolded by mutagenesis with the goal of expanding product
chemodiversity.
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3.1 Introduction
The terpenome comprises an expansive library of natural products, currently
numbering

over

81,000

compounds

produced

in

all

domains

of

life

(http://dnp.chemnetbase.com). These compounds serve myriad biological and
ecological functions, e.g., in communication and defense.1-3 For example, oleoresin from
grand fir (Abies grandis) is a complex mixture of terpenoids that deters insects and
protects wound sites.4 The sesquiterpenes 7-epi-zingiberene and (R)-curcumene are
insect repellents emitted by wild tomato (Solanum habrochaites) to protect against
whiteflies (Bemisia tabaci).5 Many plants also utilize terpenoids such as (E)-β-ocimene
and myrcene as attractants for pollinators.6 In another example, maize plants (Zea
mays) emit a terpenoid mixture containing the sesquiterpene (E)-α-bergamotene for
protection against attack by Lepidopteran species (moths and butterflies); the emitted
terpenoids attract the parasitic wasp Cotesia marginiventris, which lays eggs in
Lepidopteran larvae and thereby blocks development into adult insects.7
Many terpenoids are commercially important due to their physical or
pharmaceutical properties. For example, the cyclic monoterpenoid menthol is a flavor
additive in many consumer products due to its minty aroma, and it is well known for its
analgesic properties; menthol is also used in topical gels as a transdermal drug delivery
agent.8,9 Another monoterpenoid, D-limonene, is naturally present in lemon and orange
rinds and is well known for its citrus aroma. D-Limonene is used as a flavor additive, as a
fragrance in household products, and as a potential biofuel.10,11 Sesquiterpenes also
150

serve as advanced biofuels: (Z)-α-bisabolene is a precursor of the D2 diesel fuel
substitute bisabolane, while (E)-β-farnesene is a precursor to the bio-jet fuel
farnesane.12-15
Terpenoid cyclases are the enzymes responsible for the generation of the
hydrocarbon skeletons of these natural products as they catalyze the cyclization of
linear isoprenoid substrates, such as farnesyl diphosphate (FPP), through a well-defined
reaction sequence typically characterized by multiple carbocation intermediates. There
are two classes of terpenoid cyclases, denoted I and II, that are distinguished by
conserved metal-binding DDXXD/E and general acid DXDD amino acid sequence motifs,
respectively.16-21 Class I cyclases additionally have a second metal-binding motif,
conserved as (N,D)DXX(S,T)XX(R,K)E. Class I cyclases initiate the cyclization reaction via
metal-triggered ionization of the substrate diphosphate group, whereas class II cyclases
initiate catalysis through protonation of a carbon-carbon double bond or epoxide
moiety. For both classes of cyclases, the hydrophobic active site cavity has a welldefined contour that serves as a template for the cyclization reaction.
The sesquiterpene cyclase epi-isozizaene synthase from Streptomyces coelicolor
A3(2) (EIZS) is an excellent paradigm for the study of cyclization fidelity.22,23 The active
site of this class I cyclase is nested within a characteristic helix bundle (designated the α
fold24), in which the cyclization of farnesyl diphosphate (FPP) is initiated by metaltriggered ionization of the diphosphate group. epi-Isozizaene (Figure 3.1) is the sole
cyclization product at 4 °C (99%) and the major cyclization product at 30 °C (79%).25,26
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The crystal structure of wild-type EIZS has been determined at 1.6 Å resolution in
complex

with

3

Mg2+

ions,

inorganic

pyrophosphate

(PPi),

and

the

benzyltriethylammonium cation (BTAC), a lipophilic cation that partially mimics the
bisabolyl carbocation intermediate.25 Analysis of this structure reveals that aromatic
residues define a significant portion of the active site contour. Specifically, the ring faces
of F95, F96, and F198 largely define the walls of the active site and engage in cation-π
interactions with BTAC.25 Other aromatic residues contribute to the active site contour
but are not ideally oriented to engage in cation-π interactions with bound ligands. For
example, Y69 is in the "second shell" of residues defining the active site and buttresses
F96, whereas the edge of the indole ring of W203 partially defines the floor of the active
site (Figure 3.2).
Our initial studies of a library of 26 site-specific mutants of EIZS, which included
13 mutants in which active site aromatic residues were substituted mainly with
nonpolar amino acids, revealed that some mutants generated an alternative
predominant product (Figure 3.1).26 The formation of alternative products is a
consequence of remolding the hydrophobic active site contour, which then redirects the
cyclization cascade. Curiously, the F96Y and F198Y substitutions did not deactivate the
enzyme – a newly introduced tyrosine hydroxyl group could be susceptible to alkylation
by a carbocation intermediate in catalysis, but the hydrophobic active site nevertheless
tolerated this substitution to yield a functional catalyst. Contrary to conventional
wisdom, we hypothesized that other polar amino acids might be introduced into the
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EIZS active site in place of key aromatic residues without risk of incapacitating the
enzyme catalyst. Substitution of aromatic residues could thus influence the template
function of the active site as well as the stabilization of carbocation intermediates
through substitution of cation-π interactions with cation-dipole interactions.
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Figure 3.1: Generation of EIZ and Alternative Products. Wild-type epi-isozizaene
synthase (EIZS) generates 99% and 79% epi-isozizaene at 4 °C and 30 °C, respectively,
from substrate farnesyl diphosphate (FPP). Substitution of active site aromatic residues
leads to the formation of alternative predominant acyclic and cyclic products in
multiproduct mixtures.26 The current study reports a new predominant hydrocarbon
product, sesquisabinene, generated by F96 mutants with exceptionally high fidelity (97%
for F96Q EIZS). Additionally, the sesquiterpene alcohol products farnesol and nerolidol
are generated predominantly by the F96N and F96H mutants, respectively.
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Here, we report the preparation and analysis of 16 new EIZS mutants in which
four active site aromatic residues are substituted with various amino acids: Y69, F95,
F96, and W203 (Figure 3.2). Most mutants were designed specifically to introduce new
polar functionality in the active site. Notably, through the F96S, F96M, and F96Q
substitutions, we have converted EIZS into a high-fidelity sesquisabinene synthase
(these mutants generate 78%, 91%, and 97% sesquisabinene, respectively). We have
also discovered the generation of 8 additional sesquiterpene hydrocarbon and alcohol
products by various mutant enzymes that were not observed in our previous study.26 Xray crystal structures of selected mutants provide a framework for understanding
structure-function relationships in mutant cyclases.

155

Figure 3.2: Stereoview of the EIZS Active Site Contour (grey) defined by aromatic
residues in the active site of wild-type EIZS complexed with 3 Mg2+ ions (magenta
spheres), inorganic pyrophosphate (PPi; P = orange, O = red), and the
benzyltriethylammonium cation (BTAC; C = green, N = blue). The aromatic ring faces of
F95, F96, and F198 form walls of the active site and make cation-π interactions with
BTAC. Aromatic residue Y69 buttresses F96, and the ring edge of W203 contributes to
the floor of the active site contour; neither residue makes cation-π interactions with
BTAC.
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3.2 Materials and Methods
3.2.1 Mutagenesis. A total of 16 new EIZS single-point mutants were
prepared via polymerase chain reaction (PCR). Forward and reverse primers (Table A.1)
were used to introduce mutations into the wild-type EIZS plasmid. PCR amplification
reagents were as follows: deionized H2O (33.5 μL), 10x PFu Ultra HF Buffer (5 μL),
dimethyl sulfoxide (DMSO) (2.5 μL), 10 mM dNTPs (4 μL), 150 ng/μL forward primer (1
μL), 150 ng/μL reverse primer (1 μL), 50 ng/μL wild-type EIZS template plasmid (2 μL),
and 2.5 U/μL PFu Ultra HF enzyme (1 μL) for a solution totaling 50 μL.
PCR reactions were run as follows: initial denaturation of the mixture at 90 °C for
1 min, followed by 30 cycles of denaturation at 90 °C for 30 s, annealing at 5–10 °C
below the Tm of primers (typically 55 °C) for 1 min, and extension at 72 °C for 7 min. A
final extension after 30 cycles was conducted at 72 °C for 10 min followed by a final hold
at 4 °C. The PCR mixture was incubated at 37 °C for 2 h with DpnI (1 μL), deionized H2O
(3 μL), and 10x CutSmart Buffer (6 μL) yielding 60 μL of DpnI digestion products. These
digested PCR products were then purified by adding 300 μL Qiagen Buffer PB and mixing
with 20 μL of 3M sodium acetate (pH 5.0). The mixture was placed in a QIAquick PCR
Purification Spin Column and centrifuged at 12,045 rcf for 1 min. A total of 750 μL
Qiagen Buffer PE (with EtOH) was added and centrifuged for 1 min at 12,045 rcf. The
column was placed in a 1.5 mL tube before applying 50 μL Qiagen Buffer EB. After
incubation at room temperature for 1 min, DNA was eluted by centrifugation for 1 min
at 12,045 rcf. Purified DNA was concentrated by vacuum to a volume of approximately
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12 μL, 2 μL of which was transformed into DH5α cells. Plasmid DNA was extracted from
single colonies with a QIAprep Spin Miniprep Kit. The target mutation was verified by
sequencing at the DNA Sequencing Facility of the University of Pennsylvania Perelman
School of Medicine.

3.2.2 Expression. Mutant proteins were expressed and purified using
procedures identical to those previously described.26 Briefly, all EIZS mutants were
expressed in BL21(DE3) E. coli and purified by Co2+ immobilized metal affinity
chromatography and size exclusion chromatography. F95E and F95D EIZS formed
inclusion bodies, so these mutants were not studied further.

3.2.3 Analysis of Sesquiterpene Product Arrays. Product array analyses
were conducted using gas chromatography-mass spectrometry (GC-MS) to determine
the terpenoid natural products produced by mutant proteins using procedures identical
to those previously reported.26 Briefly, the extracts of organic products resulting from
incubation of mutant enzymes with FPP were analyzed using an Agilent 5977A Series
GC/MSD instrument. Compounds were identified by comparison of their individual mass
spectra and specific retention indices with those of authentic compounds in the
MassFinder 4.0 Database. Product arrays for F96M EIZS and F96Q EIZS were analyzed in
duplicate to confirm high levels of sesquisabinene synthase activity.

3.2.4 Catalytic activity measurements. For the measurement of specific
activities, a substrate stock solution containing 500 μM FPP [97% FPP (Tris-potassium
salt, Echelon Biosciences) and 3% 3H-FPP (Tris-ammonium salt, American Radiolabeled
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Chemicals)] was prepared. Stock solutions of wild-type and mutant EIZS enzymes were
also prepared in buffer A [50 nM enzyme, 20 mM Tris (pH 7.5), 300 mM NaCl, 10 mM
MgCl2, 10% glycerol, 2 mM TCEP]; 20-μL aliquots of each were added to 470 μL of buffer
A. After the addition of 10 μL substrate stock solution to initiate the reaction, the final
concentration of enzyme was 2 nM in a total volume of 500 μL. After 15 min, reactions
were quenched by the addition of 38 μL of buffer B [0.5 M EDTA (pH 8.0)]. Products in
the resulting organic layer, upon clear phase separation, were extracted by overlaying
the reaction mixture with 2 x 700 μL of hexane, vortexing for 10 s, and then removing 2
x 600 μL of hexane. Great care was taken not to touch the aqueous layer containing
unreacted 3H-FPP, which would give false counts. The organic extracts were transferred
to silica gel columns, and the resulting eluate was collected in scintillation vials
containing 5 mL of scintillation fluid (Ecoscint). A total of 1 mL of diethyl ether was
applied after both extractions had eluted and collected in the scintillation vial and mixed
by vortexing. The final mixture in the scintillation vial was subject to radioactive
counting using a Beckman scintillation counter. Blanks were run in the absence of
radiolabeled FPP, counted, averaged, and subtracted from averaged readings measured
for each mutant enzyme. Measurements were made in quadruplicate.

3.2.5

X-ray

crystal

structure

determinations.

Heterogeneous

microseeding was used to crystallize EIZS mutants. Crystals of wild-type EIZS in complex
with Mg2+3, benzyl triethylammonium cation (BTAC), and PPi were grown as previously
described,25 then manually crushed in the 8 μL crystallization drop. A 10 μL drop of
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precipitant solution [0.1 M bis-Tris (pH 5.5), 0.2 M (NH4)2SO4, 25% (w/v) polyethylene
glycol (PEG) 3350] was added to the drop containing crushed crystals, and the resulting
18 μL drop was transferred to 162 μL of precipitant solution to create a 10x dilution
seed stock. This tube was vortexed briefly to further break up the crystals. Finally, this
solution was diluted with precipitant solution (1:9) to generate a 100x dilution seed
stock, which was vortexed thoroughly to produce individual crystal nuclei and stored at
4 °C.
F95Y EIZS was crystallized by the sitting drop vapor diffusion method. A 0.5 μL
drop of protein solution [5 mg/mL protein, 300 mM NaCl, 20 mM Tris-HCl (pH 7.5), 10
mM MgCl2, 2 mM tris(2-carboxyethyl)phosphine (TCEP), 10% glycerol, 2 mM sodium
pyrophosphate, 2 mM BTAC] was added to 0.6 μL of precipitant solution [0.17 M sodium
acetate trihydrate, 85 mM sodium cacodylate trihydrate (pH 6.5), 25.5% PEG 8000, 15%
glycerol]. This was followed by addition of 0.1 μL of 100x dilution wild-type EIZS
crystallization seed stock. The drop was equilibrated against a 100 μL reservoir of
precipitant solution at room temperature. Crystals appeared after 6 days and diffracted
X-rays to a resolution of 1.80 Å on NE-CAT beamline 24-ID-C at the Advanced Photon
Source (APS; Chicago, Illinois). Crystals belonged to space group P21 with unit cell
parameters a = 52.1 Å, b = 46.8 Å, c = 75.7 Å; β = 96.9° (one molecule in the asymmetric
unit).
F95N EIZS was crystallized by the sitting drop vapor diffusion method. A 0.5 μL
drop of protein solution [4 mg/mL protein, 20 mM Tris (pH 7.5), 300 mM NaCl, 10 mM
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MgCl2, 10% (v/v) glycerol, 2 mM TCEP, 2 mM sodium pyrophosphate, 2 mM BTAC] was
added to 0.6 μL of precipitant solution [0.2 M MgCl2·6H2O, 0.1 M 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) (pH 7.5), 25% (w/v) PEG 3350], followed by
addition of 0.1 μL of 100x dilution wild-type EIZS crystallization seed stock. The drop was
equilibrated against a 100 μL reservoir of precipitant solution at room temperature.
Crystals appeared within 1 month and diffracted X-rays to 2.40 Å resolution at the
Stanford Synchrotron Radiation Lightsource (SSRL), beamline 14-1, SLAC National
Accelerator Laboratory (Menlo Park, CA). Crystals belonged to space group P21 with unit
cell parameters: a = 52.9 Å, b = 47.2 Å, c = 75.5 Å; β = 96.0° (one molecule in the
asymmetric unit).
F95C EIZS was crystallized by the sitting drop vapor diffusion method. A 0.5 μL
drop of protein solution [4 mg/mL protein, 20 mM Tris (pH 7.5), 300 mM NaCl, 10 mM
MgCl2, 10% (v/v) glycerol, 2 mM TCEP, 2 mM sodium pyrophosphate, 2 mM BTAC] was
added to 0.6 μL of precipitant solution [0.2 M MgCl2·6H2O, 0.1 M bis-Tris (pH 6.5), 25%
(w/v) PEG 3350], followed by addition of 0.1 μL of 100x dilution wild-type EIZS
crystallization seed stock. The drop was equilibrated against a 100 μL reservoir of
precipitant solution at room temperature. Crystals appeared within 1 week and
diffracted X-rays to 1.90 Å resolution at SSRL, beamline 14-1. Crystals belonged to space
group P21 with unit cell parameters: a = 51.6 Å, b = 46.8 Å, c = 75.4 Å; β = 98.2° (one
molecule in the asymmetric unit).
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W203Y EIZS was crystallized by the sitting drop vapor diffusion method. A 0.5 μL
drop of protein solution [4.1 mg/mL protein, 300 mM NaCl, 20 mM Tris-HCl (pH 7.5), 10
mM MgCl2, 2 mM TCEP, 10% glycerol, 2 mM sodium pyrophosphate, 2 mM BTAC] was
added to 0.6 μL of precipitant solution [0.2 M (NH4)2SO4, 0.1 M 2-(Nmorpholino)ethanesulfonic acid monohydrate pH 6.5, 30% PEG monomethyl ether
5000]. This was followed by addition of 0.1 μL of 100x dilution wild-type EIZS
crystallization seed stock. The drop was equilibrated against a 100 μL reservoir of
precipitant solution at room temperature. Crystals appeared after 2 days and diffracted
X-rays to 1.8 Å at SSRL, beamline 9-2. Crystals belonged to space group P212121 with unit
cell parameters a = 46.5 Å, b = 75.0 Å, c = 107.6 Å (one molecule in the asymmetric unit).
F96S EIZS was crystallized by the sitting drop vapor diffusion method. A 0.5 μL
drop of protein solution [5 mg/mL protein, 300 mM NaCl, 20 mM Tris-HCl (pH 7.5), 10
mM MgCl2, 2 mM TCEP, 10% glycerol, 2 mM sodium pyrophosphate, 2 mM BTAC] was
added to 0.6 μL of precipitant solution [1.0 M ammonium citrate tribasic (pH 7.0), 0.1 M
bis-Tris propane (pH 7.0)]. This was followed by addition of 0.1 μL of 100x dilution wildtype EIZS crystallization seed stock. The drop was equilibrated against a 100 μL reservoir
of precipitant solution at room temperature. Crystals appeared after 2 days and
diffracted X-rays to 2.10 Å resolution at APS, NE-CAT beamline 24-ID-C. Crystals
belonged to space group P212121 with unit cell parameters a = 46.9 Å, b = 76.7 Å, c =
108.8 Å (one molecule in the asymmetric unit).
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X-ray diffraction data sets for F95N and F95C EIZS were indexed, integrated, and
scaled using HKL2000.27 Data sets for F95Y, F96S, F96H, and W203Y EIZS were indexed,
integrated, and scaled using iMOSFLM.28 The crystal structures of these mutants were
determined by molecular replacement with PHASER29 using the crystal structure of the
wild-type EIZS-Mg2+3-PPi-BTAC complex (PDB 3KB9) as a search probe for rotation and
translation function calculations. Manual model building and refinement were
performed with COOT and PHENIX, respectively.30,31 Structure validation of each final
model was performed using MolProbity.32 All molecular superpositions were calculated
via the SSM superpose function in Coot and/or the align tool in Pymol.33,34 Data
collection and refinement statistics for EIZS mutants F95Y, F95N, F95C, F96S, and W203Y
are recorded in Table 3.1.
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Table 3.1: Data collection and refinement statistics
EIZS Mutant
(Mg2+3,–PPi– BTAC
complex)

F95Y

W203Y

APS
0.98
51.74-1.80
(1.84-1.80)

SSRL
0.98
37.52-1.82
(1.86-1.82)
193111
(11067)

F95N

F95C

F96S
(unliganded)

Data Collection
Beamline
Wavelength (Å)
Resolution (Å)
(outer shell)
Total reflections
Unique reflectionsa
Completenessa
Redundancya
I/σ(I)a
Rmergea,b
CC1/2a,c

SSRL
1.18
32.53-1.90
(1.97-1.90)

33846 (1923)
98.0 (95.1)
5.7 (5.8)
9.1 (2.8)
0.116 (0.538)
0.993 (0.802)

SSRL
1.18
39.95-2.40
(2.49-2.40)
52707
(4296)
14666 (1432)
99.9 (99.2)
3.6 (3.6)
5.6 (2.2)
0.132 (0.458)
0.988 (0.853)

54127
(10152)
28111 (2603)
98.8 (92.5)
4.1 (3.9)
9.9 (2.5)
0.143 (0.553)
0.992 (0.810)

APS
0.98
54.39-2.10
(2.18-2.10)
144593
(11901)
23391 (1886)
99.1 (98.2)
6.2 (6.3)
6.1 (2.8)
0.428 (2.410)
0.970 (0.520)

0.170/0.213
(0.223/0.264)

0.195/0.223
(0.245/0.271)

0.186/0.243
(0.227/0.256)

0.154/0.192
(0.188/0.224)

0.176/0.222
(0.212/0.273)

0.008
0.9

0.004
0.7

0.008
1.1

0.015
1.4

0.006
0.8

2710
26
262

2710
26
340

2699
26
48

2719
31
187

2497
-243

15
18
27

16
17
28

32
31
30

24
28
31

19
---29

99
1.2
0
6AXM

99
0.86
0
6AXU

97
2.96
0.30
6AX9

99
1.48
0
6AXN

99
1.31
0
6AXO

97646
(5764)
32978 (1920)
97.6 (98.6)
3.0 (3.0)
7.0 (2.5)
0.125 (0.688)
0.986 (0.572)

Refinement
Rwork/Rfreea,d
Rms deviations
bonds (Å)
angles (deg)
Number of nonhydrogen atoms
protein
ligands
solvent
Average B-factors
(Å2)
protein
ligands
solvent
Ramachandran
plote
favored
allowed
outliers
PDB accession code
a

Values in parentheses refer to the data from the highest shell. bRmerge = ∑|Ih − ⟨I⟩h|/∑Ih,
where ⟨I⟩h is the average intensity calculated for reflection h from replicate
measurements. cPearson correlation coefficient between random half-datasets. dRwork =
∑||Fo| − |Fc||/∑|Fo| for reflections contained in the working set; |Fo| and |Fc| are the
observed and calculated structure factor amplitudes, respectively. Rfree is calculated
using the same expression for reflections contained in the test set held aside during
refinement. eCalculated with MolProbity.
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3.3 Results
3.3.1 Sesquiterpene Product Generation. Product arrays generated by 14
EIZS mutants were analyzed using GC-MS (Table 3.2). All products detected and
identified in the current study and in our previous study of active site mutants26
represent derailment of key carbocation intermediates in the reaction sequence leading
to epi-isozizaene (Figure 3.3). In general, substitution of polar amino acids for F95, F96,
and W203 attenuates the production of epi-isozizaene by remolding the active site
contour, thereby enabling the generation of alternative products. In contrast, Y69
mutations largely maintain biosynthetic fidelity for the generation of epi-isozizaene,
with Y69F and Y69A EIZS generating 84% and 66% epi-isozizaene, respectively. Y69F EIZS
also generates 6% zizaene and 4% β-cedrene, while Y69A EIZS also generates 7% zizaene
and 5% prezizaene. Both mutants generate a small proportion of unidentified products
(<8%). Thus, perturbation of Y69, which buttresses F96, has a minor impact on the
template function of the active site pocket.
Polar mutations at the F95 position seem to perturb the active site contour to a
lesser degree than mutations at F96, since epi-isozizaene is generated by all four F95
mutants. F95Y EIZS maintains the highest level of cyclization fidelity, generating 67% epiisozizaene. However, acyclic side products generated by F95Y EIZS, (E)-nerolidol (27%)
and (E)-β-farnesene (5%), reflect early derailment of the FPP cyclization cascade. Other
F95 mutants that generate notable products include F95N EIZS, which generates 28% βcurcumene and 18% α-bisabolol, and F95Q EIZS, which is a curcumene synthase that
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generates 29% β-curcumene and 25% γ-curcumene. F95C EIZS also makes 22% γcurcumene in addition to 23% α-neocallitropsene. The generation of curcumene isomers
reflects successful isomerization and cyclization of FPP, as well as the 1,2-hydride
transfer leading to the homobisabolyl cation. The substitution of smaller and polar
residues in place of F95 uniformly compromises the cyclization of the homobisabolyl
cation that would generate the acorenyl cation.
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Table 3.2: Sesquiterpene products generated by EIZS mutantsa
Product
4-epi-β-patchoulene

RIb
1376

cis-α-bergamotene

1411

α-cedrene

1418

β-cedrene

1424

selina-4(15),5-diene

1433

sesquisabinene

1435

2

1

78

epi-isozizaene

1444

79

5

67

6

6

1

(E)-β-farnesene

1446

5

1

5

1

1

prezizaene

1452

zIzaene

1456

α-neocallitropsene

1475

γ-curcumene

1475

(E,E)-α-farnesene

1498

β-bisabolene

1503

β-curcumene

1503

28

29

2

(Z)-γ-bisabolene

1505

3

5

3

(E)-nerolidol

1553

6

3

9

acorenol
α-bisabolol

1667
1673

2
13

3
4

farnesol

1694

Unknown

--

Trace products

--

aEach

Wild-typec

F95N

F95Y

F95Q

F95C

F96S

F96T

F96H

F96N

F96M
9

F96Q

Y69F

Y69A

4

5

W203Y
3

W203H
6

19

9

4
2

<1

3

2

5

5
<1
18

91

97

30

18

<1

23

25

22

5

1

18

14

25

<1

<2

1

5

<1

6

7

9

<1

2

<1

2

15

3

<1
<1

8

35
5

73

5

3

42

38

2

2

10

24
24

5
39

6

5
6

27

66
2

9
1

1
84

7

46
5
<3

8

2
<2

3

5

6

<3

1

product is reported as a percentage of total products generated. bRI, retention index (MassFinder 4.0 Database). cRefs. 25 & 26
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Figure 3.3: Biosynthetic manifold illustrating the proposed reaction mechanisms of FPP
cyclization leading to products identified by GC-MS analysis catalyzed by wild-type and
mutant EIZS enzymes. The predominant product generated by the wild-type enzyme,
epi-isozizaene, is highlighted in a cyan box. Each product that is generated
predominantly by a mutant enzyme is highlighted in a blue box. Minor products are
shown in yellow boxes. This manifold updates that previously reported by Li and
colleagues.26 New products identified in the current study are highlighted by red
borders, and new EIZS mutants are italicized. With regard to product stereochemistry,
the absolute configurations of (+)-epi-isozizaene, (+)-β-cedrene, and (–)-β-cedrene
shown above have been experimentally determined.22,26 The absolute configurations of
all remaining sesquiterpene products have not been experimentally determined and are
arbitrarily illustrated. The generation of their enantiomers can be readily
accommodated by simple variations of the reaction mechanisms shown.
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Two polar amino acid substitutions were made in place of W203. Both W203H
and W203Y EIZS generate (Z)-γ-bisabolene (30% and 42%, respectively); W203H EIZS
additionally generates 19% α-bisabolol and 7% sesquisabinene. W203Y EIZS also
generates 18% sesquisabinene.
Polar and nonpolar amino acid substitutions in place of F96 generate significant
quantities of sesquisabinene. In particular, F96Q, F96M, and F96S EIZS generate
sesquisabinene with high fidelity (97%, 91%, and 78% respectively). Interestingly, F96Q
and F96S EIZS generate minor products that reflect derailment of the cyclization cascade
following the initial C1-C6 cyclization reaction yielding the bisabolyl cation, 3% βbisabolene and 8% (Z)- γ-bisabolene, respectively. In contrast, F96M EIZS generates 9%
4-epi-β-patchoulene, which represents an alternative quenching pathway for the final
carbocation intermediate.
Three more polar amino acid substitutions in place of F96 yield product arrays
reflecting early quenching of reaction intermediates just before or after formation of
the bisabolyl cation intermediate. F96T EIZS generates 35% (Z)-γ-bisabolene and 30%
(E)-β-farnesene. F96H EIZS generates (E)-nerolidol with high fidelity at 73%, in addition
to 18% (E)-β-farnesene. F96N EIZS generates 46% farnesol in addition to 18%
sesquisabinene. It is interesting to note that none of the F96 mutants generate epiisozizaene except for F96S EIZS (1%), so F96 is clearly a critical residue for cyclization
fidelity in the final steps of epi-isozizaene formation.
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3.3.2 Catalytic Activity. [All] 14 EIZS mutants exhibit specific activities that
range 21–44% of that measured for the wild-type enzyme (Table 3.3). No correlation is
evident between the measured activity loss and the site of mutation or the polarity of
the mutation. Although the mutation of aromatic residues in the enzyme active site
reduces the rate of production of hydrocarbon products, it is notable that rate
reductions are relatively minor, in that all mutants exhibit specific activities that are
within an order of magnitude of that measured for wild-type EIZS.
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Table 3.3: Catalytic Activities of EIZS Mutants
Enzyme
Wild-type
F95Y
W203Y
F96Q
F96M
F96N
W203H
F96S
F96H
F96T
F95Q
F95C
F95N
Y69A
Y69F

Specific Activity
(nmol product/min)/(μM enzyme)
18 ± 2
8±4
6±2
8±2
7.0 ± 0.6
4±1
4.2 ± 0.6
4±2
5.8 ± 0.6
5.9 ± 0.4
5.916 ± 0.002
5.5 ± 0.6
5±2
5±2
7.6 ± 0.4
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3.3.3 Crystal Structures of Selected EIZS Mutants. Crystal structures of
[5] representative EIZS mutants were determined at resolutions of [1.80 – 2.40 Å]. We
present crystal structures of three F95 mutants, [one] F96 mutant, and one W203
mutant. [The mutant crystal structure at F96 is the first structures solved for EIZS at this
position.] These mutants were selected for further structural study to determine the
consequences of aromatic-to-polar residue substitutions in the active site.
The 1.8 Å resolution structure of the F95Y EIZS-Mg2+3-PPi-BTAC complex is quite
similar to that of the wild-type EIZS-Mg2+3-PPi-BTAC complex, with a root-mean-square
deviation (rmsd) of 0.18 Å for 284 Cα atoms. The aromatic rings of Y95 and F95
superimpose nearly perfectly, and the hydroxyl group of Y95 forms a new hydrogen
bond with the backbone carbonyl of T197 (Figure 3.4). T197 is located at the break in
helix G; backbone carbonyl groups at this break, as well as the helix dipole, are
hypothesized to play a role in stabilizing carbocation intermediates in catalysis.35,36 The
position of the aromatic ring of BTAC is very similar to that observed in its complex with
wild-type EIZS. There are no significant changes in PPi and Mg2+ binding to F95Y EIZS
compared to wild-type EIZS.
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Figure 3.4: F95Y EIZS Active Site (a) Stereoview of a simulated annealing omit map of
the F95Y EIZS-Mg2+3-PPi-BTAC complex contoured at 3.0σ. Atoms are color coded as
follows: C = slate (Y95), yellow (protein), or green (BTAC); N = blue; O = red; P = orange;
Mg2+ ions = magenta spheres. The phenolic hydroxyl group of Y95 forms a new
hydrogen bond with the backbone carbonyl oxygen of T197 (dashed line). Selected
active site residues are indicated. (b) Superposition of the F95Y EIZS-Mg2+3-PPi-BTAC
complex (yellow) with the wild-type EIZS-Mg2+3-PPi-BTAC complex (blue; PDB 3KB9)
Minimal structural differences are observed for active site aromatic residues and BTAC.
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The 1.82 Å resolution structure of the W203Y EIZS-Mg2+3-PPi-BTAC complex is
very similar to that of the wild-type EIZS-Mg2+-PPi-BTAC complex, with an rmsd of 0.19 Å
for 316 Cα atoms. The W203Y substitution deepens the active site, and the hydroxyl
group of Y203 forms a new hydrogen bond with S92 (Figure 3.5). The increased active
site volume resulting from the W203Y substitution enables the binding of two new
ordered water molecules at the base of the active site. One of these water molecules,
#102, forms hydrogen bonds with Q233 and the backbone carbonyl of F198. The second
water molecule, #31, is hydrogen bonded to water #102 and also makes a 4.4 Å contact
with the BTAC cation. The BTAC molecule is characterized by clear electron density and
the orientation of its phenyl ring is similar to that observed in its complex with the wildtype enzyme; some conformational differences are observed for BTAC ethyl groups.
There are no significant changes in PPi and Mg2+ binding to W203Y EIZS compared to
wild-type EIZS.
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Figure 3.5: W203Y EIZS Active Site (a) Stereoview of a simulated annealing omit map of
the W203Y EIZS-Mg2+3-PPi-BTAC complex contoured at 2.5σ. Atoms are color coded as
follows: C = slate (Y203), yellow (protein), or green (BTAC); N = blue; O = red; P = orange;
Mg2+ ions = magenta spheres. The phenolic hydroxyl group of Y203 forms a new
hydrogen bond with S92. The steric void resulting from the W203Y substitution allows
two hydrogen bonded water molecules to bind, one of which forms a hydrogen bond
with Q233. Selected active site residues are indicated; hydrogen bonds are shown as
dashed lines. (b) Superposition of the W203Y EIZS-Mg2+3-PPi-BTAC complex (yellow) with
the wild-type EIZS-Mg2+3-PPi-BTAC complex (blue; PDB 3KB9). Apart from structural
differences at position 203, the mutation has minimal effect on active site aromatic
residues and BTAC.
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The 2.40 Å resolution structure of the F95N EIZS-Mg2+3-PPi-BTAC complex is very
similar to that of the wild-type EIZS-Mg2+-PPi-BTAC complex, with an rmsd of 0.18 Å for
304 Cα atoms. Although electron density is weak for the Nδ atom of the side chain of
N95, the N! and Oδ atoms of the substituted side chain nearly perfectly superimpose on
the Cδ1 and Cδ2 atoms of F95 in the wild-type enzyme (Figure 3.6). Additionally, the Nδ
atom of N95 forms a new hydrogen bond with Y91, and the Oδ atom is 3.1 Å from the
phenyl ring of BTAC.
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Figure 3.6: F95N EIZS Active Site (a) Stereoview of a simulated annealing omit map of
the F95N EIZS-Mg2+3-PPi-BTAC complex contoured at 3.0σ. Atoms are color coded as
follows: C = slate (N95), yellow (protein), or green (BTAC); N = blue; O = red; P = orange;
Mg2+ ions = magenta spheres. The carboxamide NH2 group of N95 forms a new
hydrogen bond with Y91 (dashed line). Selected active site residues are indicated. (b)
Superposition of the F95N EIZS-Mg2+3-PPi-BTAC complex (yellow) with the wild-type
EIZS-Mg2+3-PPi-BTAC complex (blue; PDB 3KB9). The orientation of BTAC is flipped as one
structure is compared with the other.
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The increased active site volume resulting from the F95N substitution appears to
cause BTAC to flip relative to its position in the wild-type enzyme. However, electron
density for BTAC is very noisy, which may be a consequence of the moderate resolution
of the structure determination, molecular disorder, or both. Disordered BTAC binding in
the EIZS active site enlarged by the F95N substitution could indicate that binding of
substrate and carbocation intermediate is also disordered. Such disordered binding may
be responsible for the generation of quenching products derived from carbocations
generated early in the cyclization cascade, such as 28% β-curcumene and 18% αbisabolol. This is consistent with previous studies in which changes in BTAC
conformation signaled derailed cyclization cascades for EIZS mutants.25,26 The
appearance of product α-bisabolol is particularly notable, since such hydroxylated
products were not detected in product arrays resulting from nonpolar amino acid
substitutions in the active site.26 The additional active site volume and polarity resulting
from the F95N substitution presumably allow a water molecule to become trapped in
the active site, which can then quench the bisabolyl cation intermediate.
The 1.90 Å resolution structure of the F95C EIZS-Mg2+3-PPi-BTAC complex is very
similar to that of the wild-type EIZS-Mg2+3-PPi-BTAC complex, with an rmsd of 0.17 Å for
265 Cα atoms. Electron density for C95 indicates two conformations; the major
conformation (75% occupancy) places the Sγ atom 3.6 Å away from hydroxyl group of
Y91, and the minor conformation (25% occupancy) places the Sγ atom 4.5 Å away from
the hydroxyl group of Y172 (Figure 3.7). Side chain flexibility for C95 may contribute to
the emergence of a [rarely observed] product, α-neocallitropsene (23%), which is
178

generated at only minor levels by F95N EIZS (1%) and F95Q EIZS (<1%). The binding
mode of BTAC is essentially unchanged from that observed in the wild-type enzyme,
although noisy electron density may reflect some degree of disorder.
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Figure 3.7: F95C EIZS Active Site (a) Stereoview of a simulated annealing omit map of
the F95C EIZS-Mg2+3-PPi-BTAC complex contoured at 3.0σ. Atoms are color coded as
follows: C = slate (C95), yellow (protein), or green (BTAC); N = blue; O = red; P = orange;
Mg2+ ions = magenta spheres. Selected active site residues are indicated. (b)
Superposition of the F95C EIZS-Mg2+3-PPi-BTAC complex (yellow) with the wild-type EIZSMg2+3-PPi-BTAC complex (blue; PDB 3KB9). The side chain of C95 is disordered between
two conformations.
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The 2.1 Å resolution structure of unliganded F96S EIZS is similar to that of
unliganded wild-type EIZS, with an rmsd of 0.24 Å for 246 Cα atoms. Significant disorder
is observed in the A57–L67 and G337–N355 segments located in helices adjacent to the
active site. In previously solved structures of unliganded wild-type EIZS and unliganded
D99N EIZS, the A57–L67 segment is ordered but the S336–N355 segment is
disordered.25,26 Additionally, the I249-E253 segment is disordered in unliganded wildtype EIZS, but this segment is ordered in F96S EIZS. No electron density is observed for
BTAC, Mg2+ ions, or PPi in the crystal structure of F96S EIZS even though these ligands
were included in the crystallization drop.
Two conformers of S96 are observed: The first (64% occupancy) places the
hydroxyl group 2.5 Å from the backbone carbonyl oxygen of A93 and 2.9 Å from the
backbone NH group of V97; the second (36% occupancy) places the hydroxyl group 3.1 Å
from the S96 backbone carbonyl oxygen (Figure 3.8).
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Figure 3.8: F96S EIZS Active Site (a) Simulated annealing omit map of unliganded F96S
EIZS contoured at 3.0σ. Atoms are color coded as follows: C = slate (S96) or yellow
(protein); N = blue; O = red. (b) Superposition of unliganded F96S EIZS (yellow) with
unliganded wild-type EIZS (teal; PDB 4LTV) and the wild-type EIZS-Mg2+3-PPi-BTAC
complex (blue; PDB 3KB9). The side chains of S96 and D99 are each disordered between
two conformations, and the side chain of Y69 exhibits significant conformational
variability in response to structural changes in F96, the residue that it buttresses.
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3.4 Discussion
For the past 20 years,37-39 X-ray crystal structures of class I and class II terpenoid
cyclases have revealed hydrophobic active site cavities that serve as templates to
chaperone the folding of flexible lipophilic substrates, thereby specific binding
conformations leading to the formation of specific cyclization products. The most critical
function of the template is to stabilize the flexible substrate in the correct binding
conformation before the initial carbocation is formed. Class I cyclases such as epiisozizaene synthase generate an initial allylic carbocation through the metal iontriggered ionization of the substrate diphosphate group,25 whereas class II cyclases such
as ent-copalyl diphosphate synthase generate an initial tertiary carbocation by
protonation of an isoprenoid carbon-carbon double bond (or epoxide) with an aspartic
acid serving as a general acid.40,41 Such carbocation intermediates are highly reactive
and susceptible to rapid quenching by water in the aqueous milieu of the cell. The
terpenoid cyclase active site has evolved with protective measures, however, enclosing
carbocation intermediates in a hydrophobic pocket that is usually inaccessible to bulk
solvent. Typically, chemically-inert aliphatic and aromatic amino acid residues define the
contour of the active site pocket – i.e., the cyclization template – with the added benefit
of carbocation stabilization by aromatic residues through cation-π interactions.
Conventional wisdom regarding the active site pocket of a terpenoid cyclase is
occasionally subject to curious exceptions – some active site pockets contain polar and
potentially reactive elements. For example, the crystal structures of bornyl diphosphate
synthase and aristolochene synthase complexed with analogues of substrates and
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carbocation intermediates reveal the binding of trapped water molecules in the
enclosed active site, even though these cyclases do not utilize water in their reaction
mechanisms.42,43 Additionally, the crystal structure of methylisoborneol synthase reveals
a negatively charged glutamate at the base of the active site pocket, yet this negatively
charged residue does not influence the cyclization cascade.44 Nature thus defies
conventional wisdom, in that polar residues, charged residues, and even solvent
molecules are rendered inert when they are incorporated in the active site pocket of a
terpenoid cyclase.
Can we follow Nature's lead and similarly defy conventional wisdom by
introducing polar residues in the active site pocket of a terpenoid cyclase? EIZS serves as
an excellent paradigm system to explore this question. We now show that polar
residues can be substituted for aromatic residues to yield functional EIZS catalysts that
generate new product arrays with appreciable catalytic activity. There can be
limitations, however, particularly with the most radical amino acid substitutions. For
example, F95D EIZS and F95E EIZS expressed poorly, and although expression was
confirmed the mutant proteins were generally insoluble. As with any mutagenesis
experiment, certain amino acid substitutions can compromise protein folding and
stability, and the substitution of aromatic residues in the hydrophobic protein core or a
hydrophobic active site may be particularly susceptible to such deleterious effects. Even
so, for those mutants that did express well as folded proteins and yielded X-ray crystal
structures, the amino acid substitutions did not trigger significant compensatory
structural changes in enzyme active sites. Thus, to a close approximation, the structural
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consequences of remolding a terpenoid cyclase active site by substitution of surface
residues (Figures 3.4-3.7) ought to be readily predictable by molecular modeling.
Even so, this expectation is not universal. For example, the F96S substitution
exposes the formerly-buttressing residue Y69, which undergoes compensatory
structural changes as a new surface residue additionally poised to engage in cation-π
interactions, taking the place of F96 in this role (Figure 3.8). Moreover, F96 undergoes
induced-fit conformational changes upon the binding of Mg2+3-PPi in the EIZS active
site,26,27 so this residue exemplifies the challenges in molecular modeling approaches:
the three-dimensional contour of the active site in the fully closed conformation can
differ from that in the open, unliganded conformation.
In the current work, we successfully prepared and analyzed 14 new EIZS mutants
in which active site aromatic residues were substituted mainly with neutral polar
residues (serine, threonine, asparagine, glutamine, histidine, and tyrosine) or weakly
polar residues (cysteine and methionine) as summarized in Table 3.2. Importantly, these
mutants generate 9 new products that have not been observed in the product arrays of
any previously reported EIZS mutants, with three mutants generating sesquisabinene as
the predominant product (Figure 3.3). New products include those resulting from
proton elimination from a carbocation intermediate, including γ-curcumene, βbisabolene, and 4-epi-β-patchoulene; additionally, cis-α-bergamotene results from a 7,2
ring closure reaction with the bisabolyl cation. Other products result from water capture
of a carbocation intermediate, including farnesol, nerolidol, acorenol, and α-bisabolol.
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Thus, the introduction of polarity into a terpenoid cyclase active site can enable the
generation of hydroxylated terpenoid products.
Strikingly, the F96S, F96M, and F96Q substitutions convert EIZS into a highfidelity sesquisabinene synthase, with these mutants generating 78%, 91%, and 97%
sesquisabinene in their respective product arrays. The conversion of EIZS into a highfidelity sesquisabinene synthase has not been previously observed. While D99E EIZS
generates 24% sesquisabinene,25 and other aromatic mutants generate 1–19%
sesquisabinene (Table 3.2), the substitution of smaller polar residues for F96 seems to
be of chief importance in redirecting the FPP cyclization cascade toward sesquisabinene
formation through conformational control of the preceding homobisabolyl carbocation
intermediate. Molecular features that contribute to this new enzyme activity include the
introduction of additional volume in the position of F96 in the closed conformation, and
the retention of potential cation-π interactions through compensatory structural
changes of Y69 – the ring face of this formerly-buttressing residue forms a new wall of
the active site, as observed in F96S EIZS (Figure 3.8).
In essence, F96 appears to be a hot spot for sesquisabinene formation when
substituted with smaller, polar residues. It is intriguing, however, that although the
F96S, F96M, and F96Q substitutions convert EIZS into a sesquisabinene synthase, the
F96T and F96N substitutions do not. F96T EIZS generates (Z)-γ-bisabolene and (E)-βfarnesene as its predominant products, and F96N EIZS generates a mixture of
sesquiterpene products in which farnesol predominates. At present, we do not have a
plausible explanation for this observation. However, it is interesting to note that (Z)-γ186

bisabolene can also derive from the homobisabolyl carbocation intermediate, as does
sesquisabinene, so perhaps the unique steric and polar environment resulting from the
F96T substitution is simply less conducive for the transannular ring closure leading to
sesquisabinene formation; a simple proton elimination to yield (Z)-γ-bisabolene is
instead favored.
Interestingly, two naturally occurring sesquisabinene synthases, SASQS1 and
SASQS2, have recently been isolated from Santalum album L. (Indian sandalwood),
which is well known for its fragrant heartwood oil.45 This essential oil comprises a blend
of sesquiterpene hydrocarbons and alcohols and exhibits useful antimicrobial,
antiinflammatory, and antitumor properties.46-48 SASQS1 and SASQS2 each contain 566
residues and are related by 80% amino acid sequence identity; based on amino acid
sequence analysis, each enzyme adopts the characteristic αβ domain architecture49,50 of
a plant sesquiterpene cyclase. As class I terpenoid cyclases, the locus of catalytic activity
resides exclusively in the α domain of each enzyme.
Despite the fact that crystal structures of SASQS1 and/or SASQS2 have not been
reported to date, it is reasonable to assume that the three-dimensional contours of their
active sites are similar to those of F96 EIZS mutants that generate sesquisabinene with
high fidelity. Although a detailed comparison between the naturally occurring enzymes
and EIZS mutants must await experimental crystal structure determinations of SASQS1
and/or SASQS2, it is interesting to note that both sesquisabinene synthases have a polar
amino acid side chain in a position that aligns with F96 of EIZS based on amino acid
sequence analysis. On helix D of EIZS, the amino acid sequence is F95FVWDDRHD,
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whereas the corresponding sequence of both sesquisabinene synthases is I312TTIDDVYD.
Thus, F96 of EIZS aligns with T313 of sesquisabinene synthase. Perhaps the polar amino
acid side chain on the active site face of helix D of sesquisabinene synthase plays a role
in facilitating sesquisabinene formation. Future structural and functional studies of the
sesquisabinene synthases may clarify this speculation.
Finally, it is interesting to compare the results acquired with EIZS with those
reported for mutants of 5-epi-aristolochene synthase in which nucleophilic cysteine and
glutamate residues were similarly introduced in the hydrophobic active site pocket.51
Alkylation and inactivation of certain mutants was observed; however, the substituted
nucleophilic side chain was not the site of covalent modification. Instead, conserved
active site residues were alkylated in response to perturbation of the active site
structure. Thus, for a nucleophilic side chain to react with a carbocation in a terpenoid
cyclase active site, it must be precisely positioned for reaction. If not, then the
nucleophile is essentially inert.
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3.5 Concluding Remarks
Including the 14 new mutants described in the current work, our EIZS library now
contains 40 different single-site mutants in which the hydrophobic active site pocket is
modified. Each mutant exhibits a distinct product profile – remolding the contour of the
active site pocket, even by just a single residue, can unmask new reaction pathways.
Notably, each new pathway represents a derailment of the natural cyclization cascade,
in that each new product identified derives from a key carbocation intermediate
encountered in the cyclization pathway leading to epi-isozizaene. Overall, we have
quintupled the number of characterized products generated by EIZS. Moreover, we have
converted EIZS into 9 different sesquiterpene synthases, as summarized in Figure 3.1.
Our previous study26 focused on the substitution of aromatic and aliphatic
residues in the EIZS active site with other nonpolar residues. We had assumed that the
introduction of polar residues would disfavor binding of the lipophilic substrate and risk
reaction with carbocation intermediates to deactivate the enzyme. Surprisingly,
however, EIZS appears to be quite tolerant of polar residues introduced in the
hydrophobic active site pocket. Indeed, the substitution of polar residues for F96 led to
the generation of new high-fidelity sesquisabinene synthases. Thus, more radical
nonpolar-polar amino acid substitutions in the hydrophobic pockets of terpenoid
cyclases should be considered in efforts to explore and expand product chemodiversity
through protein engineering.
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3.6 Additional Information
The Supporting Information is available free of charge on the ACS Publications
website. Table S1 has been adapted to A.1 and is included in the Appendix of this
dissertation for reader convenience.
Accession Codes pertaining to the atomic coordinates and crystallographic
structure factors of EIZS mutants F95Y, W203Y, F95N, F95C, and F96S have been
deposited in the Protein Data Bank (www.rcsb.org) with accession codes 6AXM, 6AXU,
6AX9, 6AXN, and 6AXO, respectively.
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Chapter 4: Crystal Structure of F95Q epi-Isozizaene Synthase, an
Engineered Sesquiterpene Cyclase that Generates Biofuel
Precursors β- and γ-Curcumene
Adapted with permission from Blank, P.N., Barrow, G.H., Christianson, D.W.
(2019) Crystal Structure of F95Q epi-Isozizaene Synthase, an Engineered
Sesquiterpene Cyclase that Generates Biofuel Precursors β- and γ-Curcumene.
Journal of Structural Biology 207(1), 218-224. Copyright 2019 Elsevier.

4.0 Abstract
The saturated hydrocarbon bisabolane is a diesel fuel substitute that can be
derived from sesquiterpene precursors bisabolene or curcumene. These sesquiterpenes
are generated from farnesyl diphosphate in reactions catalyzed by eponymous
terpenoid cyclases, but they can also be generated by engineered terpenoid cyclases in
which cyclization cascades have been reprogrammed by mutagenesis. Here, we describe
the X-ray crystal structure determination of F95Q epi-isozizaene synthase (EIZS), in
which the new activity of curcumene biosynthesis has been introduced and the native
activity of epi-isozizaene biosynthesis has been suppressed. F95Q EIZS generates β- and
γ-curcumene regioisomers with greater than 50% yield. Structural analysis of the closed
active site conformation, stabilized by the binding of 3 Mg2+ ions, inorganic
pyrophosphate, and the benzyltriethylammonium cation, reveals a product-like active
site contour that serves as the cyclization template. Remolding the active site contour to
resemble curcumene instead of epi-isozizaene is the principal determinant of the
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reprogrammed cyclization cascade. Intriguingly, an ordered water molecule comprises
part of the active site contour. This water molecule may also serve as a final proton
acceptor, along with inorganic pyrophosphate, in the generation of curcumene
regioisomers; it may also contribute to the formation of sesquiterpene alcohols
identified as minor side products. Thus, the substitution of polar side chains for
nonpolar side chains in terpenoid cyclase active sites can result in the stabilization of
bound water molecules that, in turn, can serve template functions in isoprenoid
cyclization reactions.
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4.1 Introduction
Ubiquitous in all forms of life, terpene cyclases are enzymes that catalyze the
conversion of linear isoprenoid substrates such as geranyl diphosphate, farnesyl
diphosphate, or geranylgeranyl diphosphate into a wide variety of polycyclic natural
products (Cane,1985, 1990; Croteau et al. 1987; Wendt et al., 2000; Tholl, 2006; Austin
et al., 2008; Miller & Allemann, 2012; Gao et al., 2012). There are two cyclase classes
characterized by distinct α-helical folds and distinct chemical mechanisms for substrate
activation (Christianson, 2006, 2008, 2017). Class I enzymes initiate catalysis by metal
ion-dependent substrate ionization to form co-product inorganic pyrophosphate (PPi)
and a reactive allylic cation, while class II enzymes initiate catalysis by protonation of a
carbon-carbon double bond to generate a tertiary carbocation intermediate. At the level
of primary structure, most class I cyclases contain conserved “aspartate-rich” DDXX[D/E]
and “NSE” [N/D]DXX[S/T]XX[K/R]E metal ion-binding motifs, in which boldface residues
typically coordinate to three catalytic metal ions (usually Mg2+, but sometimes Mn2+)
(Aaron & Christianson, 2010). Rarely, a class I cyclase contains two aspartate-rich metalbinding motifs (Gennadios et al., 2009). Class II cyclases contain a DXDD motif in which
the central aspartic acid serves as a catalytic general acid (Wendt et al., 2000).
The sesquiterpene cyclase epi-isozizaene synthase (EIZS) is a class I enzyme that
converts farnesyl diphosphate (FPP) into epi-isozizaene as the major hydrocarbon
product, approximately 80% at 30 °C (Lin et al., 2006, 2009; Aaron et al., 2010).
Cyclization fidelity improves markedly at lower temperature, with epi-isozizaene
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formation approaching 100% at 4 °C (Li et al., 2014). The crystal structure of wild-type
EIZS from Streptomyces coelicolor has been solved in complex with three Mg2+ ions, PPi,
and the benzyltriethylammonium cation (BTAC), revealing an active site contour largely
defined by aromatic residues F95, F96, F198, and W203 (Aaron et al., 2010). In addition
to providing a three-dimensional template for catalysis that ensures the proper
conformation of FPP prior to the initiation of catalysis, these residues help stabilize
cationic intermediates through cation–π interactions.
The substitution of other amino acids for these aromatic residues can
dramatically reprogram the cyclization cascade to yield different cyclization products
(Aaron et al., 2010; Li et al., 2014; Blank et al., 2017). Some amino acid substitutions
yield cyclases that have completely lost the capacity for epi-isozizaene generation, but
instead generate brand new sesquiterpene products (Li et al., 2014; Blank et al., 2017).
The engineering of a terpene cyclase to generate completely new cyclization products
represents a significant advance, especially if such products are commercially useful. For
example, F95Q EIZS catalyzes the cyclization of FPP to form the β and γ regioisomers of
curcumene as major cyclization products (54% total at 30 °C) with a specific activity 33%
of that measured for the wild-type enzyme (Figure 4.1) (Blank et al., 2017). As noted for
F95H EIZS, which generates 50% β-curcumene at 30 °C, curcumene regioisomers can be
chemically hydrogenated to yield bisabolane (Li et al., 2014), a diesel fuel substitute
(Peralta-Yahya et al., 2011) (Figure 4.1). Engineered bacterial cyclases can be used as
robust components in metabolic engineering experiments to expand biosynthetic
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capabilities beyond the limitations of naturally occurring cyclases (Li et al., 2014;
McAndrew et al., 2011).
Here, we report the crystal structure of F95Q EIZS complexed with Mg2+3-PPi and
BTAC, which partially mimics the bisabolyl cation intermediate in the FPP cyclization
cascade leading to β- and γ-curcumene. Structural comparisons with F95N, F95H, and
F95C EIZS, which also generate curcumene regioisomers (Li et al., 2014; Blank et al.,
2017), are also discussed. These studies comprise the first step in evaluating F95
mutants of EIZS as potential “plug and play” components for synthetic biology
approaches toward the generation of hydrocarbon fuels.
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Figure 4.1: Proposed Mechanism for F95Q EIZS-Catalyzed Cyclization of farnesyl
diphosphate to form β- and γ-curcumene regioisomers. C3-C2 bond rotation indicated
by magenta arrow, 1,2-hydride shift indicated by green arrow. Red and blue arrows
correspond to proton elimination reactions yielding β- and γ-curcumene, respectively.
The deprotonation reaction leading to γ-curcumene could be mediated by water #372
trapped in the active site as indicated, or it could be mediated by metal-bound inorganic
pyrophosphate (–OPP) as discussed in the text. Although the stereochemistry of β- and
γ-curcumene has not been established, it is presumed to derive from the 7(S)homobisabolyl cation definitively established in the biosynthesis of epi-isozizaene. Even
if the 7(R)-homobisabolyl cation is formed, either enantiomer of β- and γ-curcumene
could be chemically hydrogenated to yield diesel fuel substitute bisabolane.
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4.2 Results
4.2.1 Crystal structure determination
The 1.91 Å resolution crystal structure of the F95Q EIZS-Mg2+3-PPi-BTAC complex
reveals the characteristic class I terpene cyclase fold identical to that of the wild-type
EIZS-Mg2+3-PPi-BTAC complex (PDB 3KB9), with a root-mean-square (rms) deviation of
0.11 Å for 300 Cα atoms (Figure 4.2). The active site of F95Q EIZS is in the fully closed
conformation, stabilized by full-occupancy binding of 3 Mg2+ ions and the PPi anion. In
the fully closed conformation, the active site is completely encapsulated, thereby
preventing premature quenching of carbocation intermediates by bulk solvent during
catalysis. The overall polypeptide chain is well ordered, with no major gaps in the
electron density corresponding to main chain atoms. However, the chain termini are
disordered: the N-terminal hexahistidine tag and M0-I15 at the N-terminus, and E356K361 at the C-terminus, lack well-ordered electron density and are omitted from the
final model. Polypeptide chain termini are similarly disordered in the wild-type EIZSMg2+3-PPi-BTAC complex.
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Figure 4.2: Wild-type Superposition with F95Q EIZS (Left) Ribbonplot of F95Q EIZS
color-coded as follows: backbone atoms, blue; DDXXD metal-binding motif, red; NSE
metal-binding motif, orange; BTAC, stick figure with pink C atoms and blue N atom;
magnesium ions, green spheres; PPi, stick figure with orange P atoms and red O atoms.
(Right) Superposition of the F95Q EIZS-Mg2+3-PPi-BTAC complex with the wild-type EIZSMg2+3-PPi-BTAC complex (all atoms yellow; PDB 3KB9).
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Electron density for the Q95 side chain is well defined (Figure 4.3a). Although the
carboxamide group rotamer cannot be unambiguously established, the rotamer was
selected that oriented the side chain carbonyl group into the active site cavity. As
refined in this conformation, the carboxamide NH2 group donates a hydrogen bond to
Y91 (2.8 Å), and the carboxamide C=O group accepts a hydrogen bond from water #372
(3.1 Å) and also makes a weakly polar interaction with an indole C-H of W203 (3.2 Å)
(Figure 4.3b). The conformation of Q95 is such that the side chain packs against residues
defining the active site surface, such that the enclosed active site volume of 331 Å3 is
greater than that of 303 Å3 measured for the wild-type enzyme. The volume of the
hydrocarbon moiety of FPP is 245 Å3; there is a relatively snug fit when substrate binds
to wild-type EIZS, but this fit loosens when the substrate binds to F95Q EIZS. Increased
active site volume results in a more permissive template that is not as strict in exerting
conformational control over the substrate and reactive carbocation intermediates,
thereby accounting for the generation of only 6% epi-isozizaene by this mutant. Since
the majority of products generated by F95Q EIZS derive from the bisabolyl or
homobisabolyl cations, the additional active site volume introduced at the F95 position
must compromise the homobisabolyl cation conformation required to form the acorenyl
cation enroute to epi-isozizaene generation (Figure 4.1).
The F95Q substitution stabilizes the binding of water #372 through hydrogen
bonding. In addition, water #372 forms hydrogen bonds with rotamer C of the side chain
hydroxyl group of S92 and the backbone carbonyl oxygen of S92. Since water #372 is
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tethered in place by multiple hydrogen bonds and is not sterically required to be
displaced by FPP binding, it likely remains firmly bound in the active site throughout
catalysis. While the aromatic ring of BTAC remains sandwiched in place by F96 and F198
in wild-type EIZS and F95Q EIZS complexes, the triethylamino moiety of BTAC undergoes
a conformational change in the active site of F95Q EIZS to accommodate the binding of
water #372. This water molecule may be responsible for the generation of
sesquiterpene alcohol side products α-bisabolol (13%), (E)-nerolidol (3%), and acorenol
(2%), by quenching the corresponding carbocation intermediates (Blank et al., 2017).
Notably, if water #372 does not react with carbocation intermediates, then it serves as
part of the active site contour that governs the conformation of the substrate as well as
carbocation intermediates. Water #372 is unique to F95Q EIZS and is not observed in
the active site of any other F95 mutant studied by X-ray crystallography (Li et al., 2014;
Blank et al., 2017).
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Figure 4.3: F95Q EIZS Active Site (a) Stereoview of F95Q EIZS-Mg2+3-PPi-BTAC complex,
showing Polder omit maps for BTAC and Q95 (contoured at 6σ and 4σ, respectively).
Color codes are as follows: C (protein) = blue, C (BTAC) = cyan, N = dark blue, O = red, P
= orange, Mg2+ ions = green spheres. Water #372 is shown as a small red sphere. (b)
Complex in (a) superimposed on the wild-type EIZS-Mg2+3-PPi-BTAC complex (gold; Mg2+
ions = magenta spheres). Hydrogen bond interactions are indicated by red dashed lines.
Other interactions are shown as black dashed lines.
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4.2.2 Modeling enzyme-intermediate and enzyme-product complexes
Analysis of the three-dimensional contour of the enclosed active site of wild-type
EIZS reveals a product-like shape that is highly complementary to the molecular
structure of epi-isozizaene (Figure 4.4a). Thus, the active site contour serves as a
template for cyclization and enforces the proper sequence of carbon-carbon bondforming reactions, including the compressed conformation of the homobisabolyl cation
required to form the acorenyl cation (Figure 4.1).
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Figure 4.4: F95Q EIZS Active Site Modeling (a) Stereoview of the EIZS-Mg2+3-PPi-BTAC
complex, less the BTAC molecule. Color coding is as follows: Mg2+ ions = large magenta
spheres; F95 and PPi are shown with C = aqua, O = red, P = orange. The active site
contour is represented by firebrick red meshwork and is fit by a model of epi-isozizaene
(gold). (b) Stereoview of the F95Q EIZS-Mg2+3-PPi-BTAC complex, less the BTAC
molecule. Color coding is as follows: Mg2+ ions = large green spheres, water #372 = small
red sphere; Q95 and PPi are shown with C = green, N = dark blue, O = red, P = orange.
The Q95---water #372 hydrogen bond is represented by a blue dashed line. The active
site contour is represented by purple meshwork and is fit by models of β- and γcurcumene and the 7(S)-homobisabolyl cation (red, blue, and gold, respectively).
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In contrast, analysis of the three-dimensional contour of the enclosed active site
of F95Q EIZS reveals a more extended contour that is highly complementary to the
extended conformation of β- and γ-curcumene, as well as the 7([S])-homobisabolyl
cation intermediate preceding the formation of these products (Figure 4.4b). Thus, the
active site contour is still quite product-like in shape, but since this contour has been
remolded by mutagenesis it serves as a template for the generation of new products.
Binding modes calculated for β-curcumene, γ-curcumene, and the homobisabolyl cation
with the docking software NRGsuite FlexAID (Gaudreault et al. 2015) reveal a consistent
binding orientation in which the pendant isoprenoid tail occupies the newly introduced
volume resulting from the F95Q substitution. The conformation of the homobisabolyl
cation is such that it would easily support the 1,2-hydride transfer leading from the
bisabolyl cation precursor.
The positively charged carbon atoms of the bisabolyl and homobisabolyl
carbocation intermediates would be positioned in the same vicinity as the positively
charged nitrogen atom of BTAC in the F95Q EIZS-Mg2+3-PPi-BTAC complex. Therefore,
these carbocations would similarly be stabilized by cation-π interactions with F96 and
F198, as observed for BTAC in Figure 4.3. Additional electrostatic stabilization of
carbocation intermediates and their flanking transition states would be provided by the
PPi anion. The break in helix G near F198 (Figure 4.3) may provide further electrostatic
stabilization, since the negative electrostatic potential of the C-terminal end of the helix
break is oriented into the active site. This structural feature is conserved in terpenoid
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synthases as first described in squalene synthase (Pandit et al., 2000) and subsequently
in other terpenoid cyclases (Baer et al., 2014a,b).
Insofar that water #372 is chemically inert with respect to carbocation
intermediates in the cyclization reactions catalyzed by F95Q EIZS, its molecular surface
must contribute to the active site contour that serves as the template for catalysis. The
active site contour of F95Q EIZS takes into account the likelihood that water #372 serves
as part of the template that governs the binding orientation of the homobisabolyl
cation. However, it is possible that water #372 also plays a role as a general base in the
final step of the reaction leading to product formation. The 7(S)-homobisabolyl cation
undergoes proton elimination at C5 or C1 to yield β-curcumene and γ-curcumene,
respectively. Given the modeled binding orientation of the homobisabolyl cation in
Figure 4.4b, water molecule #372 is poised to accept the C1 proton of the
homobisabolyl cation to generate γ-curcumene. The other possible general base in the
active site, the PPi anion, is properly oriented to accept the C5 proton to generate βcurcumene. The possibility of tandem general base catalysis by water #372 and the PPi
anion may account for nearly identical yields of β-curcumene and γ-curcumene, with the
slight preference of β-curcumene formation resulting from the PPi anion being a
stronger base than a water molecule. Of course, the PPi anion could accept the C1
proton from the homobisabolyl cation if the 6-membered ring were to flip 180°.
However, since F95H EIZS generates 50% β-curcumene and cannot fit a trapped water
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molecule comparable to water #372 in F95Q EIZS, this may imply that the generation of
γ-curcumene requires water #372 or its equivalent.
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4.3 Discussion
There is precedent for the binding of water molecules in the hydrophobic active
site cavity of EIZS, but none correspond to the position observed for water #372 in F95Q
EIZS. For example, the increased active site volume of W203Y EIZS enables the binding
of two new water molecules in the active site, and these water molecules may quench
carbocation intermediates to yield sesquiterpene alcohol products (Blank et al., 2017).
Specifically, quenching of the nerolidyl cation and bisabolyl cation by an active site
water molecule results in the formation of (E)-nerolidol (10%) and (Z)-γ-bisabolene
(42%).
Other amino acid side chains substituted for F95 similarly result in enzymes that
generate major products resulting from the quenching of the bisabolyl cation or
homobisabolyl cation intermediate, either by proton elimination or by solvolysis. For
example, F95H EIZS generates β-curcumene (50%) (Li et al., 2014), F95N EIZS generates
β-curcumene (28%) and α-bisabolol (18%), and F95C EIZS generates γ-curcumene (22%)
and (E)-nerolidol (9%). The crystal structures of these mutants each reveal an enlarged
active site cleft resulting from the substitution of a smaller side chain for that of F95.
Even though the reduction in active site volume is relatively little for F95H EIZS, the
substitution of a polar imidazole side chain for the aromatic side chain of F95 appears to
influence the derailment of the cyclization cascade to form β-curcumene (Li et al.,
2014). It is interesting, too, that F95Y EIZS generates (E)-nerolidol (27%) despite the
larger side chain substituted for F95 (Blank et al., 2017). Here, the introduction of a
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polar side chain in place of F95 enables solvent access to the active site to enable
quenching of the nerolidyl cation by a water molecule.
In EIZS mutants containing a smaller, polar side chain substituted for F95 (F95N,
F95Q, F95C), it is interesting to note that the generation of epi-isozizaene is substantially
reduced to 5–6% of total sesquiterpene products formed. In contrast, F95Y EIZS and
F95H EIZS generate 67% and 44% epi-isozizaene, respectively. The substitution of a
comparably sized but polar side chain in place of F95 preserves some measure of
cyclization fidelity for epi-isozizaene generation, since the net change to the threedimensional active site contour is minimal. Thus, it appears that the introduction of
polarity into the hydrophobic active site is responsible for derailing the cyclization
cascade in the F95N, F95Q, and F95C mutants.
In conclusion, the crystal structure determination of the F95Q EIZS-Mg2+3-PPiBTAC complex illuminates the molecular basis of the reprogrammed FPP cyclization
cascade leading to the formation of regioisomers β-curcumene and γ-curcumene, both
of which can be chemically hydrogenated to yield the diesel fuel substitute bisabolane.
While F95Q EIZS is almost identical in overall structure to wild-type EIZS, the increased
active site volume and elongation of its three-dimensional contour, along with the
introduction of the polar glutamine side chain that stabilizes the binding of water #372,
yields a template for catalysis that is highly complementary in shape to the extended
conformation of the curcumene products. The PPi co-product as well as water #372 are
possible general bases that mediate deprotonation of the homobisabolyl cation
216

intermediate in the final step of catalysis. Additionally, water #372 comprises part of the
active site contour that governs substrate and intermediate conformations in catalysis.
This water molecule may also account for the formation of sesquiterpene alcohols
formed as minor side products.
It is remarkable that a bound water molecule in a terpenoid cyclase active site
does not pose a significant risk to a cationic isoprenoid cyclization cascade unless it is
precisely positioned to react with an sp2-hybridized carbon atom in a catalytic
intermediate. This suggests significant potential for exploring and exploiting
carbocation-mediated organic synthesis using enzymes in aqueous solution, which
represents an environmentally-friendly option for organic synthesis of terpenoid natural
products.
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4.4 Materials and Methods
4.4.1 Crystallization
Recombinant F95Q EIZS was prepared as previously described (Blank et al.,
2017). Crystals were grown using the sitting drop vapor diffusion method at 21 °C.
Typically, a 0.5-μL drop of protein solution [4 mg/mL F95Q EIZS, 20 mM Tris (pH = 7.5),
300 mM NaCl, 10 mM MgCl2, 2 mM tris(2-carboxyethyl)phosphine (TCEP), 2 mM sodium
pyrophosphate, 2 mM benzyltriethylammonium chloride, 10% (v/v) glycerol] was added
to a 0.6-μL drop of precipitant solution [0.2 M magnesium acetate tetrahydrate, 0.1 M
sodium cacodylate trihydrate (pH = 6.5), 20% (w/v) PEG 8000]. Immediately afterwards,
a 0.1-μL drop of 100X diluted wild-type EIZS crystallization microseeding stock was
added, the preparation of which has been reported previously (Blank et al., 2017). The
resulting 1.2-μL drop was equilibrated against a 100-μL reservoir of precipitant solution
at 21 °C. Crystals appeared after 1 week and were cryo-protected with 30% (v/v)
glycerol and flash-frozen in liquid nitrogen.

4.4.2 Data collection and structure determination
Crystals diffracted X-rays to 1.91 Å resolution at the Advanced Photon Source,
Argonne National Laboratory, Northeastern Collaborative Access Team beamline 24-IDE. Data were collected over 180° with 20% transmission of the 12.68 keV beam and 250
mm crystal-to-detector distance. Crystals belonged to space group P21 with the
following unit cell dimensions: a = 53.25 Å, b = 47.09 Å, c = 75.59 Å, β = 95.13° (one
monomer in the asymmetric unit). Diffraction data were indexed and integrated in
218

iMOSFILM (Battye et al., 2011) and scaling was performed in AIMLESS (Evans et al.,
2013). The crystal structure of the F95Q EIZS-Mg2+3-PPi-BTAC complex was determined
by molecular replacement with PHASER (McCoy et al., 2007) using the structure of the
wild-type EIZS-Mg2+3-PPi-BTAC complex (PDB 3KB9) as a search probe. Manual model
building and refinement were performed with COOT and PHENIX, respectively (Emsley
et al., 2010, Adams et al., 2010). Solvent molecules and residues with multiple
conformations were modeled during the final stages of refinement; residues with
multiple conformations included Q33, S92, V97, T123, S127, R174, E192, R227, K247,
S260, R278, C283, V290, R292, and S327. Validation of the structure was performed
initially using MOLPROBITY (Chen et al., 2010). All data collection and refinement
statistics are detailed in Table 4.1.

4.4.3 Modeling
Molecular models of the closed conformations of wild-type EIZS and F95Q EIZS
without bound BTAC were generated using COOT (Emsley et al., 2010). The atomic
coordinates of epi-isozizaene as well as β- and γ-curcumene were generated in .pdb
format by converting a SMILES string generated from the SMILES Translator and
Structure

File

Generator

(National

Cancer

Institute,

https://cactus.nci.nih.gov/translate/). Molecular geometries were optimized using
Phenix (Adams et al., 2010). Active site pocket meshes were initially generated using the
DoGSiteScorer (http://dogsite.zbh.uni-hamburg.de), the results of which guided the
cavity function in Pymol. GetCleft and FlexAID as implemented in the NRGsuite plugin
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were used to generate enclosed active site contours, into which catalytic products and
the homobisabolyl cation intermediate could be docked (Gaudreault et al. 2015). The
resulting models of enzyme-ligand complexes underwent minor manual adjustments to
optimize enzyme-ligand fit, but the final conformations largely followed the autodocking
solutions.
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4.5 Additional Information
Atomic coordinates and structure factor amplitudes of F95Q EIZS have been
deposited in the Protein Data Bank (www.rcsb.org) with accession number 6OFV.
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Table 4.1: Data collection and refinement statistics for the F95Q EIZSMg2+3-PPi-BTAC complex
Synchrotron
Beamline
Detector
Energy
Space group
a, b, c (Å)
α, β, γ (°)
Resolution (Å)a
Total/unique no. of
reflections
Rmergea,b
Rp.i.m.a,c
CC1/2a,d
I/σ(I)a
Redundancy a
Completeness (%) a
Rwork a,e
Rfree a,e
No. of non-hydrogen
atoms:
protein
ligands
solvent
Average B-factors (Å2)
protein
ligands
solvent
Rms deviation from
ideal geometry
bonds (Å)
angles (°)

APS
24-ID-E
CCD
12.68 keV
P21
53.25, 47.09, 75.59
90.00, 95.13, 90.00
53.04-1.91 (1.981.91)
104897/29257
(7131/1968)
0.189 (1.009)
0.116 (0.611)
0.987 (0.551)
8.1 (2.1)
3.6 (3.6)
100.0 (100.0)
0.155 (0.226)
0.203 (0.278)

2868
49
372
16
24
29

0.016
1.3
222

Ramachandran plot (%)
f

favored
allowed
outliers
Rotamer outliers (%)
Clashscore

99.11
0.89
0.00
0.66
4.9

PDB accession code

6OFV

a

Values in parentheses correspond to data in highest resolution shell. bRmerge = ∑hkl∑i|Ii,hkl
− ⟨I⟩hkl|/∑hkl∑i Ii,hkl; ⟨I⟩hkl = mean intensity of Ihkl calculated from replicate measurements.
Note that Rmerge can sometimes be inordinately high for highly redundant data sets, in
which case CC1/2 can be a better indicator of data quality. cRp.i.m.= (∑hkl(1/(N-1))1/2∑i|Ii,hkl −
⟨I⟩hkl|)/∑hkl∑i Ii,hkl; ⟨I⟩hkl = mean intensity of Ihkl calculated from replicate measurements, N
= number of reflections. dPearson correlation coefficient between random half-datasets.
e
Rwork = ∑||Fo| − |Fc||/∑|Fo| for reflections contained in the working set. |Fo| =
observed structure factor amplitude, |Fc| = calculated structure factor amplitude. Rfree is
calculated in the same manner using test set reflections held aside during refinement.
f
Calculated with MolProbity.
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Cyclase that Generates a Sesquiterpene with Strained [3.1.0]
Bridged-Bicyclic Architecture
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5.0 Abstract
The natural product sesquisabinene is a key component of the fragrant essential
oil of the sandalwood tree, currently valued at $5,000/L. Sesquisabinene contains a
highly strained [3.1.0] bicyclic ring system and is generated from farnesyl diphosphate in
a reaction catalyzed by a class I terpene cyclase. To understand how the enzyme directs
the formation of a strained hydrocarbon ring system, we now report the X-ray crystal
structure of sesquisabinene synthase 1 (SQS1) from the Indian sandalwood tree
(Santalum album). Specifically, we report the structure of unliganded SQS1 at 1.90 Å
resolution and the structure of its complex with three Mg2+ ions and the inhibitor
ibandronate at 2.10 Å resolution. The bisphosphonate group of ibandronate coordinates
to all three metal ions and makes hydrogen bond interactions with basic residues at the
mouth of the active site. These interactions are similarly required for activation of the
substrate diphosphate group to initiate catalysis, although partial occupancy binding of
the Mg2+B ion suggests that this structure represents the penultimate metal
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coordination complex just prior to substrate activation. The structure of the liganded
enzyme enables a precise definition of the enclosed active site contour that serves as a
template for the cyclization reaction. This contour is very product-like in shape and
readily fits an extended conformation of sesquisabinene and its precursor, the
homobisabolyl cation. Structural comparisons of SQS1 with epi-isozizaene synthase
mutants that also generate sesquisabinene suggest that [3.1.0] ring formation is not
dependent on the isoprenoid tail conformation of the homobisabolyl cation.
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5.1 Introduction
The terpenome comprises an expansive and diverse library of more than 86,000
terpenes, steroids, and carotenoids, as classified in the Dictionary of Natural Products
(version 27.2; http://dnp.chemnetbase.com).1,2 The remarkable chemodiversity of this
molecular library arises largely from the catalytic activity of terpenoid cyclases, enzymes
that establish the structure and stereochemistry of the carbon skeleton in the first
committed step of a terpene biosynthetic pathway.3-10 The molecular diversity of
terpene natural products reflects their functional diversity in all forms of life; this
diversity additionally underlies the commercial value of many terpene natural products
as flavors, fragrances, fuels, and pharmaceuticals.11-17
The first step in a reaction catalyzed by a terpenoid cyclase is the generation of a
reactive carbocation intermediate that initiates a specific sequence of intramolecular
carbon-carbon bond-forming reactions.3-10 The reaction sequence is usually terminated
to form a single predominant product by proton elimination from, or addition of water
to, the final carbocation intermediate. A class I terpenoid cyclase initially generates an
allylic carbocation through the metal-triggered ionization of a linear isoprenoid
diphosphate substrate such as farnesyl diphosphate (FPP). By contrast, a class II
terpenoid cyclase initially generates a tertiary carbocation through protonation of a
carbon-carbon double bond. At the level of primary structure, class I terpenoid cyclases
are usually characterized by an aspartate-rich motif DDXXD/E and the “NSE/DTE” motif
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(N,D)DXX(S,T)XXXE, both of which coordinate to a trinuclear metal cluster.18 However,
there are rare exceptions in which a class I cyclase contains two aspartate-rich motifs
and no NSE/DTE motif.19 Class II terpenoid cyclases lack these metal-binding motifs, but
instead are characterized by the general acid motif DDXD. The central aspartic acid of
this motif protonates a carbon-carbon double bond in the substrate to initiate catalysis.
For both classes of terpenoid cyclases, the three-dimensional contour of the
active site cavity directs the cyclization cascade by enforcing a specific substrate
conformation prior to initial carbocation formation. The linear isoprenoid substrate is
very flexible – there is free rotation about 3 carbon-carbon single bonds per 5-carbon
isoprenoid unit – so its conformation must be fixed by a template prior to reaction. The
active site contour thus serves as the template for catalysis, and this template also
chaperones the conformations of reactive carbocation intermediates. Accordingly, the
identity of the specific cyclization product is encoded in the three-dimensional contour
of the terpenoid cyclase active site. If the active site contour is remolded by
mutagenesis, then the cyclization cascade will be reprogrammed to generate an
alternative product.
Alternative major products generated by mutant terpenoid cyclases can
correspond to minor products generated by the wild-type cyclase.20 However, new
alternative products are sometimes generated by mutant terpenoid cyclases. Consider
the sesquiterpene cyclase epi-isozizaene synthase, which serves as a paradigm for
engineering bacterial terpenoid cyclase reactions.21 A total of 40 site-specific mutants of
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epi-isozizaene synthase with remolded active site contours generate an overall product
array five times larger than that of the wild-type cyclase, enabling the conversion of epiisozizaene synthase into nine different sesquiterpene synthases.22,23 Some of these new
enzymes generate cyclic products for which no naturally occurring cyclase is known.
For those epi-isozizaene synthase mutants that generate new products for which
a naturally occurring sesquiterpene cyclase has been identified, it can be instructive to
compare cyclases to better understand structure-function relationships. Consider the
F96S, F96M, and F96Q mutants of epi-isozizaene synthase, which generate the bicyclic
product sesquisabinene with yields of 78%, 91%, and 97%, respectively (Figure 5.1).23
First identified in Piper nigrum (black pepper),24 sesquisabinene is an essential
component of the fragrant heartwood oil of sandalwood trees. The substitution of a
smaller, polar side chain in place of F96 in certain epi-isozizaene synthase mutants
derails the FPP cyclization sequence by favoring transannular carbon-carbon bond
formation instead of the reaction sequence leading to epi-isozizaene. The unusual
[3.1.0] bicyclic ring system of sesquisabinene is especially intriguing in view of its highly
strained bridged ring architecture, but it is not clear how F96 substitutions direct this
chemistry.

233

farnesyl diphosphate

farnesyl cation

3(R)-nerolidyl diphosphate

+
OPP

–OPP

Mg2+3

Mg2+3

sesquisabinyl cation

7(S)-homobisabolyl cation
H

OPP

OPP

Mg2+3

Mg2+3

4(R)-bisabolyl cation

nerolidyl cation

H
+

+
+

+
H

–OPP

–OPP

–OPP

–OPP

Mg2+3

Mg2+3

Mg2+3

Mg2+3

sesquisabinene

HOPP
Mg2+3

1(S),4(R),5(R)-acorenyl cation

+

epi-isozizaene

–OPP

HOPP

Mg2+3

Mg2+3

Figure 5.1: The Cyclization of FPP to Generate Sesquisabinene or Epi-Isozizaene
proceeds through a common homobisabolyl cation intermediate. The active site
contours of wild-type epi-isozizaene synthase, its F96 variants, and SQS1 play a critical
role in chaperoning carbon-carbon bond-forming reactions through one pathway or the
other. Red arrow indicates conformational change about the C2-C3 bond of 3(R)nerolidyl diphosphate; green arrow indicates 1,2-hydride transfer in the 4(R)-bisabolyl
cation. Magenta arrows indicate pathway from the 7(S)-homobisabolyl cation to
sesquisabinene; blue arrows indicate pathway from the 7(S)-homobisabolyl cation to
epi-isozizaene. Diphosphate = PPO, inorganic pyrophosphate = PPO– or PPOH.
Stereochemistry has been definitively established for intermediates leading up to and
including epi-isozizaene; stereochemistry has not been definitively established for
sesquisabinene formation by SQS1, but in F96 variants of epi-isozizaene synthase
sesquisabinene formation is presumed to proceed from the 7(S)-homobisabolyl cation.
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Recently, naturally occurring sesquisabinene synthases from Western Australian
sandalwood (Santalum spicatum) and Indian sandalwood (Santalum album) have been
discovered.25,26 The high commercial value of sandalwood oil (ca. $5,000/L) motivates
the exploration of renewable approaches for the generation of its components through
synthetic biology, requiring the identification and characterization of the enzymes that
generate the terpene blend in the oil. In order to fully characterize structure-mechanism
relationships for sesquisabinene biosynthesis and understand active site features that
direct the formation of strained [3.1.0] bicyclic ring systems, we have determined the Xray crystal structure of sesquisabinene synthase 1 from S. album (SQS1).26 Crystal
structures of SQS1 determined in the presence and absence of ligands reveal substrateinduced conformational changes defining the template that directs the cyclization
reaction. Structural comparisons of SQS1 and F96S epi-isozizaene synthase provide clues
regarding the generation of sesquisabinene by naturally occurring and engineered
terpenoid cyclases.
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5.2 Results and Discussion
5.2.1 Structure of Unliganded SQS1. The crystal structure of unliganded
SQS1 was determined at 1.90 Å resolution and reveals αβ domain architecture27,28
characteristic of a plant-derived class I terpenoid cyclase (Figure 5.2). The enzyme
crystallizes as a monomer as confirmed with PISA.29 The active site cavity in the α
domain is largely defined by hydrophobic aromatic and aliphatic residues and is located
in the middle of the α-helical bundle. Topological analysis suggests that the α domain
resulted from gene duplication and fusion of two primordial 4-helix bundles.30 The
aspartate-rich metal-binding motif DDXXD and the NSE/DTE metal-binding motif are
located at topologically equivalent positions on helices D and H, respectively. These
motifs bind catalytically-required Mg2+ ions only when substrate or diphosphatecontaining ligands are bound. The NSE/DTE motif is partially disordered in unliganded
SQS1.
The β domain has no direct function in catalysis, other than to provide an Nterminal segment that can stabilize interactions required to cap the active site upon the
binding of Mg2+ ions and substrate. This structural feature has been observed in plant
cyclases that adopt αβ domain architecture, such as 5-epi-aristolochene synthase,
bornyl diphosphate synthase, δ-cadinene synthase, and (–)- and (+)-limonene
synthases.19,31-35 However, this is not a universal phenomenon, since active site capping
by the N-terminus is not observed in plant isoprene synthase, which similarly adopts αβ
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domain architecture.36 Most bacterial and fungal terpenoid cyclases lack a β domain
altogether and consist of just a single α domain, in which the N-terminus is distant from
the active site and does not undergo conformational changes to accommodate
substrate binding.6,10 Thus, the assistance of the N-terminus in active site capping is not
common to all class I terpenoid cyclases. The β domain forms a barrel-like architecture
similar in topology to that of the (αα)6-barrel structure of protein farnesyl
transferase.37,38
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Figure 5.2. Structure of Unliganded SQS1 color coded as follows: α domain, cyan; β
domain, light green; DDXXD metal-binding motif, red; NSE/DTE metal-binding motif,
orange. N- and C-termini are indicated; disordered polypeptide segments are indicated
by dotted lines.
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Disordered segments in the polypeptide chain include the N-terminus (M1–Y32,
32 residues), the C-terminus (Y538–N544 and D564–E566, 10 residues), and one
segment that includes part of the NSE/DTE metal-binding motif on helix H (S465–N474,
10 residues), such that a total of 52 residues are disordered. These segments are not
included in the final model of unliganded SQS1. It is not unusual to observe disorder or
weak electron density in the vicinity of the NSE/DTE motif in unliganded plant terpenoid
cyclases. For example, the NSE/DTE motif on helix H of bornyl diphosphate synthase is
partially disordered, along with the following polypeptide chain; this segment becomes
fully ordered upon ligand binding, forming the Hα1 helix and corresponding loop
segment.33
It is interesting to note that despite cocrystallization of SQS1 with Mg2+,
inorganic pyrophosphate (PPi), and benzyltriethylammonium chloride (BTAC), SQS1
crystallizes in the open active site conformation with no trace of ligand binding.
Cocrystallization of the bacterial cyclase epi-isozizaene synthase with millimolar
concentrations of these species yields the crystal structure of the liganded enzyme, in
which the BTAC cation binds in the hydrophobic active site and the enzyme is stabilized
in the fully closed conformation by the Mg2+3-PPi complex.21,22 Lattice packing forces in
this crystal form of SQS1 apparently drive the crystallization of only the unliganded form
of the enzyme.

5.2.2 Structure of the SQS1-ibandronate complex. The crystal structure
of the SQS1-Mg2+3-ibandronate complex was determined at 2.10 Å resolution, and
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electron density maps clearly reveal the binding of ligands in the active site (Figure 5.3).
Ligand binding does not trigger any major structural changes, and the root-mean-square
(rms) deviation is 0.49 Å for 452 Cα atoms between the unliganded and liganded
structures (Figure 5.4). Curiously, 58 residues are disordered in the enzyme-inhibitor
complex, which is comparable to the 52 disordered residues in the unliganded enzyme.
While this could arise in part from the slightly lower resolution of the structure
determination, it is unusual that ligand binding does not stabilize disordered segments
observed in the unliganded enzyme. Disordered segments in the SQS1-Mg2+3ibandronate complex include the N-terminus (M1–L36 and S49–T52, 40 residues), the Cterminus (Y538–E546 and D564–E566, 12 residues), and one segment that includes part
of the NSE/DTE metal-binding motif on helix H (S465–E470, 6 residues).
The aspartate-rich metal-binding motif on helix D is fully ordered. The side chains
of D316 and D320 in this motif coordinate to Mg2+A and Mg2+C, and both metal ions are
fully occupied, octahedrally coordinated, and characterized by strong, ~10σ electron
density peaks in Polder omit maps (Figure 5.3). Also bound is the Mg2+B ion, but this
metal ion is characterized by a weaker, 4σ electron density peak. The Mg2+B ion is
usually coordinated by the NSE/DTE motif, but here the Mg2+B ion is too far from N460
and T464 in this motif to achieve proper coordination (Figure 5.3). The electron density
peak corresponding to Mg2+B is 2.1 Å away from an ordered water molecule, consistent
with a water-metal coordination interaction; however, this peak is also 2.4 Å and 2.7 Å
away from bisphosphonate oxygen atoms, and 2.7–2.8 Å away from two other solvent
240

molecules, consistent with a hydrogen bond interaction. Possibly, the peak interpreted
as Mg2+B also corresponds to a partially-occupied water molecule. Since the third Mg2+B
ligand in the NSE/DTE motif (E468) is disordered, it is clear that the NSE/DTE motif is not
engaged in binding the Mg2+3-ibandronate complex.
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Figure 5.3: SQS1-Ibandronate Complex Active Site (a) Stereoview of Polder omits maps
of ibandronate (green meshwork, contoured at 4σ) and Mg2+A, Mg2+B, and Mg2+C, ions
(brown meshwork, contoured at 9σ, 5σ, and 11σ, respectively) bound in the active site
of SQS1. Selected active site residues are indicated; the DDXXD and NSE/DTE metalbinding motifs are maroon and orange, respectively. Water molecules are small red
spheres and Mg2+ ions are purple spheres. Disordered polypeptide segments are
indicated by thick orange and blue dashed lines. (b) Stereoview showing intermolecular
interactions in the SQS1-Mg2+3-ibandronate complex. Atom colors are the same as in (a).
Metal coordination interactions are shown as yellow dashed lines; some interactions are
rather long to be considered inner sphere metal coordination (2.5 Å or greater) and are
indicated by blue dashed lines. Hydrogen bond interactions appear as red dashed lines.
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Figure 5.4: Liganded and Unliganded SQS1 Superpositions (a) Stereoview showing the
least-squares superposition of the SQS1-Mg2+3-ibandronate complex α domain, dark
blue, β domain, dark green) and unliganded SQS1 (α domain, cyan, β domain, light
green). The DDXXD and NSE/DTE metal-binding domains are red and orange,
respectively. Disordered polypeptide segments are indicated by dashed lines. (b) Closeup view of the SQS1 active site in the liganded and unliganded conformations (same
color scheme as in (a)). Of note, R279 and its associated polypeptide chain undergoes a
significant conformational change upon ibandronate binding to form a bisphosphonateR279-D317 hydrogen bond network (D317 is the second aspartate in the DDXXD motif).
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5.2.3 Structural aspects of active site closure. A fully-occupied trinuclear
metal cluster is required for catalysis by a class I terpenoid synthase, since 3 metal ions
as well as 3 hydrogen bonds with basic residues (arginine and/or lysine residues) are
needed to trigger the departure of the diphosphate leaving group from the substrate.18
Thus, lacking a full-occupancy Mg2+B ion, the structure of the SQS1-Mg2+3-ibandronate
complex reflects the penultimate active site conformation, in that the final active site
conformation is achieved when Mg2+B is fully bound. Metal ions can bind sequentially in
terpenoid cyclase active site closure, as demonstrated in X-ray crystallographic studies
of aristolochene synthase from Aspergillus tereus.39,40 However, in this fungal cyclase
the Mg2+C ion is thought to bind last, whereas in SQS1 the Mg2+B ion appears to bind last.
Regardless of incomplete Mg2+B binding, the SQS1 active site is essentially fully
closed, and one indicator of active site closure is the bisphosphonate-R279-D317
hydrogen bond network. The role of the second aspartate in the aspartate-rich DDXXD
motif is to hydrogen bond with a conserved arginine residue so as to stabilize the closed
active site conformation. The conserved arginine residue also hydrogen bonds with the
substrate diphosphate group, thereby linking substrate binding with the tertiary
structural changes that bring about active site closure. Comparison of the liganded and
unliganded conformations of SQS1 reveals that R279 is disordered in the unliganded
enzyme; it becomes ordered and its associated polypeptide loop moves approximately 3
Å to enable formation of the bisphosphonate-R279-D317 hydrogen bond network
(Figure 5.4b).
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A similar hydrogen bond interaction is observed in plant terpenoid cyclases
between the second aspartate in the aspartate-rich DDXXD motif and an arginine
residue conserved approximately 40 residues preceding this motif. For example, in 5epi-aristolochene synthase, R264 undergoes a ~3 Å conformational change upon ligand
binding to form a hydrogen bond with D302.32 The structures of bornyl diphosphate
synthase and isoprene synthase similarly reveal an arginine-aspartate hydrogen bond
when ligands are bound, but this tertiary structural interaction is maintained in the
structures of the unliganded enzymes.33,36
A diphosphate-arginine-aspartate interaction is also observed with the second
aspartate in the DDXXD motif of bacterial and fungal terpenoid cyclases, but the
conserved arginine residue involved in this interaction is approximately 200 residues
upstream from the aspartate and is thus topologically unrelated to the arginine involved
in plant cyclases. For example, R304 of trichodiene synthase accepts hydrogen bonds
from PPi and D101 in the structure of the trichodiene synthase-Mg2+3-PPi complex, but
the R304-D101 interaction is absent in the structure of the unliganded enzyme.41 The
same holds true for R314-D91 in aristolochene synthase39,40 and R338-D100 of epiisozizaene synthase.21-23 Thus, the second aspartate of the aspartate-rich metal-binding
motif DDXXD appears to be conserved to make a hydrogen bond interaction with a
conserved arginine residue that also hydrogen bonds with the substrate diphosphate
group. The conserved arginine residue is ca. 40 residues downstream in plant cyclases
with αβ domain architecture, but ca. 200 residues upstream in bacterial and fungal
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cyclases with single α domain architecture. In each case, the aspartate-arginine
hydrogen bond helps to stabilize the closed conformation of the active site required for
catalysis. In the fully closed conformation, carbocation intermediates in the cyclization
cascade are protected from premature quenching by bulk solvent.

5.2.4 Chemistry of strained ring formation. The function of the terpenoid
cyclase active site as a template for catalysis is important not only for enforcing the
proper substrate conformation, but also the proper conformations of reactive
intermediates. This function is especially important for directing the reaction of the
homobisabolyl carbocation in the generation of sesquisabinene. Consider the cyclization
reaction catalyzed by epi-isozizaene synthase. Site-specific mutants in which smaller
amino acid side chains are substituted for F96 generally lose the capacity to form the
acorenyl carbocation or any hydrocarbon product derived from this carbocation,
presumably due to the loosening of the strict template that would otherwise hold the
pendant isoprenoid chain of the homobisabolyl cation adjacent to the carbocation
center as outlined in Figure 5.1. Acorenyl carbocation formation is significantly
sustained only in F96W epi-isozizaene synthase,22 in which the steric bulk of the
engineered W96 side chain ensures that the pendant isoprenoid chain of the
homobisabolyl cation is conformationally constrained to support acorenyl cation
formation. In contrast, the F96A mutant predominantly generates farnesene, indicating
that the ability of the template to direct even the initial 6-membered ring cyclization
reaction is lost. The enclosed active site volume of a terpenoid cyclase generally
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matches the molecular volume of its substrate;41,42 if the active site volume is increased
by mutagenesis, this loosens the enzyme-substrate fit to result in a more permissive
template.
When intermediate-size side chains are substituted for F96 in epi-isozizaene
synthase, 6-membered ring formation and even acorenyl carbocation formation can still
be achieved. For example, the F96V mutant generates predominantly (Z)-γ-bisabolene,
but also generates small amounts of epi-isozizaene.22 Curiously, however, when certain
intermediate-size side chains that are polar or weakly polar are substituted (F96S, F96Q,
F96M), sesquisabinene formation is significantly favored.23 These side chains provide
enough steric guidance to direct the generation of the bisabolyl carbocation, and they
confer sufficient conformational control to enable the 1,2-hydride shift leading to the
homobisabolyl carbocation. The same steric guidance evolved naturally in the active site
of SQS1, since the homobisabolyl carbocation is the critical intermediate required for
the formation of sesquisabinene.
In F96 epi-isozizaene synthase mutants and SQS1, how does the active site
template direct transannular carbon-carbon bond formation in the homobisabolyl
cation to generate a highly strained bicyclic [3.1.0] system while preventing proton
elimination to yield a bisabolene regioisomer? The minimum energy conformation for
the homobisabolyl carbocation should be similar to that of cyclohexene, which is a halfchair conformation.43-45 With the homobisabolyl carbocation fixed in a half-chair
conformation, no C-H bonds would be perfectly parallel to the empty p orbital of the
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carbocation, and those that are closest to an axial conformation are oriented away from
PPi, the likely general base that would facilitate deprotonation (Figure 5.5a). Thus, no CH bonds of the homobisabolyl cation can undergo facile proton elimination. Moreover,
the half-chair conformation of the cyclohexenyl ring would orient the carbocation
favorably with respect to the C=C bond for transannular carbon-carbon bond formation,
which would yield the final [3.1.0] bicyclic tertiary carbocation. This [3.1.0] bicycle will
adopt a boat-like conformation46 and is characterized by a ring strain energy of 33.9
kcal/mol (as a point of comparison, the ring strain energy of cyclohexane is 1.4
kcal/mol).47 Despite the substantial ring strain energy of the [3.1.0] bicyclic carbocation,
however, this is the only reaction that the homobisabolyl carbocation can undergo.
Thus, the catalytic strategy for the generation of a highly strained cyclization product by
a terpenoid cyclase is for the active site template to block alternative pathways that
would lead to more stable products, leaving only the kinetically-favored yet
thermodynamically-unfavored reaction of transannular carbon-carbon bond formation
as the only possible alternative. Precise structures of carbocation intermediates and
their flanking transition states in the pathway of sesquisabinene formation have been
calculated in elegant quantum mechanical studies by Hong and Tantillo.48
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Figure 5.5: SQS1 Active Site Modeling. Stereoview of the enclosed active site contour in
a model of the SQS1-Mg2+3-PPi complex based on the crystal structure of the SQS1Mg2+3-ibandronate complex. (a) A model of the homobisabolyl cation is fit into the
active site contour. This conformation would support the 1,2-hydride shift leading from
the bisabolyl cation intermediate. Although two of the C-H groups adjacent to the
carbocation center of the homobisabolyl cation approach an axial conformation that
could facilitate elimination to form a bisabolene regioisomer, these C-H groups are
oriented away from the PPi ion, the likely general base. (b) A model of product
sesquisabinene is fit into the active site contour. The active site contour is product-like
in shape.
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5.2.5 Active site templates that facilitate strained ring formation.
The active site of SQS1 has evolved naturally to catalyze formation of the strained
[3.1.0] bicyclic ring system of sesquisabinene. Analysis of the active site contour
illuminates features contributing to the catalytic strategy of strained ring formation. The
volume enclosed by the active site contour is 314 Å3, slightly larger than the volume of
the isoprenoid moiety of substrate FPP (245 Å3), which ensures a snug fit in the enzymesubstrate complex upon full active site closure. Notably, the three-dimensional contour
of the active site is highly complementary to that of product sesquisabinene (Figure
5.5b). Therefore, the active site contour must fix the homobisabolyl cation in a half-chair
conformation so as to disable proton elimination reactions that would yield a bisabolene
regioisomer (Figure 5.5a). Moreover, the relatively snug fit of sesquisabinene in the
active site contour helps compress the homobisabolyl cation to enable transannular
carbon-carbon bond formation and generation of the [3.1.0] bicyclic ring system.
Analysis of the active site contour of SQS1 informs our understanding of
structure-activity relationships in F96 epi-isozizaene synthase mutants that generate
sesquisabinene. In the wild-type enzyme, the active site volume is 303 Å3 and the
enclosed active site contour is quite complementary in shape to that of epi-isozizaene
(Figure 5.6a). The crystal structure of F96S epi-isozizaene synthase, which generates
78% sesquisabinene, has been determined only in the open, unliganded state,23 but the
closed active site conformation can be modeled in silico using the structure of the wildtype epi-isozizaene synthase-Mg2+3-PPi-BTAC complex21 as a starting point. The resulting
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model of the F96S epi-isozizaene synthase-Mg2+3-PPi complex reveals an enclosed active
site volume of 372 Å. Inspection of the active site contour reveals that the mutation
introduces an “L”-shaped bend (Figure 5.6b). With the active site contour thus widened,
formation of the acorenyl cation leading to epi-isozizaene is disabled, since the loosened
template can no longer hold the pendant isoprenoid tail of the homobisabolyl cation in
the proper conformation adjacent to the carbocation center. Additionally, axial C-H
groups adjacent to the carbocation are distant from the PPi anion, the likely general
base, so transannular carbon-carbon bond formation is the only kinetically-feasible
mechanistic option. Of note, the isoprenoid tail of sesquisabinene must be bent to fit in
the active site of F96S epi-isozizaene synthase (Figure 5.6b), in contrast with its
extended conformation in the active site of SQS1 (Figure 5.5b). Thus, [3.1.0] ring
formation is not dependent on the isoprenoid tail conformation of the preceding
homobisabolyl cation intermediate. Similar conclusions can be made based on models
of F96Q and F96M epi-isozizaene synthases (Figure A.1).
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Figure 5.6: Modeling Sesquisabinene into EIZS Active Site (a) Stereoview of the
enclosed active site contour in the epi-isozizaene synthase-Mg2+3-PPi-BTAC complex,
omitting the atomic coordinates of BTAC and instead fit with a model of product epiisozizaene. The active site contour is product-like in shape. (b) Stereoview of the
enclosed active site contour in a model of the F96S epi-isozizaene synthase-Mg2+3-PPi
complex based on the structure in (a) after introduction of the F96S mutation in silico.
The active site contour is distinct from that of wild-type epi-isozizaene synthase and
SQS1. A model of sesquisabinene is fit into the “L”-shaped active site contour.
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5.3 Conclusions
Crystal structures of unliganded and liganded wild-type sesquiterpene synthase
SQS1 illuminate molecular details underlying the generation of sesquisabinene from
farnesyl diphosphate. The SQS1 active site contour is complementary to the shape of
the product and serves as a template for catalysis, directing the cyclization and
subsequent stabilization of the strained [3.1.0] bicyclic ring system. Modeling shows
that sesquisabinenend the intermediate homobisabolyl cation fit snugly into the
product-like contour of the SQS1 active site. The three-dimensional contour
accommodates the favorable half-chair conformation of the homobisabolyl cation and
hinders conformations and orientations that would lead to premature elimination of
axial protons adjacent to the carbocation center to yield bisabolene regioisomers.
The SQS1 active site contour is longer and narrower than the smaller, roughly
ellipsoidal active site contour of epi-isozizaene synthase. Here, the homobisabolyl cation
intermediate must be held in a compressed conformation to direct acorenyl cation
formation. However, the substitution of smaller residues for F96 in the F96S, F96Q, and
F96M mutants results in a wider, “L”-shaped active site contour that loosens the
conformational restraints on the homobisabolyl cation. Consequently, acorenyl cation
formation becomes disfavored and the homobisabolyl cation instead diverts to
sesquisabinene formation.
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Remarkably, the overall active site contours of SQS1 and F96S epi-isozizaene
synthase are different, even though both enzymes generate sesquisabinene with high or
relatively high fidelity. The active site contour of SQS1 is elongated (Figure 5.5), whereas
that of F96S epi-isozizaene synthase is L-shaped (Figure 5.6b). This may reflect the fact
that the pendant isoprenoid tail of the homobisabolyl cation is merely a spectator to the
transannular [3.1.0] cyclization reaction, so the isoprenoid tail can adopt an extended or
bent conformation without compromising cyclization. These structure-function lessons
promise to inform our continuing protein engineering experiments aimed at developing
“designer cyclases” capable of generating new terpenoid natural products, and our
results in this regard will be reported in due course.
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5.4 Methods
A gene encoding full-length SQS1 (residues 1-566) was synthesized by Biomatik
(Wilmington, DE) using codon optimization for expression in Escherichia coli. The gene
was cloned into the pHIS parallel expression vector,49 and the resulting plasmid was
transformed into BL21(DE3) E. coli for expression and purification as described in the
Supporting Information [see Appendix].
Crystallization of unliganded SQS1 was achieved in sitting drops at 21 °C. Crystals
of unliganded and liganded SQS1 diffracted X-rays to 1.90 Å resolution and 2.10 Å
resolution, respectively, using synchrotron radiation. The initial electron density map of
the unliganded enzyme was phased by molecular replacement using the atomic
coordinates of (+)-limonene synthase from Citrus sinensis (PDB code: 5UV0)31 as a
search probe, and the structure of unliganded SQS1 was used as a search probe for the
structure determination of liganded SQS1. Crystallographic refinement of each structure
converged smoothly to Rwork/Rfree values of 0.195/0.232 for unliganded SQS1 and
0.221/0.246 for liganded SQS1. Complete details of the structure determination are
outlined in the Supporting Information; data collection and refinement statistics are
recorded in Table A.2.
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5.5 Additional Information
The Supporting Information is available free of charge on the ACS Publications
website. However, the SI has been adapted here for reader convenience in the Appendix
of this dissertation to include detailed methods; Table A.2 [online Table S1] (X-ray
crystallographic data collection and refinement statistics); and Figure A.1 [online Figure
S1] (models of sesquisabinene bound in the active sites of F95Q and F95M epiisozizaene synthases).
The atomic coordinates and crystallographic structure factors of liganded and
unliganded SQS1 have been deposited in the Protein Data Bank (www.rcsb.org) with
accession codes 6O9P and 6O9Q, respectively.
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Chapter 6: Crystal Structure of Cucumene Synthase, a Terpenoid
Cyclase that Generates a Linear Triquinane Sesquiterpene
Adapted with permission from Blank, P.N., Pemberton, T.A., Chow, J.,
Christianson, D.W. (2018) Crystal Structure of Cucumene Synthase, a Terpenoid
Cyclase that Generates a Linear Triquinane Sesquiterpene. Biochemistry 57(44),
6326-6335. Copyright 2018 American Chemical Society.

6.0 Abstract
Linear triquinanes are sesquiterpene natural products with hydrocarbon
skeletons consisting of three fused 5-membered rings. Importantly, several of these
compounds exhibit useful anti-cancer, anti-inflammatory, and antibiotic properties.
However, linear triquinanes pose significant challenges to organic synthesis due to the
structural and stereochemical complexity of their hydrocarbon skeletons. To illuminate
nature’s solution to the generation of linear triquinanes, we now describe the crystal
structure of Streptomyces clavuligerus cucumene synthase. This sesquiterpene cyclase
catalyzes the stereospecific cyclization of farnesyl diphosphate to form a linear
triquinane product, (5S,7S,10R,11S)-cucumene. Specifically, we report the structure of
the wild-type enzyme at 3.05 Å resolution and the structure of the T181N variant at 1.96
Å resolution, both in the open active site conformations without any bound ligands. The
high-resolution structure of T181N cucumene synthase enables inspection of the active
site contour, which adopts a three-dimensional shape complementary to a linear
triquinane. Several aromatic residues outline the active site contour and are believed to
facilitate cation-π interactions that would stabilize carbocation intermediates in
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catalysis. Thus, aromatic residues in the active site not only define the template for
catalysis, but these residues also play a role in reducing activation barriers in the multistep cyclization cascade.
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6.1 Introduction
During the past decade, approximately 3,000 new terpenoid natural products
have been discovered per year, and to date more than 80,000 terpenoids have been
identified in all forms of life.1 Genome mining has accelerated the identification of new
terpenoids through the discovery and characterization of new terpenoid cyclases.2 The
catalytic activity of these enzymes underlies exquisite chemodiversity in the
hydrocarbon skeletons of all terpenoid natural products.3-8 The active site contours of
terpenoid cyclases function as templates in catalysis. Each template constrains a flexible
prenyl diphosphate substrate with a specific conformation that facilitates a specific
multi-step reaction.9-13 Active site contours differ from one cyclase to another; different
active site contours, i.e., different cyclization templates, direct different reaction
sequences.
Class I terpenoid cyclases utilize 3 Mg2+ ions (or sometimes 3 Mn2+ ions) to
trigger the ionization of the prenyl diphosphate substrate, resulting in the formation of
an allylic cation-inorganic pyrophosphate ion pair. One of the remaining substrate π
bonds then reacts with the allylic cation to generate a new carbon-carbon π bond. The
catalytic metal ions initiating this chemistry are coordinated by the aspartate-rich metal
ion-binding

motif

DDXXD

and

the

NSE/DTE

metal

ion-binding

motif

(N,D)D(L,I,V)X(S,T)XXXE (metal ion ligands are indicated in boldface).15-18 While these
sequence motifs comprise a reliable signature to facilitate the discovery of new
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terpenoid cyclases, it is generally impossible to predict exactly what product(s) a
terpenoid cyclase will generate based solely on analysis of its amino acid sequence or
three-dimensional structure. Such product determination always requires biochemical
analysis.
Recently, however, a successful de novo prediction of terpenoid cyclase product
formation has been reported based solely on analysis of primary structure and modeling
of tertiary structure.19 Genome mining experiments with Streptomyces clavuligerus led
to the discovery of a new terpenoid cyclase (Uniprot: B5GLM7) exhibiting 33% sequence
identity with Streptomyces coelicolor epi-isozizaene synthase and 27% identity with
Streptomyces exfoliatus pentalenene synthase. Network analysis using the StructureFunction Linkage Database and generation of a three-dimensional homology model
provided a platform for computational studies, leading to the suggestion that B5GLM7 is
a sesquiterpene cyclase that generates a linear triquinane hydrocarbon from substrate
farnesyl diphosphate (FPP).19 Subsequent biochemical analysis confirmed that the new
linear triquinane (5S,7S,10R,11S)-cucumene was the major cyclic sesquiterpene product
generated by B5GLM7 (Figure 6.1). Accordingly, this new sesquiterpene cyclase was
named cucumene synthase.19
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H
+

PPOH

H
OPP
farnesyl diphosphate

5S,7S,10R,11S-cucumene

Figure 6.1: Reaction Catalyzed by Streptomyces Cucumene Synthase. OPP =
diphosphate, PPOH = inorganic pyrophosphate.
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Of the three sub-families of triquinane natural products – linear triquinanes,
angular triquinanes, and propellanes – linear triquinanes such as cucumene have
presented critical challenges for synthetic organic chemistry. The synthesis of
sesquiterpenes containing multiple fused 5-membered rings through multi-step
reactions has required the development of new synthetic methodology.20-27 Interest in
this family of natural products has also been inspired by the biological activity of certain
linear triquinanes. For example, capnellane triquinanes exhibit sub-micromolar toxicity
against leukemia and renal cancer cell lines,28 and capnellene itself exhibits potent antineuroinflammatory and analgesic effects.29 In another example, hirsutane triquinanes
exhibit useful antimicrobial properties,30,31 and recently identified chondrosterin
triquinanes exhibit cytotoxicity against seven different cancer cell lines.32 Thus, the
discovery of cucumene synthase, which generates a linear triquinane in a single enzymecatalyzed reaction, represents a significant advance for biosynthetic chemistry and the
generation of triquinane hydrocarbon skeletons.19
To assess the quality of the homology model used to predict the function of
cucumene synthase,19 and to provide a foundation for studying terpenoid cyclase
structure-function relationships, we now describe crystal structures of wild-type
cucumene synthase and T181N cucumene synthase from S. clavuligerus. As a
sesquiterpene cyclase that catalyzes an anti-Markovnikov C1-C11 cyclization reaction,
cucumene synthase is only the second such cyclase to yield a crystal structure (the first
anti-Markovnikov cyclase to yield a crystal structure was pentalenene synthase33).
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Comparisons of cucumene synthase with other sesquiterpene cyclases reveal active site
features that direct this unusual chemistry, including a product-like active site contour
containing aromatic side chains oriented to provide electrostatic stabilization of
carbocation intermediates in catalysis through cation-π interactions.
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6.2 Materials and Methods
6.2.1 Expression and purification. The wild-type cucumene synthase
plasmid,19 comprised of an N-terminal hexahistidine tag with a TEV protease cleavage
site, was transformed into Escherichia coli BL21 (DE3) RIL cells. Cells were plated on LB
agar and grown overnight. Single colonies were picked and used to inoculate 10 mL
starter cultures of LB Broth with 500 μM ampicillin and 50 μM chloramphenicol. Starter
cultures were grown at 37º C overnight and subsequently used to inoculate 1 L LB Broth
with 500 μM ampicillin and 50 μM chloramphenicol and grown at 37º C until OD600 =
0.8. Cultures were then induced with 500 μM IPTG for approximately 8 h. Cells were
centrifuged for 15 min at 5400 g. The pellet was collected, flash frozen, and stored at 80º C.
Frozen pellets were thawed at room temperature, resuspended in buffer A [20
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 8.0), 300 mM NaCl,
5% glycerol], sonicated, and centrifuged for 1h at 37,000 g. The clarified supernatant
was diluted approximately 3-fold with buffer A and run over a 5 mL Ni-NTA column (GE
Healthcare). The column was subsequently washed with buffer A containing 30 mM
imidazole, and then with buffer A containing 300 mM imidazole. Fractions containing
cucumene synthase were pooled and treated with 1.0 mL of 1 mg/mL TEV protease. The
mixture was dialyzed overnight in a semi-permeable membrane (molecular weight
cutoff = 10 kDa) against 2 L buffer A.
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The protein sample was centrifuged for approximately 5 min at 5,400 g to
remove precipitate, and a 5 mL Ni-NTA column was loaded with the supernatant.
Cucumene synthase exhibited a small degree of non-specific binding and was eluted
with buffer A augmented with 30 mM imidazole. Protein-containing fractions were
pooled and loaded onto a Superdex 200 (GE Healthcare) column equilibrated with
buffer B [50 mM Tris (pH 7.5), 300 mM NaCl, 5% glycerol, 0.1 mM tris(2carboxyethyl)phosphine (TCEP)]. A small amount of soluble aggregate was removed, but
fractions corresponding to the correct molecular weight were collected and the enzyme
was concentrated to approximately 10 mg/mL.
The T181N cucumene synthase variant was prepared by PCR mutagenesis34
starting with the wild-type cucumene synthase plasmid.19 This residue was among a
group of residues selected for substitution based on their anticipated locations in the
active site as suggested by homology modeling. The expression and purification of
T181N cucumene synthase followed the same protocol described above for wild-type
cucumene synthase. Only this particular variant yielded crystals, but these crystals
exhibited superior X-ray diffraction properties.

6.2.2 Crystallization. Wild-type cucumene synthase was crystallized by the
vapor diffusion method. Briefly, a 1 µL drop containing 10 mg/mL cucumene synthase,
1.0 mM MgCl2, 2.0 mM sodium pyrophosphate, and 2.0 mM benzyltriethylammonium
chloride (BTAC) was added to a 1 µL drop consisting of 0.1 M Bis-Tris (pH 6.0–7.5) and
12-25% PEG 3,350, and then equilibrated against a 500 µL reservoir of precipitant
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solution. Thin plate-like crystals appeared after 1 day at room temperature. These
crystals were transferred to a cryoprotectant buffer consisting of 0.1 mM Bis-Tris (pH
7.0), 25% PEG 3350, 1.0 mM MgCl2, 2.0 mM sodium pyrophosphate, 2.0 mM BTAC, and
5–20% ethylene glycol. The concentration of ethylene glycol was initially 5% and then
gradually increased by 5% increments to a final concentration of 20%. This gradual
transfer was done to preserve the integrity of the crystals, since direct transfer to 20%
ethylene glycol solutions caused crystal cracking and resulted in poor diffraction. Finally,
crystals were flash-cooled in liquid nitrogen.
The site-specific variant T181N cucumene synthase was similarly crystallized by
the vapor diffusion method. Briefly, a 1 µL drop of 10 mg/mL T181N cucumene
synthase, 1.0 mM MgCl2, 2 mM sodium pyrophosphate, and 2 mM BTAC was added to a
1 µL drop of 0.1 M Bis-Tris (pH 6.5–8.0) and 12-25% PEG monomethyl ether 5,000, and
then equilibrated against a 500 µL reservoir of precipitant solution. Clusters of square
rod-shaped crystals appeared after 1 day at room temperature. Crystals were
transferred to a cryoprotectant buffer consisting of 0.1 mM Bis-Tris (pH 7.0), 25% PEG
monomethyl ether 5,000, 1.0 mM MgCl2, 2.0 mM pyrophosphate, 2.0 mM BTAC, and 520% ethylene glycol. The ends of these rod-shaped crystals were snapped off from
clusters and flash-cooled in liquid nitrogen.

6.2.3 Data collection and refinement. X-ray diffraction data from crystals
of wild-type cucumene synthase were collected using beamline 17-ID AMX at the
National Synchrotron Light Source (NSLS-II), Brookhaven National Laboratory. Crystals
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diffracted to 3.05 Å resolution and belonged to monoclinic space group P21 (a = 63.75 Å,
b = 95.85 Å, c = 102.30 Å, α = 90.0º, β = 96.9º, γ = 90.0º). Data reduction was achieved
using XDS35 as implemented in Aimless.36 The initial electron density map was phased by
molecular replacement with Phaser,37 using the crystal structure of wild-type
pentalenene synthase (amino acid sequence identity = 33% (PDB accession code
1PS1))33 as a search model. The AutoBuild routine implemented in Phenix38 was used to
fit the electron density map to generate an initial model of cucumene synthase. Several
rounds of refinement with routines implemented in Phenix and model rebuilding using
Coot39 yielded a final model with Rwork = 0.244 and Rfree = 0.299.
Diffraction data from crystals of T181N cucumene synthase were collected using
beamline 24-ID-C of the Northeast Collaborative Access Team (NE-CAT) at the Advanced
Photon Source, Argonne National Laboratory. Crystals diffracted to 1.96 Å resolution
and belonged to orthorhombic space group P22121 (a = 58.33 Å, b = 91.81 Å, c = 124.96
Å). Data reduction was performed with XDS as implemented in Aimless.35,36 Phaser37
was used to solve the structure by molecular replacement using the 3.05 Å-resolution
structure of wild-type cucumene synthase as a search model. The structure was refined
using Phenix.38 Water molecules were built into the electron density map in the later
stages of refinement and visualized using Coot.39 Refinement converged to Rwork = 0.174
and Rfree = 0.210. All statistics for data collection and crystallographic structure
refinement are recorded in Table 6.1. MolProbity was used for analysis and validation of
final refined structures.40
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6.2.4 Product docking in the cucumene synthase active site. The
(5S,7S,10R,11S)-cucumene structure was drawn in a structure editor and converted to a
SMILES format string for input to the SMILES Translator and Structure File Generator
(https://cactus.nci.nih.gov/translate/), which yielded a coordinate file in .pdb format. To
guide the docking of cucumene in the active site of T181N cucumene synthase, the
molecular surface of the protein was generated using the surface cavity function in
Pymol with a probe radius of 1.6 Å. Cucumene was docked manually in the active site
pocket, such that the curvature of the triquinane skeleton matched the natural
curvature of the pocket. Computational approaches are available for docking ligands in
terpenoid cyclase active sites, e.g., those developed by Jacobson,41 Major,42 and
Tantillo,43 but given the product-like active site contour these approaches were not
utilized for product docking. However, computational approaches will be invaluable for
future studies of the binding of reaction intermediates.
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Table 6.1: Cucumene Synthase Data Collection and Refinement Statistics
Cucumene synthase
Synchrotron
Beamline
Detector
Wavelength (Å)
Resolution (Å)a
Total/unique no. of
reflectionsa
Rmerge a
Rp.i.m. a,b
CC1/2 a,c
I/σ(I) a
Redundancy a
Completeness (%) a
Rwork a
Rfree a
No. of non-hydrogen
atoms:
protein
solvent

Wild-type

T181N

NSLS-II
17-ID-1; AMX
EIGER
0.979
29.90-3.05 (3.163.05)
79691/23205
(13732/4044)
0.147 (0.672)
0.093 (0.424)
0.995 (0.876)
5.7 (1.7)
3.4 (3.4)
98.6 (92.6)
0.244 (0.354)
0.299 (0.407)

APS
24-ID-C
PILATUS
0.979
62.48-1.96 (2.031.96)
290219/47590
(19636/3316)
0.133 (1.020)
0.058 (0.468)
0.996 (0.547)
12.9 (3.3)
6.1 (5.9)
97.5 (98.0)
0.174 (0.230)
0.205 (0.299)

7854
4

4700
451

63
42

30
37

0.003
0.57

0.007
0.77

96.12
3.88
0.0
1.59
5.91
0

98.16
1.51
0.33
0.64
5.99
0

Average B-factors (Å2)
macromolecules
solvent
Rms deviations from
ideal geometry
bonds (Å)
angles (°)
Ramachandran plot
(%)d
favored
allowed
outliers
Rotamer outliers (%)
Clashscore
Cβ outliers (%)
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PDB accession code

6M7F

a

6EGK

Values in parentheses refer to data in the highest resolution shell. bRp.i.m.= (∑hkl(1/(N1))1/2∑i|Ii,hkl − ⟨I⟩hkl|)/∑hkl∑i Ii,hkl; ⟨I⟩hkl = average intensity for reflection hkl, N = number of
reflections. cPearson correlation coefficient between random half-datasets. dCalculated
with MolProbity.
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6.3 Results
6.3.1 Structure of Cucumene Synthase. The 3.05 Å-resolution structure of
wild-type cucumene synthase exhibits the class I terpenoid cyclase fold, which consists
of an α-helix bundle (Figure 6.2a). Four independent monomers of wild-type cucumene
synthase are found in the asymmetric unit. Monomer A and monomer B form a dimer;
monomer C and monomer D form a second dimer. Active site orientations in each dimer
are antiparallel, with a C2 symmetry axis roughly perpendicular to the α-helix bundles.
The quaternary structure of the related sesquiterpene synthase, pentalenene
synthase,33

is

defined

as

dimeric

by

analysis

with

the

PISA

server

(http://www.ebi.ac.uk/pdbe/pisa/). In the pentalenene synthase dimer, one active site
is oriented approximately 90º away from the other (Figure 6.2b). However, since
pentalenene synthase is observed to be a monomer in solution,44 its apparent dimeric
structure in the crystal may be artifactual.
The overall fold of each cucumene synthase monomer is nearly identical. The
root-mean-square (rms) deviations of 176–234 Cα atoms between any two monomers
range 0.21–0.57 Å. The AB dimer and CD dimer are also quite similar, with a rms
deviation for 412 Cα atoms between each dimer of 0.25 Å. Electron density for each
monomer is absent for 6–8 residues and 37 residues at the N- and C-termini,
respectively. Additionally, various loop residues in each monomer are characterized by
missing electron density, such that 59, 111, 76, and 117 total residues are missing from
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monomers A, B, C and D, respectively. Missing or weak electron density is likely
attributable to molecular disorder and the relatively low resolution.
The active site of cucumene synthase is located within the α-helix bundle, as is
typical for class I bacterial cyclases.8,45 The metal ion-coordinating motifs DDXXD and
(N,D)D(L,I,V)X(S,T)XXXE (boldface indicates typical metal ligands) are located at the ends
of helices D and H, respectively, at the entrance to the active site. The aspartate-rich
motif is ordered in monomers A and B of one dimer but disordered to varying degrees in
monomers C and D; the NSE motif is disordered to varying degrees in all monomers.
The enzyme adopts the open, unliganded active site conformation despite
having been crystallized in the presence of Mg2+ and inorganic pyrophosphate, which
were expected to bind and stabilize the closed active site conformation.5,8 Least-squares
superposition with the homology model of cucumene synthase in the closed
conformation initially constructed to predict the triquinane product19 yields rms
deviation = 2.2 Å (252 Cα atoms). Since rms deviations between open and closed
terpenoid cyclase conformations typically range 1.5–2.0 Å, the rms deviation of 2.2 Å
obtained for this comparison serves to validate the homology model of cucumene
synthase and the computational approach used for its construction.
It has been noted recently that the evolutionary origins of the class I terpenoid
synthase fold reside in the primordial gene duplication and fusion of a 4-helix bundle
protein.46 This is the case for all class I terpenoid cyclases, including cucumene synthase,
in which helices C, D, E, and F are topologically equivalent to helices G, H, I, and J,
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respectively (Figure 6.2c). The aspartate-rich and NSE metal ion-binding motifs thus
reside in topologically identical positions on helices D and H, respectively. Terpenoid
synthases of primary metabolism, such as the prenyltransferase farnesyl diphosphate
synthase, contain aspartate-rich motifs on helices D and H (i.e., they do not contain NSE
motifs). This could suggest that the ancestral 4-helix bundle precursor contained an
aspartate-rich motif, and that this motif persisted after gene duplication and fusion. If
so, the NSE motif on helix H in terpenoid cyclases diverged from an aspartate-rich motif
during the evolution of secondary (specialized) metabolism.
The 1.96 Å-resolution structure of unliganded T181N cucumene synthase
crystallized in the open active site conformation reveals an α-helical fold essentially
identical to that of wild-type cucumene synthase (rms deviation = 0.37 Å for 277
Cα atoms between monomer B of T181N cucumene synthase and monomer C of the
wild-type enzyme). One dimer resides in the asymmetric unit and exhibits identical
quaternary structure to that observed for the wild-type enzyme. The rms deviation for
234 Cα atoms between monomers A and B of the dimer is 0.36 Å. Electron density is
absent for 6 residues at the N-termini of monomers A and B, 33 residues at the Cterminus of monomer A, and 37 residues at the C-terminus of monomer B. Additionally,
various loop residues in each monomer are characterized by missing electron density,
such that 44 and 51 total residues are missing from monomer A and monomer B,
respectively. Given the higher resolution of the T181N cucumene synthase structure, we
attribute these missing residues mainly to molecular disorder. We speculate that
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disordered loops might become ordered after ligand binding, e.g., as found in the
related sesquiterpene cyclase epi-isozizaene synthase.47
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Figure 6.2: Cucumene Fold and Bundle Comparisons (a) The wild-type cucumene
synthase monomer exhibits the class I terpenoid synthase fold, an α-helix bundle. The
locations of metal ion-binding motifs are indicated in red (aspartate-rich motif) and
orange (NSE motif); dash lines indicate disordered segments. (b) Subunits in the
cucumene synthase dimer adopt antiparallel orientation with C2 symmetry (left). This
quaternary structure differs from that found in the related dimeric cyclase, pentalenene
synthase (right), in which one subunit is rotated approximately 90º away from the other,
as evident in the superposition of dimers (center). (c) The 4-helix bundles of wild-type
cucumene synthase are highlighted as follows: helices C (blue), D (red), E and E’ (green),
and F (yellow) (far left), and helices G (blue), H (red), I (green), and J (yellow) (far right);
the remainder of the protein structure is gray in each image (the monomer is oriented
upside down relative to the monomer orientation in panel (a)). The respective individual
4-helix bundles are more easily viewed after removing the remainder of the protein
structure (center left and center right), and these 4-helix bundles are aligned as
superimposed (center). This topological relationship suggests that the class I terpenoid
synthase fold arose from gene duplication and fusion of a 4-helix bundle, as first
proposed by Huang and colleagues.46
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The aspartate-rich motif D82DQFD is ordered in monomer A and disordered in
monomer B of T181N cucumene synthase, whereas the NSE motif N223DLCSAEKE is
ordered in both monomers (Figure 6.3a). Molecular disorder for these metal ion-binding
motifs is also found in wild-type cucumene synthase, but they are expected to become
fully ordered upon metal ion and substrate binding. Protein-metal ion-substrate binding
interactions would likely induce a structural transition to a closed active site
conformation. Similar substrate-induced conformational transitions have been observed
in other bacterial cyclases, e.g., epi-isozizaene synthase.47 Active site closure protects
carbocationic reaction intermediates from premature quenching by solvent molecules.
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Figure 6.3: Cucumene Synthase Motifs and Active Site (a) Polder omit map (in stereo)
of T181N cucumene synthase (monomer A, contoured at 2.5σ) in which the aspartaterich motif starting with D82 (magenta backbone), the NSE metal binding motif starting
with N223 (orange backbone), and N181 were omitted from the structure factor
calculation. The carboxamide side chain of N181 donates a hydrogen bond to N223
(dashed line). (b) Active site superposition in stereo of wild-type (green with salmon
DDXXD motif and gold NSE motif) and T181N (marine with magenta DDXXD motif and
orange NSE motif) cucumene synthase, showing that the structures of each are almost
identical. Selected residues are labeled; the conformation of F78 is slightly different in
each structure.
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The T181N substitution appears to be responsible for stabilizing the NSE motif in
an ordered conformation, in contrast with the apparent disorder for this motif observed
in the structure of wild-type cucumene synthase. The newly introduced N181 side chain
forms hydrogen bonds with S183 and N223, the latter of which is part of the NSE metal
ion-binding motif on helix H. In turn, the ordering of the NSE motif and the loop
segment that follows may explain why T181N cucumene synthase consistently yields
higher quality crystals that diffract to much higher resolution than crystals of the wildtype enzyme. The NSE motif is disordered in some but not all terpenoid cyclase
structures determined in the open conformation. Possibly, a comparable mutation in
other terpenoid cyclases that are refractory to crystallization might make such cyclases
more amenable to crystallization.
Since the structure of T181N cucumene synthase is determined at a much higher
resolution than the structure of wild-type cucumene synthase, the structure of the
former serves as a useful surrogate of the latter for purposes of structural analysis. That
being said, superposition of wild-type and T181N cucumene synthase structures shows
that their active sites are essentially identical, so the higher resolution structure serves
to validate the lower resolution structure (Figure 6.3b). Regardless, T181N cucumene
synthase is used here for structural comparisons with other bacterial sesquiterpene
cyclases. Least-squares superposition of chain A with unliganded wild-type epiisozizaene synthase (PDB 4LTV; 33% sequence identity) yields rms deviation = 2.9 Å
between 220 Cα atoms, whereas superposition with unliganded pentalenene synthase
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(PDB 1PS1; 27% sequence identity) yields rms deviation = 1.5 Å between 241 Cα atoms.
Thus, the three-dimensional structure of cucumene synthase is more similar to the
structure of pentalenene synthase despite sharing lower amino acid sequence identity
with this sesquiterpene synthase relative.

6.3.2 Structural inferences on catalysis. Despite cocrystallization of wildtype and T181N cucumene synthase enzymes with Mg2+ and inorganic pyrophosphate,
neither structure contains bound ligands. Even so, structures of the unliganded enzymes
provide valuable inferences with regard to catalytic function. Hydrophobic residues
define the active site contour, including the aromatic side chains of F58, Y77, F78, and
W310. These aromatic residues are oriented such that their ring π electrons could
provide electrostatic stabilization for carbocation intermediates and the cationic
transition states flanking these intermediates. Such interactions have been definitively
observed in terpenoid cyclase complexes with quaternary ammonium analogues of
carbocation intermediates,47,48 and the contribution of aromatic residues to catalytic
efficiency and cyclization specificity has been probed by mutagenesis of the related
cyclase epi-isozizaene synthase.47,49,50 Density functional theory calculations by Hong
and Tantillo show that active site aromatic residues in terpenoid cyclases may interact
with C–H bonds hyperconjugated with adjacent carbocations to form C–H•••π
interactions.51,52
Using the high-resolution structure of T181N cucumene synthase, we generated
a molecular contour of the enzyme active site and manually docked cucumene into this
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contour. The curvature of the triquinane skeleton of cucumene appears to match the
natural curvature of the active site pocket (Figure 6.4). As mentioned above, aromatic
residues defining the contour are poised for interactions with carbocation
intermediates. Additionally, the backbone carbonyl of A180 at the helix G break may
also provide electrostatic stabilization of cationic intermediates through charge-dipole
interactions. The helix G break is common to class I terpenoid synthases; the possible
catalytic importance of the backbone carbonyl group exposed at the break was first
noted by Pandit and colleagues53 and further explored by Dickschat and colleagues.54,55
The experimentally-determined crystal structure of cucumene synthase and the
model of the enzyme-product complex serve as a platform for understanding the
chemical mechanism of triquinane formation. A proposed mechanism of cucumene
synthase is outlined in Figure 6.5. This mechanism shares several identical features with
that proposed for pentalenene synthase, which similarly catalyzes an initial C1-C11
macrocyclization reaction.56-59 Related mechanisms have also been computed using the
Artificial Force Induced Reaction method.60 First, ionization of the substrate diphosphate
group is triggered by coordination to the Mg2+3 cluster. Elegant quantum chemical
studies on the pentalenene synthase reaction indicate that C1-C11 bond formation
occurs in concerted fashion with C1-O bond dissociation, leading directly to humulyl
cation 1,56 a common intermediate in sesquiterpene biosynthesis.58 Humulyl cation 2
subsequently results from a 1,2-hydride shift and then undergoes a concerted reaction
to yield two new carbon-carbon bonds, forming the tricyclic protoilludyl cation
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intermediate with 5-6-4 ring structure. This intermediate has been confirmed in the
pentalenene synthase mechanism through kinetic isotope effects using an isotopically
labeled substrate;57 similarly, we advance that the protoilludyl cation is an intermediate
in the cucumene synthase reaction.19
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Figure 6.4: Modeling Cucumene in the Cucumene Synthase Active Site (a) Stereoview
of a plausible model of (5S,7S,10R,11S)-cucumene (C = salmon, H = white) complexed in
the active site pocket of T181N cucumene synthase. For reference, the aspartate-rich
(red) and NSE (orange) motifs are indicated. (b) Same as (a), but a side-on view. The
active site opens to the top of the figure. Selected active site residues are labeled.
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Following formation of the protoilludyl cation, tandem 1,2-alkyl migrations are
proposed to generate the triquinane skeleton.13 The first alkyl migration converts the
protoilludyl cation into the cerapicyl cation, and the second alkyl migration yields
cucumyl cation 1 with 5-5-5 ring structure. We suggest that a 1,3-hydride transfer
follows to form cucumyl cation 2, and then a final proton elimination yields cucumene.
Since the proton elimination and hydride transfer occur on opposite sides of the 5-5-5
ring system, it is possible that these steps could occur in concerted fashion. We
speculate that the co-product, inorganic pyrophosphate, is the general base that
quenches the final carbocation intermediate. We note that an alternative biosynthetic
pathway has been suggested that leads from humulyl cation 1 to the protoilludyl cation
through a bicyclic cation with 5-8 ring structure.13,61 However, this proposed pathway
does not accommodate the trans-cis isomerization of a carbon-carbon double bond in
humulene that is required to form the bicyclic cation.
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Figure 6.5: Proposed mechanism of cucumene synthase. Red arrows indicate 1,2- or
1,3-hydride transfers, green arrows indicate 1,2-alkyl migrations. PPO = diphosphate, –
OPP and PPOH represent different protonation states of inorganic pyrophosphate.
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Among sesquiterpene cyclases that catalyze initial anti-Markovnikov C1-C11
cyclization reactions, only cucumene synthase and pentalenene synthase have yielded
X-ray crystal structures. Both of these cyclases share a common mechanism through the
formation of the protoilludyl cation; however, the mechanisms subsequently diverge,
with cucumene synthase generating a linear triquinane product (Figure 6.5) and
pentalenene synthase generating an angular triquinane product (Figure 6.6) Even so, the
active site contours of these enzymes share features that facilitate the shared chemistry
of initial C1-C11 cyclization and protoilludyl cation formation.
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Figure 6.6: Proposed mechanism of pentalenene synthase. This mechanism reflects the
most recent details emanating from experimental and computational studies.56-59 Red
arrows indicate 1,2-hydride transfers. PPO = diphosphate, –OPP and PPOH represent
different protonation states of inorganic pyrophosphate.
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The four aromatic residues defining much of the active site surface contour of
cucumene synthase, F58, Y77, F78, and W310, align with F57, F76, F77, and W308,
respectively, in the pentalenene synthase active site. Each corresponding pair of
residues adopt similar conformations except for the third pair: F78 of cucumene
synthase and F77 of pentalenene synthase (Figure 6.7).
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Figure 6.7: Pentalenene Synthase Modeling and Superposition (a) Stereoview of T181N
cucumene synthase complexed with cucumene (C = salmon, H = white) (same as in
Figure 6.4, but a different orientation). (b) Stereoview of wild-type pentalenene
synthase (PDB 1PS1) complexed with pentalenene (C = purple, H = white). (c)
Stereoview of the aligned active sites of cucumene synthase (gray) and pentalenene
synthase (yellow), highlighting aromatic residues common to both active sites. Modeled
product orientations are such that the final deprotonation steps yielding these products
could be mediated by the co-product, inorganic pyrophosphate (not shown).
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Most other residues defining the active site contour of each enzyme are similar,
with two notable exceptions. First, D307 of cucumene synthase corresponds to S305 of
pentalenene synthase, and their side chain conformations differ substantially.
Parenthetically, we note that it is unusual to find a negatively charged carboxylate side
chain in the active site of a terpenoid cyclase; however, the side chain of D307 does not
protrude into the active site due to its hydrogen bond with S222. Second, L303 of
cucumene synthase corresponds to V301 in pentalenene synthase, and their side chain
conformations differ substantially. The overall result of structural differences with these
three pairs of corresponding residues is an elongated active site contour in cucumene
synthase and a wider, more triangular-shaped active site contour in pentalenene
synthase (Figure 6.7). Thus, each active site contour adopts a product-like shape similar
to that of its respective triquinane product, yet the common features of these contours
– defined by the conserved residues and residue conformations in each active site –
presumably enable the initial anti-Markovnikov C1-C11 cyclization reaction and
formation of the common protoilludyl cation intermediate.
Although comparisons of cucumene synthase and pentalenene synthase are
restricted to crystal structures of their unliganded conformations, the active site
contours of terpenoid cyclases in their open and closed conformations can be quite
similar, as first demonstrated for aristolochene synthase.62 Thus, just as a product-like
active site contour would be expected for the closed conformations of cucumene
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synthase and pentalenene synthase, many features of the product-like contour are
preserved in their open conformations.
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6.4 Concluding remarks
Crystal structures of wild-type cucumene synthase and T181N cucumene
synthase provide the first insight as to how a linear triquinane sesquiterpene is
generated from farnesyl diphosphate in an enzyme-catalyzed reaction. The active site
contour functions as a template for catalysis and is quite complementary in shape to
that of the specific stereoisomer, (5S,7S,10R,11S)-cucumene, generated by the enzyme.
This product-like template constrains the substrate conformation to ensure that the
correct sequence of bond forming reactions follows metal ion-triggered substrate
ionization.
The active site template enforces only the precatalytic substrate conformation
that leads to initial C1-C11 bond formation and prevents conformations that would lead
to initial C1-C10 or C1-C6 cyclization. Curiously, initial C1-C11 cyclization leads to the
generation of a secondary carbocation intermediate, the humulyl cation, whereas
alternative C1-C10 bond formation would lead to a tertiary carbocation intermediate,
which would be energetically more favorable than a secondary carbocation
intermediate. Thus, the cucumene synthase active site must play a decisive role in
directing the anti-Markovnikov cyclization reaction, both by serving as a rigid template
and also by providing preferential stabilization for the less stable secondary carbocation
intermediate. Aromatic residues defining the active site contour likely engage in cationπ interactions to stabilize carbocation intermediates. Thus, aromatic residues not only
comprise an important part of the catalytic template, but these residues also provide a
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means to stabilize otherwise unfavorable cationic intermediates and the transition
states leading to and away from these intermediates. Future studies will allow us to test
this mechanism in greater detail.
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6.5 Additional Information
The atomic coordinates and crystallographic structure factors of wild-type and
T181N cucumene synthase have been deposited in the Protein Data Bank
(www.rcsb.org) with accession codes 6M7F and 6EGK, respectively.
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Chapter 7: Summary of Results and Concluding Remarks
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7.2 Protein Data Bank Submissions
Since joining Penn Chemistry and learning macromolecular crystallography from the
ground up, I am honored to have contributed to the scientific community via the
deposition of 11 protein crystal structures to the Protein Data Bank (PDB):
•

6OFV – F95Q Epi-isozizaene Synthase – Complexed with BTAC, POP, Mg2+3

•

6O9P – Wild-type SaSQS1 – Complexed with Ibandronate

•

6O9Q – Wild-type SaSQS1 – Unliganded

•

6NKE – Wild-type tvGGGPS – Complexed with SO42- and GOL

•

6EGK – T181N Cucumene Synthase – Unliganded

•

6M7F – Wild-type Cucumene Synthase – Unliganded

•

6AX9 – F95N Epi-isozizaene Synthase – Complexed with BTAC, POP, Mg2+3

•

6AXM – F95Y Epi-isozizaene Synthase – Complexed with BTAC, POP, Mg2+3

•

6AXN – F95C Epi-isozizaene Synthase – Complexed with BTAC, POP, Mg2+3

•

6AXO – F96S Epi-isozizaene Synthase – Unliganded

•

6AXU – W203Y Epi-isozizaene Synthase – Complexed with BTAC, POP, Mg2+3
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7.3 Summary of Main Discoveries
7.3.1 Geranylgeranylglyceryl Phosphate Synthase (GGGPS)
The crystal structure of thermoplasma volcanium geranylgeranylglyceryl
phosphate synthase (tvGGGPS) is the first crystal structure from Archaea to be
crystallized in the Christianson Laboratory, out of over 450 PDB submissions. While the
enzyme crystallized as a monomer in the asymmetric unit, it is very clearly a dimer in
space as evidenced by symmetry mate quaternary analysis and by PISA software. Three
of these dimers overlap quite well with the mtGGGPS hexamer (PDB Code: 4MM1),
which in essence, upon further inspection, is actually a trimer of dimers. Inspection of
and modeling studies on our dimer with other homologous dimers and the mtGGGPS
hexamer reveal a conclusion that GGGPS dimers may be able to accommodate
substrates longer than 20 carbons as proposed in the literature, but hexamerization may
impede activity.

7.3.2 Epi-Isozizaene Synthase (EIZS)
The product activities and specific catalytic activities of 14 new EIZS mutants
were reported, expanding the library to 40 different single-site mutants modifying the
hydrophobic enzyme core. Interestingly, each of these mutants exhibited a different
catalytic product profile, and generally, making a mutation decreased the specific
activity by half compared to wild-type enzyme. It was concluded that these active site
mutations recontoured the enzyme active site, opening access toward new reaction
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pathways. Surprisingly, polar mutants generated the most interesting new natural
products, and did not destabilize the enzyme as canonical biochemistry teachings would
otherwise indicate. This work resulted in the conversion of EIZS into 9 different
sesquiterpene synthases, several of which are high fidelity. It was found that,
specifically, introduction of polar residues in the F96 position led to the reengineering of
EIZS to sesquisabinene synthases. Several of these 14 new mutants were crystallized
and investigation yielded discoveries of template and water molecule combinations that
evidence the mechanism for generation of respective hydroxylated products.
In 2019, the crystal structure of F95Q EIZS was reported on which intensive
modeling studies were conducted to unravel the molecular basis for generation of
biofuel precursors β-curcumene and γ-curcumene. It was found that the active site
volume had increased, and molecular contour had elongated, compared to wild-type
EIZS. According to current modeling studies, these differences combine to yield optimal
conditions for the generation of either regioisomer. Depending on whether the PPi coproduct or water #372 acts as a general base to mediate deprotonation of the
homobisabolyl cation intermediate in the final step of catalysis. Additionally, perhaps
more importantly, water #372 was found to comprise part of the active site contour that
governs substrate and intermediate conformations in catalysis. This water molecule
probably accounts for the formation of sesquiterpene hydroxylated minor side products,
as previously reported in other mutants of EIZS. While this is not the first EIZS mutant
structure containing discrete electron density for a water molecule in the active site,
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this is the first description of a water molecule acting as a critical part of a terpene
cyclase molecular contour required to generate new products.

7.3.3 Sesquisabinene Synthase (SaSQS1)
The crystal structures of liganded and unliganded wild-type sesquisabinene
synthase isoform 1 from Santalum album were reported recently. Conformational
changes between unliganded and liganded enzyme were observed upon binding of the
bisphosphonate inhibitor ibandronate chrloride. Modeling inside the crystal structures
showed that the active site contour is complementary to the molecular space fill of the
sesquisabinene small molecule, and that the enzyme stabilizes the half-chair
conformation of the homobisabolyl cation intermediate while also hindering
orientations that would lead to cascade derailment products induced by premature
elimination reactions as aforementioned.
These active sites were compared to the active site of F96S EIZS, which also
generated sesquisabinene, and was the original spark for this study. The sesquisabinene
synthase active site contour is noted as being longer and narrower than the ellipsoidal
active site contour of wild-type EIZS, because the acorenyl cation intermediate is more
favored in an ovular, squeezed environment. The F96S EIZS mutation as observed in the
crystal structure (and evidenced by modeling of F96Q and F96M mutants) resulted in an
“L”-shaped cavity that restrains the homobisabolyl cation more effectively, thus
disfavoring the acorenyl cation formation. This led to a mechanism proposal for the
synthesis of sesquisabinene involving the diversion from acorenyl cation formation
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toward sesquisabinene formation. Interestingly, SQS1 and F96S EIZS generate the same
products with remarkable fidelity, their active site contours are different, respectively
long and narrow compared to “L”-shaped as mentioned above. It was speculated that
this is likely due to the pendant isoprenoid tail of the homobisabolyl cation intermediate
merely serving as a spectator to the transannular [3.1.0] cyclization reaction; so,
whether the tail is extended or bent into an “L”-shape is immaterial. It was hypothesized
that as long as an enzyme holds the tail in a position scew from the cationic carbon of
homobisabolyl cation, the facilitation of the spirocenter ring closure leading to the
acorenyl cation would be disfavored.

7.3.4 Cucumene Synthase
The crystal structures of wild-type cucumene synthase and T181N cucumene
synthase from Streptomyces clavuligerus were solved recently and remain the only
solved structures pertaining to this system. For the first time, preliminary understanding
was ascertained regarding how an enzyme might catalyze the cyclization of farnesyl
pyrophosphate to a linear triquinane sesquiterpene. It was previously shown that the
enzyme generated a specific isomer of cucumene, specificly (5S,7S,10R,11S)-cucumene.
The active site contour was reported to be a template for catalysis, as expected, and
docking studies displayed the complementary shape to that of said specific
stereoisomer. Several aromatic residues were shown to be part of the active site cavity
and were speculated to engage in cation-π interactions which stabilize relatively
carbocation intermediates; as aforementioned, the initial C1-C11 cyclization leads to the
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generation of a secondary carbocation intermediate, the humulyl cation, as opposed to
the C1-C10 bond formation which would lead to a tertiary carbocation intermediate.

7.4 Concluding Remarks
It is apparent that the aromatic residues buttressing the active site cavity of a
terpene cyclase enzyme serve dual functionality. They serve the purpose of defining the
active site contour to be complementary in shape to the small natural product of
interest. They also serve to engage in the stabilization of carbocation intermediates
through cation-π interactions. This interesting combination of a complementary
template with electrostatics guides the generation of the natural product, sometimes
through intermediates that would be otherwise unfavorable.
To obtain clues regarding the mechanisms of terpene catalysis beyond that
inherent in studying the template and electrostatic interactions, hybrid modeling can be
an excellent tool. Hybrid modeling applies computational docking software to real
crystallographic terpene synthase coordinates. Through hybrid modeling, the active site
boundaries can be determined and thence defined as a docking target for small
molecules, whether they be substrates, intermediates or products. This allows the
generation of a model to gain insight regarding biocatalysis. Hybrid modeling eliminates
a lot of the guesswork involved with pure homology modeling and serves as a more
trusted source of generating proposed chemical mechanisms.
As aforementioned, all of this work was reported with the hopes that these
structure-function lessons will lead to future engineering experiments aimed at
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developing “designer cyclases” capable of generating new, useful organic products that
span multiple industries.
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Chapter 8: Future Directions and Unpublished Works
8.1 GGGPS
8.1.1 Other complexes needed
It would be useful to have a crystal structure of with substrate, GGPP, bound.
This would be the first of its kind for all GGGPS structures. Currently, the only potential
GGPP binding information is based on modeling studies and how the smaller FSPP
molecule binds in other GGGPS homologous structures. Obtaining a structure with GGPP
would be quite informative.

8.1.2 Assays and biochemical troubleshooting
The enzyme from Thermoplasma volcanium has been tested extensively with
several fluorescence assays, circular dichoism, and ultracentrifugation studies;
measurements have been attempted regarding kinetics, stability, and oligomerization
respectively. The protein does not purify well off size exclusion chromatography, yet
surprisingly, seems to only crystallize when purified from a Ni2+ column at room
temperature. Essentially, it is too impure to perform assays reliably, but the impurity is
conducive to crystallography. This is not unheard of but is quite rare. More
troubleshooting is needed.
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8.2 EIZS
The EIZS system has been explored in detail over the past decade, but there are
still several sub-projects of import.

8.2.1 The F96 residue and double mutants
The F96 residue remains a highly important polar mutagenesis target but
remains the least crystallizable. Initial diffraction on F96T, F96N, and F96H EIZS has been
obtained, but as of now, F96S EIZS is the only published structure of EIZS at the F96
residue position at a resolution high enough to discern chemical information. Moreover,
the F96S structure is unliganded, so there is much to be desired in terms of
crystallography to gain insight into how mutants at this position are generating their
interesting products. Even F96Q and F96M, the structures generating sesquisabinene in
extremely high fidelity, remain elusive. Perhaps, an indirect way of gaining insight into
the chemistry of the F96 mutation is through double mutagenesis. Many double mutant
plasmids with multiple combinations of F95 and F96 in order to test their viability have
been designed. While initial purification of these double mutants was only sometimes
favorable, double mutagenesis in this system would be a fairly straightforward way to
expand this project. Also, exploring F96C would be a great way to test serine versus
cysteine effects on the system. Perhaps F96C, compared to F96S, changes
sesquisabinene generation fidelity.
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8.2.2 Mutating F95 and initial F95S studies
Conceivably, an easier starting point would be mutating the F95 residue, as this
residue crystallizes more readily while still maintaining ease of workup, except for F95E
and F95D residues that were previously reported to express in inclusion bodies. This
likely had more to do with the charged residue mutation than the location of the
mutation, however. Regardless, there are still mutants that have yet to be crystallized at
this position, such as F95S. This mutant has been expressed, purified, and potentially
crystallized (Figures 8.1, 8.2, 8.3).
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Figure 8.1: F95S Epi-isozizaene synthase off HIS column SDS-Page gel showing a large,
overexpressed band corresponding to the molecular weight of EIZS after Co2+ HIS
column.
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Figure 8.2: F95S Epi-isozizaene synthase SEC gel SDS-Page gel showing overexpressed
bands corresponding to the molecular weight of EIZS after SEC column.
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Figure 8.3: F95S Epi-isozizaene synthase potential crystal hits (Top Right) a large, platelike hexagonal crystal bearing concentric hexagons repeating inwardly. This crystal grew
after 3 days in PEG/ION D6 crystal condition. This is theoretically a crystal of the
apoprotein and refracts light quite well. The uniform, subdued birefringence suggests
protein rather than salt. (Bottom Left) A medium sized, 3-dimensional crystal bearing
strong, clear edges. This crystal grew after 1 week in the E2 PEG/Rx crystal condition.
This is theoretically a crystal of the enzyme complexed with pamidronate. The uniform,
subdued birefringence suggests protein rather than salt.
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8.2.3 Second shell mutants
In the past we have focused on the primary shell of the active site, mutating
critical aromatic residues F95, F96, W203, and F198 with a focus on F95 and F96.
However, several secondary shell mutants may be of interest regarding mutagenesis
studies. L67 and Y69, for example, have been briefly studied and generally show a
maintenance of epi-isozizaene production despite moderate mutations. Some
previously unreported mutants also confirm this: L67G EIZS generates 71% epiisozizaene along with 8% unknown and 5% generation of β-funebrene. L67V EIZS
generates 68% epi-isozizaene, along with 4% prezizaene and 1% β-cedrene. L67A was
also prepared but expressed poorly and was not pursued further regarding activity
assays. Y69F and Y69A EIZS product arrays have been reported, but to date, no crystal
structures of L67 or Y69 mutants exist so this could be an avenue to explore. It would be
more prudent, however, to explore polar mutagenesis at these sites. This could turn out
to be a way to tune the effects of a primary shell mutation. Any result of this work
would indeed be interesting.

8.2.4 Variety of complexes needed, inhibitors and metals
BTAC, or benzyltriethylammonium chloride, is the only inhibitor that has been
bound in the EIZS system to study its mechanism of biocatalysis to form epi-isozizaene
or other natural products produced by mutants. A variety of other inhibitors exist for
terpene

cyclase

crystallographic

studies,

including

alendronate,

neridronate,

pamidronate, risendronate, and others. However, BTAC remains the best and only one
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to be successfully complexed with this system. Perhaps this is because it is a partial
lipophilic mimic of the bisabolyl cation. A high-resolution structure of wild-type EIZS that
may have (R)-azabisabolene bound has been obtained, but the density is inconclusive.
Exploring other inhibitor complexes would be useful, but also, other metal
complexes may indeed prove enlightening. Interestingly, Hg2+ has been bound in this
system, but no other divalent metal experiments have been successful, except for the
usual suspect, Mg2+. Screening wild-type EIZS with a battery of other metals was tried,
including Ni2+, Co2+, Mn2+, etc., but to no avail. Often this readily produced salts rather
than enzyme complexes. Metal chelation studies were performed, starting with the
crystallization of wild-type using readily available protocols from the 2010 paper,
followed by the use of EDTA or DOTA to chelate the metal ions, and ending with soaking
of the metal-less crystal with new metals of interest. This was tried on multiple
timescales.
These sub-projects would be interesting if successfully optimized to better
understand this system for the purposes of bioengineering.

8.2.5 Advanced modeling methods needed
Right now, as shown most recently in the 2019 paper on F95Q EIZS, it is possible
to model in an intermediate and final product in this system to gain insight as to the
mechanism of catalysis. However, a predictive method correlating the active site
contours to the final organic products would be much more useful. Predicting the
generation of natural products from a designed, theoretical structure of EIZS was be of
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high impact. Controlling this system would be an amazing piece of bioengineering and
would be much more interesting than using 23c-trick or another method of designed
evolution via mass mutagenesis.

8.2.6 Concluding remarks
It is still unknown why the aliphatic EIZS mutants crystallize more readily in wildtype crystallization condition than the polar mutants, which generally crystallize in
completely different conditions. Crystallography foundations indicate that mutating the
active site would not profoundly affect the crystallization condition, since crystallization
is largely reliant on surface residues. However, active site polar mutagenesis clearly
changes the energetics of this system. Rarely the polar mutants do crystallize in the
wild-type condition, but more often they require extensive screening and optimization,
as well as microseeding to nucleate.
Given the robust nature of this system overall, pertaining mostly to the simple
purification and expression protocols, and its tolerance toward the introduction of polar
residues, EIZS is a phenomenal learning system for new graduate students. However, it
is also an exceptional system for more advanced graduate students and post-doctoral
candidates to test new techniques or combine molecular modeling with protein
engineering. The wide variety of engineered products through EIZS mutagenesis over
the years regularly sparks new comparison study projects. For example, with
sesquisabinene synthase, initial exploration into this system was sparked by the reengineering of EIZS to generate sesquisabinene.
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8.3 SaSQS1
Sesquisabinene synthase was originally explored after discovering that several
EIZS mutants generate sesquisabinene, as mentioned above. There are several avenues
that can be taken to expand on this project, the results of which would be enlightening
and further the understanding of this intricate bicyclic strained ring generation.

8.3.1 Unreported details
There are some unreported details in the 2019 SaSQS1 paper that may be useful
to anyone picking up this project. The unliganded wild-type enzyme, isoform 1, was
originally crystallized at 2.9 Angstrom resolution. This result was decent and used to
show that SaSQS1 superimposes nicely with similar enzymes (Figure 8.4). The liganded
enzyme crystallized readily, right from the screen, in 0.2M KCl and 20% w/v PEG 3350.
The unliganded enzyme, however, required a variety of crystallization optimization to
yield higher resolution crystals (Figure 8.5).
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Low Resolution SASQS1
Bornyl diphosphate synthase
5-epi-aristolochene synthase
Isoprene synthase
Limonene synthase

Figure 8.4: Low resolution SaSQS1 structure superpositions The low resolution
structure of SaSQS1 was solved and superimposed with similar enzymes.
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Figure 8.5: Optimization of SaSQS1 crystallization (a and b) Two crystallization hits from
similar conditions both containing 0.1M MES monohydrate pH 6.0. However, a
additionally contains 20% w/v PEG monomethyl ether 2000, while b also contains 25%
w/v PEG 4000. Even though these are still PEG types, they are quite different, which is
interesting. Simply switching the PEG yielded bigger crystals. Additionally, b also
contains 6% Tacsimate pH=6.0, which may have played a role. (c) Even larger, cleaner
crystals were obtained with ratio screening, which increased the ratio to 3:3
[protein:precipitant]. These resulted in higher resolution data. (d and e) The best looking
crystals were obtained after optimizing the Tacsimate portion of the crystallization
condition to 6.5% and pH=7.0 instead of 6% and pH=6.0 previously. Despite
appearances, these better-looking crystals diffracted the same.
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8.3.2 Derivative ideas
Sabinene synthase generates the monoterpenoid version of sesquisabinene, and
a comparison study showing similarities and differences between sesquisabinene
synthase and sabinene synthase would indeed be interesting. Perhaps their active sites
are almost the same, with sesquisabinene synthase containing a relatively elongated
cavity. Or, it is possible sabinene synthase has a different active site cavity altogether. A
grand comparison of these two enzymes with F96S EIZS would indeed be interesting.
Soaking the small molecule sabinene into the sesquiterpene synthase SaSQS1
was attempted but was unsuccessful. While this would not exactly depict what is
happening in nature, it could be indicative as to how sesquisabinene is bound prior to
release from the active site, complementing the published modeling studies.
It would be interesting to reverse-engineer sesquisabinene synthase, through
mutagenesis, to generate epi-isozizaene. This would be the first ‘full-circle’ engineering
project regarding terpene cyclase systems.
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8.4 Cucumene synthase
Cucumene synthase performs perhaps the most complicated chemistry of all of
the sesquiterpene cyclases, and is relatively understudied in the literature, despite it
having the highest chance for impact. The small molecule natural product is a derivative
of capnellane, which is a triquinane with activity against renal cancer and and leukemia
cell lines, as aforementioned. Also, the linear triquinane architecture is coveted
structure for organic chemists, and many steps could be skipped if pure cucumene could
be biologically synthesized readily. Further studies into the mechanism of biocatalysis
could yield ways to tune the enzyme pocket for even more efficient velocity or perhaps
to reengineer the activity to other quinane derivatives of alternative usefulness.

8.4.1 Inhibitor complexes and S183C
Wild-type cucumene synthase and T181N cucumene synthase were crystallized,
but these structures were unliganded. It would further the field if liganded complexed
were obtained. Even if the structures complexed with substrate or intermediates were
not solved, hybrid modeling as described in this dissertation would be an excellent tool
to gain mechanistic insight. Currently, the only clues of how the final product rests in the
active site are reported in manual docking studies.
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8.5 EZBS
Epi-zingiberene synthase is an interesting enzyme that generates a
sesquiterpenoid that is involved in a variety of industries. The Christianson lab has
several plasmids from collaborators at Cardiff, which are stored and ready to be used for
the purpose of continuing this project.

8.5.1 Purification troubleshooting
Enzyme purification has been attempted many times but has yielded mixed
results, the best shown in Figure 8.6. The enzyme preparation was difficult, involving a
basic extraction protocol to pull out inclusion bodies from the insoluble fractions after
centrifugation, and was difficult to reproduce. Tween and other detergents were tried,
but to no avail. Many alternative columns were tried, such as anion exchange. The
enzyme simply did not behave well, even in a variety of salt concentrations, often
crashing out despite being prepped exclusively in cold temperatures. A variety of tags
were also tried, but these also did not work. More troubleshooting is necessary.
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Figure 8.6: Best EZBS gel run after basic extraction protocol. Large molecular weight
bands resulting from the basic extraction protocol. The gel is fairly clean after a Ni2+
column. While there is a lot in the flow through, there is clearly an overexpressed band
present in the elution peaks as well. This seemingly positive result was never
reproduced, however, by multiple graduate students and post docs.
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8.6 (E)-(γ)-bisabolene synthase
After reporting on F95Q EIZS and its generation of biofuel precursors in the form
of curucmene isomers, (E)-(γ)-bisabolene synthase (PmeTPS3) was explored. Similar
enzymes have already been solved and reported on in the PDB, but the structure of this
particular enzyme generating this particular isomer has never been published. The
enzyme expresses and purifies decently, and its presence was confirmed through gel
extraction LC-MSMS analysis. Initial gels and chromatograms still stand to be optimized,
but this is certainly an interesting project that could be picked up readily, and plasmid is
frozen and ready for the next eager graduate student.
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APPENDIX
A.1 EIZS 2017 Supplemental Information
Mutation
F95N
F95Y
F95Q
F95C
F96S
F96T
F96H
F96N
F96M
F96Q
Y69F
Y69A
W203Y
W203H

F/R*
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

5’ to 3’ sequence
GAT AGC GGA CTA CAG CGC GTG GAA TTT TGT CTG GGA CGA CCG TCA C
GTG ACG GTC GTC CCA GAC AAA ATT CCA CGC GCT GTA GTC CGC TAT C
GAC TAC AGC GCG TGG TAC TTC GTC TGG G
CCC AGA CGA AGT ACC ACG CGC TGT AGT C
GAT AGC GGA CTA CAG CGC GTG GCA ATT TGT CTG GGA CGA CCG TCA C
GTG ACG GTC GTC CCA GAC AAA TTG CCA CGC GCT GTA GTC CGC TAT C
GAT ACG GGA CTA CAG GCG GTG GTG TTT TGT CTG GGA CGA CCG TCA C
GTG ACG GTC GTC CCA GAC AAA ACA CCA CGC GCT GTA GTC CGC TAT C
GAC TAC AGC GCG TGG TTC TCT GTC TGG GAC GAC CGT CAC
GTG ACG GTC GTC CCA GAC AGA GAA CCA CGC GCT GTA GTC
GAC TAC AGC GCG TGG TTC ACT GTC TGG GAC GAC CGT CAC
GTG ACG GTC GTC CCA GAC AGT GAA CCA CGC GCT GTA GTC
GAC TAC AGC GCG TGG TTC CAT GTC TGG GAC GAC CGT CAC
GTG ACG GTC GTC CCA GAC ATG GAA CCA CGC GCT GTA GTC
GAC TAC AGC GCG TGG TTC AAC GTC TGG GAC GAC
GTC GTC CCA GAC GTT GAA CCA CGC GCT GTA GTC
GAC TAC AGC GCG TGG TTC ATG GTC TGG GAC GAC
GTC GTC CCA GAC CAT GAA CCA CGC GCT GTA GTC
GAC TAC AGC GCG TGG TTC CAG GTC TGG GAC GAC
GTC GTC CCA GAC CTG GAA CCA CGC GCT GTA GTC
GCC GAC GGT CTG TGC TTT ACG GAC CTC ATG GCG
CGC CAT GAG GTC CGT AAA GCA CAG ACC GTC GGC
GAA TAT GCC GAC GGT CTG TGC GCT ACG GAC CTC ATG GCG
CGC CAT GAG GTC CGT AGC GCA CAG ACC GTC GGC ATA TTC
C GCG CAC TGG ATC TAC ACC GAC CTG CTG
CAG CAG GTC GGT GTA GAT CCA GTG CGC G
GTT CGC GCA CTG GAT CCA TAC CGA CCT GCT GG
CCA GCA GGT CGG TAT GGA TCC AGT GCG CGA AC

*F, forward; R, reverse

Table A.1: Primers used for construction of EIZS mutants.
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A.2 SaSQS1 Supplemental Information
A.2.1 Methods
A.2.1.1 Expression and Purification of SQS1. A gene encoding full-length SQS1
(residues 1-566) was synthesized by Biomatik (Wilmington, DE) using codon
optimization for expression in Escherichia coli. The gene was cloned into the pHIS
parallel expression vector1 using the 5’ BamHI site and the 3’ XhoI site through standard
molecular biology techniques. DNA sequencing was used to confirm the correct
insertion and orientation of the gene within the vector. PCR amplification was achieved
using forward primer 5’-AAAGGATCCGATGGATCTGTGCCAGA-3’ and reverse primer 5’AAACTCGAGTTATTCTTCATCCAGGGTAATCGG-3’ and product purity assessed by agarose
gel. The resulting plasmid was transformed into BL21(DE3) E. coli for expression.
For expression, 2 μL of plasmid DNA was added to a 50-μL aliquot of BL21(DE3)
E. coli stored on ice and allowed to sit for 25 min. Cells were then heat-shocked at 42 °C
for 45 s, after which they were put back on ice for 2 min. Lysogeny Broth (LB) media
(100 μL) was pipetted into the mixture and incubated with shaking at 250 rpm for 1 h at
37 °C. After incubation, the mixture was applied to a pre-warmed LB agar plate and
incubated overnight for 14 h at 37 °C. The plate was stored at 4 °C.
Colonies that were uniform in shape with clean, defined edges were extracted
via 1-μL pipette tip suction and deposited into 6 individual Falcon tubes, each containing
5 mL of sterile LB media and 5 μL of 100 mg/mL Ampicillin. The 6 mixtures were grown
overnight for 13 h with shaking at 250 rpm at 37 °C. The resultant overnight cultures
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were then used to inoculate 6 x 1.0-L flasks containing sterilized LB media and 1 mL of
100 mg/mL Ampicillin. Flasks were shaken at 250 rpm for 3 h at 37 °C until the optical
density at 600 nm (OD600) reached 0.8, after which flasks were equilibrated for 45 min
without shaking at 16 °C. The cell mixture in each flask was then induced with 1.0 M
IPTG (500 μL). Flasks were shaken for 20 h at 250 rpm and then centrifuged at 11700g
for 12 min at 4 °C. The resultant cell pellets were combined and stored at -80 °C.
Pellets were thawed and resuspended in Buffer A [50 mM Na2PO4 (pH = 7.7), 300
mM NaCl, 10 mM β-mercaptoethanol (BME), 20% v/v glycerol] by vortexing for 30 s on30 s off (3 times) and chilled on ice. Protease inhibitor cocktail tablets (Roche) were
added at a ratio of 1 tablet per 30 mL of cell suspension after 1 round of vortexing. The
crude cell resuspension was transferred to a stainless steel beaker on ice and sonicated
using a Q700 (Qsonica) with amplitude set at 30% for 10 min, cycling between 1 s on
and 1 s off. Crude cell lysate was clarified by centrifugation at 41000g for 1 h at 4 °C.
Supernatant was collected carefully so as to exclude cell debris, and then applied to a
5mL HisTrapTM HP column (GE Healthcare). The column was washed with 10% Buffer B
[25 mM Na2PO4 (pH = 7.6), 300 mM NaCl, 5 mM BME, 200 mM imidazole, 20% v/v
glycerol] to remove contaminants with weak Ni2+ affinity. The SQS1 protein was eluted
at 100% Buffer B at 4 °C, concentrated to 5 mL, filtered, and then applied to a HiLoadTM
SuperdexTM 26/600 200 pg column (GE Healthcare). The buffer was exchanged on
column with size-exclusion chromatography buffer [50 mM Tris (pH=7.5), 300 mM NaCl,
10 mM MgCl2, 5 mM β-mercaptoethanol (BME), 10% v/v glycerol], concentrated to 11.4
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mg/mL, and stored at -80 °C in 600 μL aliquots. The final protein construct consisted of
residues 1-566 of SQS1 plus a 6-residue N-terminal His tag that is cleavable by TEV
protease.
A.2.1.2 Crystallization and Structure Determination of unliganded SQS1.
Crystallization of unliganded SQS1 was achieved in sitting drops consisting of 1 μL
protein solution [5 mg/mL SQS1, 50 mM Tris (pH=7.5), 300 mM NaCl, 10 mM MgCl2, 5
mM BME, 2 mM benzyltriethylammonium chloride (BTAC), 2 mM sodium
pyrophosphate, 10% v/v glycerol] and 2 μL of precipitant solution [6% (v/v) Tacsimate,
0.1 M MES monohydrate (pH = 6.0), 25% (w/v) polyethylene glycol 4000] and
equilibrated with a reservoir of 300 μL precipitant solution at 21 °C. Crystals appeared in
14 days and were harvested and cryoprotected in 25% (v/v) glycerol prior to flashcooling in liquid nitrogen.
Crystals diffracted X-rays to 1.9 Å resolution at the Advanced Photon Source
(APS), Northeastern Collaborative Access Team (NE-CAT) beamline 24-ID-E. Crystals
belonged to space group I212121 with the following unit cell parameters: a = 63.42 Å, b =
85.84 Å, c = 220.31 Å (one molecule in the asymmetric unit). The X-ray diffraction
dataset was indexed and integrated using iMOSFLM.2 Scaling was performed using
AIMLESS.3 Phasing was initiated using the atomic coordinates of (+)-limonene synthase
from Citrus sinensis (PDB code: 5UV0)4 as a search model for molecular replacement
calculations with PHASER.5 The model of SQS1 was built, refined, and validated using
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COOT, PHENIX, and MOLPROBITY, respectively.6-8 Data collection and refinement
statistics are recorded in Table A.2.
A.2.1.3 Crystallization and Structure Determination of liganded SQS Complex.
Crystallization of SQS1 in the closed active site conformation, complexed with Mg2+3 and
ibandronate, was achieved in sitting drops consisting of 600 nL protein solution [5
mg/mL SQS1, 50 mM Tris (pH=7.5), 300 mM NaCl, 10 mM MgCl2, 5 mM BME, 2.0 mM
ibandronate chloride, 10% v/v glycerol] and 600 nL of precipitant solution [0.2 M KCl,
20% w/v polyethylene glycol 3350 and equilibrated with a reservoir of 100 mL
precipitant solution at 21 °C. Crystals appeared in 20 days and were harvested and
cryoprotected in 25% (v/v) ethylene glycol prior to flash-cooling in liquid nitrogen.
Crystals diffracted X-rays to 2.1 Å resolution at the Stanford Synchrotron
Radiation Lightsource (SSRL), beamline 9-2. Crystals belonged to space group C2 with
unit cell parameters a = 181.55 Å, b = 58.69 Å, c = 53.59 Å, β = 93.10° (one molecule in
the asymmetric unit). The X-ray diffraction dataset was indexed and integrated using
iMOSFLM,2 and scaling was performed using AIMLESS.3 Phasing was achieved using the
atomic coordinates of unliganded SQS1 as a search model in PHASER.5 The model of the
enzyme-inhibitor complex was built, refined, and validated using COOT, PHENIX, and
MOLPROBITY respectively.6-8 Data collection and refinement statistics are recorded in
Table A.2. All figures were generated with Pymol.9
A.2.1.4 Molecular modeling. The small molecules epi-isozizaene and
sesquisabinene were drawn in a structure editor and converted to a SMILES format
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string. This string was input into the SMILES Translator and Structure File Generator
(National Cancer Institute, https://cactus.nci.nih.gov/translate/), which output the file in
.pdb format. The resultant .pdb file was double checked and optimized for proper
spatial geometry using Phenix,7 before being opened in Pymol9 along with the atomic
coordinates of EIZS and SQS1. To visualize the active site contour, a mesh was first
generated using the DoGSiteScorer (http://dogsite.zbh.uni-hamburg.de). This program
detects all pockets within the protein using a Difference of Gaussian method to
generate a drug score for each pocket.10,11 The resulting mesh pockets with the highest
scores corresponded to the active sites of each enzyme. Each mesh was imported into
Pymol and used to guide the generation of the active site contour with the surface
cavity function in Pymol (probe radius = 1.6 Å). The surface cavity function was
complemented by the NRGsuite subroutine implemented in Pymol,12 which was used to
delineate the surface adjacent to the Mg2+3-bound pyrophosphate anion in the active
site of EIZS and the Mg2+3-bound bisphosphonate pyrophosphate mimic in the active site
of SQS1. The enclosed volumes of the resultant active site contours were then
measured in Å3. Conformations of epi-isozizaene, sesquisabinene, and the
homobisabolyl cation were selected using the FlexAid function in NRGsuite and
manually docked into active site clefts.
Models of F96M, F96Q, F96S, and F96N EIZS mutants were generated in Coot6
using the simple mutate function with the closed conformation of wild-type EIZS as a
starting point (PDB 3KB9).13 Chemically reasonable side chain rotamers were chosen for
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each mutant that appeared to accommodate stabilizing interactions. The side chain
rotamer of M96 was chosen to optimize interactions with the spatially adjacent side
chain of Y69, in view of the strong geometric preference for S–π interactions at
approximately 5 Å and 45˚ away from the ring normal.14 The side chain rotamer of Q96
was chosen to optimize a hydrogen bond interaction with R338. The side chain rotamer
of S96 was chosen to optimize hydrogen bond interactions with R338, Y69, and water
452. Furthermore, this S96 rotamer is consistent with one of the S96 rotamers observed
in the crystal structure of unliganded F96S EIZS (PDB 6AXO). Finally, the side chain
rotamer of N96 was chosen to optimize hydrogen bonds with R338 and Y69.
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Figure A.1: (a) Stereoview of the enclosed active site contour in a model of the F96M
epi-isizizaene synthase-Mg2+3-PPi complex based on the structure of the epi-isozizaene
synthase-Mg2+3-PPi-BTAC complex, omitting the atomic coordinates of BTAC and instead
fit with a model of product sesquisabinene. (b) Stereoview of the enclosed active site
contour in a model of the F96Q epi-isozizaene synthase-Mg2+3-PPi complex based on the
structure of the epi-isozizaene synthase-Mg2+3-PPi-BTAC complex, omitting the atomic
coordinates of BTAC and instead fit with a model of product sesquisabinene.
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SQS1
Synchrotron
Beamline
Detector
Wavelength (Å)
Space group
a, b, c (Å)
a, b, g (°)
Resolution (Å)a
Total/unique no. of reflections
Rmergea,b
Rp.i.m.a,c
CC1/2a,d
I/s(I)a
Redundancya
Completeness (%)a
Rworka,e
Rfreea,e
No. of non-hydrogen atoms:
protein
water
other
Average B-factors (Å2)
macromolecules
water
other
Rms deviations from ideal
geometry
bonds (Å)
angles (°)
Ramachandran plot (%)f
favored
allowed
outliers
Rotamer outliers (%)
Clashscore
Cb outliers (%)

Liganded

Unliganded

SSRL
9-2
PILATUS 6M
0.979
C2
181.55, 58.69, 53.59
90.00, 93.10, 90.00
55.84-2.10 (2.16-2.10)
102065/31346
(7447/2469)
0.087 (0.770)
0.057 (0.524)
0.997 (0.715)
6.2 (1.3)
3.3 (3.0)
95.1 (91.8)
0.221 (0.352)
0.246 (0.404)

APS
24-ID-E
EIGER 16M
0.979
I212121
63.42, 85.84, 220.31
90.00, 90.00, 90.00
60.95-1.90 (1.94-1.90)
523533/47868
(33854/3065)
0.075 (1.460)
0.023 (0.457)
0.999 (0.580)
15.2 (1.8)
10.9 (11.0)
100.0 (100.0)
0.192 (0.321)
0.232 (0.376)

4044
190
46

4125
295
20

43
41
44

43
47
52

0.003
0.6

0.005
1.2

97.20
2.80
0.00
0.24
5.75
0

96.65
3.15
0.20
0.23
4.16
0

Table A.2: Data collection and refinement statistics for SQS aValues in

parentheses correspond to data in highest resolution shell. bRmerge = ∑hkl∑i|Ii,hkl − ⟨I⟩hkl|/∑hkl∑i Ii,hkl;
⟨I⟩hkl = mean intensity of Ihkl calculated from replicate measurements. Note that Rmerge can
sometimes be inordinately high for highly redundant data sets. cRp.i.m.= (∑hkl(1/(N-1))1/2∑i|Ii,hkl −
⟨I⟩hkl|)/∑hkl∑i Ii,hkl; ⟨I⟩hkl = mean intensity of Ihkl calculated from replicate measurements, N =
number of reflections. dPearson correlation coefficient between random half-datasets. eRwork =
∑||Fo| − |Fc||/∑|Fo| for reflections contained in the working set. |Fo| = observed structure
factor amplitude, |Fc| = calculated structure factor amplitude. Rfree is calculated in the same
manner using test set reflections held aside during refinement. fCalculated with MolProbity.
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